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Abstract 
 
Calcific aortic valvular disease (CAVD) is the most common valvular pathology in the developed 
world. CAVD results in calcifications forming on the aortic valve leaflets, inhibiting proper closure 
and causing complications of stenosis and regurgitation. Although, the mechanisms behind the 
disease initiation are unknown, it is believed to be a cell-mediated phenomenon, and not the result 
of passive degradation of the valve as once believed due to the increased prevalence with age. 
Currently, there are no pharmaceutical options for the prevention or reversal of calcifications, the 
only treatment option is complete valve replacement, an imperfect solution. Hindering the 
development of potential therapeutics is that currently there are no adequate animal models which 
replicate the calcification and cell death seen in disease explanted valves. 
 An in vitro model has been develop where valvular interstitial cells (VICs), the main cell type of the 
valve, are seeded at high density into tissue culture polystyrene dishes and cultured with TGF-β1. 
This results in VICs activating to the myofibroblast phenotype and forming cell aggregates. Due to 
currently unknown mechanisms, apoptosis occurs within the center of the aggregates and 
calcification ensues. Although simplistic, this model has been used to show that rate and frequency 
of aggregation is affected by cellular tension; conditions of high tension increase aggregation 
response, while conditions of low tension prevent aggregation and calcification from occurring. It is 
important to note; however, that despite its wide usage, the current model is limited as the 
aggregation and subsequent calcification are random occurrences and are not consistent across 
literature where same conditions for control samples are used. 
The motivation of the presented work is two-fold. First, high intracellular tension has been 
suggested as one of the mechanisms leading to disease in the valve. Despite the clear and important 
Abstract 
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role of cell tension, VIC tension has never before been measured in a dynamic environment. The 
ways in which dynamic stimulation affects individual VIC tension is not known. In aim one, a method 
is developed to allow for long-term cyclic stretch of VICs with measurement of cell traction force. It 
was found that cyclic stretch decreased cell tension in cells with high prestress and increased cell 
tension for conditions of low prestress. Combined, these findings indicate a homeostatic cellular 
tension which is dependent upon the mechanical environment.  
In the second aim, a novel method for creating VIC aggregates is validated. Micro-contact printing, 
essentially “stamping” of a protein in a defined pattern, is used to create circular aggregates on 
polyacrylamide gels. This method allows for the separation of the aggregation from the subsequent 
calcification, an improvement over the current in vitro model. The method is then used to explore 
the role of the distribution of tension in the initiation of disease 
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Chapter 1: Introduction 
 
Calcific aortic valve disease (CAVD) is the most prevalent valvular disorder in the United States [1]. 
Currently, 2.8% of the population over 65 is believed to be affected by the disease [2]; the 
prevalence increases to 9.8% in octogenarians [3]. There are no medicinal or pharmaceutical 
interventions which can be prescribed to slow, halt, or reverse the progression of disease. The only 
remedy is a complete valve replacement surgery [4]. Due to the high risk and associated 
complications, valve replacement surgery is usually reserved for patients with late-stages of disease 
(see section 2.1.1 for details) [3]. Patients experience decreased quality of life until the disease 
progresses to the point that they are symptomatic and eligible for valve replacement [3]. The 
medical cost associated with such surgeries is a huge economic burden, estimated in the billions [5], 
and is expected to increase as the population ages. 
CAVD results in calcific lesions forming on the valve leaflets. These calcifications inhibit normal 
function of the valve, resulting in stenosis and regurgitation [6]. There are two types of calcification 
that have been identified in explanted valves: dystrophic and osteogenic, present in 82% and 13% of 
diseased valves, respectively [7]. As defined, dystrophic calcification is calcification that occurs along 
with cell death [8], while osteogenic calcification is defined as calcifications created by bone-forming 
cells (osteoblasts) and is structurally similar to hydroxyapatite[9]. CAVD typically affects older 
patients, and for many years it was believed to be the result of degenerating valve cusp matrix. 
However, in recent decades, the study of valvular cells in vitro has given rise to the hypothesis that 
calcification may be cell-mediated, giving hope that future development of medicinal treatments is 
achievable [4]. 
Introduction 
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CAVD is challenging to study as currently there are no acceptable animal models [10]. Additionally, 
examination of calcified pathological valves only reveals one time-point of the disease [7, 11] 
making it impossible to study the initiating factors and disorder progression. An in vitro model has 
been developed which replicates the dystrophic calcification seen in vivo [12]. The in vitro model of 
CAVD is created by seeding valvular interstitial cells (VICs), which are the main cell type in the aortic 
valve [13], onto tissue culture treated polystyrene dishes at high density in the presence of TGF-β1 
[12, 14]. The VICs “activate” from a fibroblast-like phenotype found in a healthy valve to 
myofibroblasts [13], which are a highly contractile and synthetic cell type characterized by the 
presence of alpha-smooth muscle actin (α-SMA) [15]. After approximately one week in culture, VICs 
aggregate together. VICs within the center of the aggregate undergo apoptosis, and calcification 
ensues. Although two-dimensional and relatively simplistic, this model has revealed a number of 
important factors which affect rates of VIC aggregate formation and subsequent calcification 
including the following: type of ligand coating [9], substrate stiffness [16], presence of stretch [17], 
Rho-pathway activity [18] as well as in vitro assessment of the efficacy of statins [19, 20] - a 
potential medicinal treatment for CAVD. However, the mechanisms behind the cell death within the 
center of the aggregate remains incompletely understood. 
Despite the wide usage of the in vitro model to study CAVD, it does have certain limitations. It 
requires the aggregation to occur in order to initiate apoptosis and calcification. However, this 
approach is inefficient since the aggregation process is random, resulting in unpredictable aggregate 
formation. Aggregates for controls in vitro (on TCPS) have been reported by the same author in 
different manuscripts to range from 9-90 aggregates per sample [9, 18]. Further, aggregate size is 
not controlled; a range of sizes has been reported in the literature [9, 18].  Additionally, TCPS (E = 1 
GPa) is not representative of the stiffness of the native heart valve, which has been reported as 4-20 
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kPa [21, 22], depending upon method of mechanical testing. Finally, calcifications take 
approximately one week or longer to form, making the in vitro studies slow and laborious. 
High intracellular tension has been suggested as one of the mechanisms leading to disease in the 
valve. However, VIC tension has never before been measured in a dynamic environment. The ways 
in which dynamic stimulation affects individual VIC tension is not known. Although studies with VICs 
suggest that stretch regulates α-SMA expression [23] and collagen production [24], two measures of 
myofibroblast activity, these studies were done on VICs in high-density culture. Expression of α-SMA 
has previously been shown to be dependent upon cell density [25]; additionally, cyclic stretch on 
other types of fibroblasts has shown to prevent activation of the contractile myofibroblast 
phenotype [26]. More research is needed to determine how individual VIC tension is affected by 
cyclic stretch. 
The motivation for this project is two-fold and arises from the need to study the following aspects of 
VIC behavior: 1) VIC traction force of cells undergoing dynamic stimulation, and 2) understanding of 
the differential behavior of VICs within the central aggregate region in contrast to that of cells along 
the aggregate periphery. Two aims have been established to explore these research areas. In the 
first aim, a method for measuring the cell traction force of isolated VICs undergoing 24-hour cyclic 
stretch at physiologically relevant strain magnitudes was developed and validated. In the second 
aim, a high-content in vitro model for calcific aortic valve disease is validated. This novel in vitro 
system can be employed to study apoptosis and calcification within the center of the VIC aggregates 
and potentially be used to test effectiveness of promising pharmaceuticals that could be used to 
treat CAVD.  
The first aim, as detailed in Chapter 3, a method is developed for applying physiologically relevant 
cyclic stretch to VICs cultured on tunable modulus substrates which enables cell traction force 
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measurements. We then compare VIC traction force with stretch to control, statically cultured cells. 
By varying the pre-stress conditions, defined in the literature as the initial tension state of the cell, 
we can understand how the traction force response with stretch depends upon the initial cell 
tension state. This is important as stiffness and stretch have been shown to regulate many aspects 
of cell behavior including migration [27], spreading [28, 29], reorientation [30], proliferation [31], 
differentiation [32], and apoptosis [33, 34]. 
Chapter 4 addresses the need for a more repeatable and reliable method for studying cell apoptosis 
within VIC aggregates. By using micro-contact printing of bovine type-I collagen on polyacrylamide 
gels in defined shapes, we can remove the aggregation step of the in vitro model and focus solely on 
the apoptosis and subsequent calcification. Currently, the in vitro model relies on aggregate 
formation to study the subsequent apoptosis and calcification, a random process that does not have 
a repeatable time-course. In order to effectively investigate mechanisms of cell death, a more 
repeatable and concise method for aggregate generation is needed.  Micro-contact printing enables 
investigation of factors affecting apoptosis and calcification, such as TGF-β1, which is required in 
most in vitro cultures to induce VIC aggregation. The utility of this method is demonstrated with 
studies that vary both the stiffness of hydrogels and the size of aggregates, as well as with and with-
out TGF-β1. 
Chapter 5 investigates the mechanisms behind apoptosis and calcification within the central portion 
of the aggregate. We hypothesize that the cells in the center of the aggregate undergo apoptosis 
due to a decrease in cell tension. Previously, tension distribution levels have been correlated with 
proliferation in micro-contact printed endothelial cells. However, it is currently unknown how 
apoptotic behavior is regulated on the macroscale with geometric control of aggregate shape. 
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Chapter 6 discusses study limitations, future directions and clinical significance of the work 
presented herein. Knowledge of cellular mechanisms initiating apoptosis and calcification within the 
central portion of the aggregate is essential for the development of pharmaceutical treatments that 
would allow patients to avoid risky valve replacement surgery and would reduce the economic 
burden of the disease. Chapter 7 summarizes thesis conclusions. 
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Chapter 2: Background 
Calcific aortic valvular disease (CAVD) is the third most prevalent cardiac disease in the United 
States. It affects 2.8% of the population over the age of 65 [2], or about 81 million Americans; The 
prevalence of CAVD increases to 9.8% in octogenarians [3]. Although mortality does not increase 
when aortic stenosis is asymptomatic, the risk of death is more than 50% at two years for patients 
with symptomatic diseases unless aortic-valve replacement is preformed promptly. A total of 65,000 
aortic-valve replacements were performed in the United States in 2010, the majority of which were 
necessitated by aortic stenosis; 70% of these procedures were done in patients greater than 65 
years of age, which contributes to the high cost of health care. 
CAVD results in sclerosis and calcification of the valve tissue, which inhibit normal function, causing 
complications such as  valve stenosis (improper valve opening) and regurgitation (retrograde blood 
flow from the aorta to the left ventricle) [6]. In patients with CAVD, risk of another cardiovascular 
complication increases by 50%. Importantly, patients with CAVD are at risk of left ventricular 
hypertrophy and heart failure. In patients that present with symptomatic CAVD, death can occur 
within two years if medical intervention is not taken. Although previously thought to be a 
degenerative condition, studies with valvular interstitial cells have shown that they are capable of 
creating calcifications in vitro, suggesting that CAVD might be a cell-mediated disease. This finding 
gives hope that pharmaceutical interventions could be developed to halt, slow, or reverse the 
progression of CAVD.  
Examination of explanted calcified valves shows multiple mechanisms of cell mediated calcification. 
Currently, there appears to be two types of cell-mediated calcification: dystrophic (83% of explanted 
valves) and ossific (13% of explanted valves) [7]. Dystrophic calcification is identified by 
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myofibroblast cell aggregates with an apoptotic core that is co-localized with calcifications with poor 
crystalline structure [8]. On the contrary, ossific calcifications are highly structured analogous to   
hydroxyapatite found in bone. 
In this background chapter, normal heart valve function and biology will be discussed, as well as the 
medical management of CAVD. Theories of pathophysiology of CAVD will be introduced and in vitro 
models of CAVD highlighted. Culture factors which increase aggregation in vitro will be noted, as 
well as the mechanoregulation of apoptosis and its relevance to in vitro models of CAVD. As 
dystrophic calcification is believed to be caused by the cellular activation to a highly contractile 
myofibroblastic state, methods of measuring cellular tension and stiffness will be discussed. Since 
the valve is a dynamic environment, studies that combine measurement of cell tension and stretch 
will be recounted. Finally, I will review measurement metrics used 
2.1 Calcific Aortic Valve Disease Overview 
 
2.1.1 Risk of Aortic Stenosis 
Anatomical, genetic, and clinical factors all contribute to the pathogenesis of aortic stenosis. 
Although aortic stenosis occurs in many patients with a normal tricuspid valve, 60% of patients 
presenting aortic stenosis have a bicuspid valve. Rheumatic heart disease can also cause aortic 
stenosis in association with mitral-valve disease. However, rheumatic fever is rare in the United 
States and conditions of rheumatic heart disease are mostly located in developing nations, where 
improvements in streptococcal throat infection treatments are needed [1]. 
Several genetic mutations appear to be associated with CAVD. These include abnormalities in the 
NOTCH1 protein [35] (a transmembrane receptor associated with many signaling pathways) and a 
specific lipoprotein(a) polymorphism, which has been shown to be associated with elevated serum 
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levels of lipoprotein(a) and aortic valve calcification [36]. Risk of aortic stenosis increases in 
populations that are older, male sex, have elevated serum levels of low-density lipoprotein 
cholesterol and lipoprotein(a), hypertension, smoking, diabetes, and metabolic syndrome [37]. 
2.1.2 Progression of Disease 
 CAVD is a spectrum disorder. The disease starts initially with leaflet changes, which progresses from 
early calcification lesions to valve obstruction, and then eventually becomes severe with or without 
clinical symptoms. Figure 2.1a shows a representative image of a healthy aortic valve. Figure 2.2b 
shows a calcified valve undergoing replacement; notice the calcified nodules which inhibit normal 
valve function as well as the thickened leaflets. The severity of aortic stenosis is grouped into 7 
stages (A, B, C1, C2, D1, D2, and D3) which are distinguished between one another by 
hemodynamics, symptoms, and left ventricular response to pressure overload [3]. A summary of the 
different stages of disease, outcome, and disease management are shown in table 2.1. 
 
Figure 2.1: Representative images of a healthy valve (a) and a calcified valve undergoing 
replacement (b). Notice how the healthy valve is very thin and the three leaflets nicely cohere 
enabling the efficient pumping capacity of the heart. When diseased, valve leaflets are thickened 
(termed sclerosis) and do not nicely cohere, resulting in regurgitation and decreased cardiac output 
adapted from https://science.nichd.nih.gov/confluence/display/~michael.hoaglin/Aortic+Valve and 
www.usccardiology.org respectively. 
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Table 2.1 Classification of CAVD based upon blood ejection velocity, patient outcomes and disease 
management. Adapted from [3]. 
 
The factors which are responsible for CAVD onset may not be the same factors responsible for its 
progression. One such example is elevated lipid levels, which are associated with aortic valve 
sclerosis. Currently, there is no convincing evidence that links high serum levels to CAVD progression 
[38]. Therefore; the relevance of many animal models currently being used to study calcific aortic 
disease is questionable. This includes the murine model, which requires high cholestermia to induce 
aortic valve calcification [10], however, elevated lipid levels in humans does not predict CAVD onset 
or progression. Additionally, systemic markers of inflammation are not associated with progression 
of aortic-valve disease. Once aortic sclerosis is present, aortic obstruction occurs in 15% of patients 
over a period of two to five years [3]. On average, the maximum transvalvular velocity increases 0.1 
to 0.3 m/s per year, with the mean gradient increasing by 3-10 mmHg per year, and the valve area 
decreasing by 0.1 cm
2
 [3, 39]. 
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Anatomical changes caused by the onset of CAVD and aortic sclerosis affect the whole heart and are 
not isolated to the aortic valve alone. Aortic sclerosis and valve thickening affect the upstream left 
ventral, left atrium, and often the ascending aorta. Left atrial enlargement is common with aortic 
stenosis due to the elevated left ventricular filling pressures [3]. The wall of the left ventricle often 
undergoes hypertrophy as more force is needed to push the blood through a narrow aorta. In many 
patients, there is also altered coronary blood flow. For a schematic of the aforementioned changes, 
please see figure 2.2. 
 
Figure 2.2. The whole heart is affected by aortic valve calcification. Left atrium often enlarges to 
account for increased left ventricular filling pressures. Although ejection fraction is often normal, 
left ventricular hypertrophy (muscle thickening) is common to allow the blood to be pushed through 
the aorta. Many patients also experience altered coronary blood flow. Reproduced with permission 
from Otto, C. M., & Prendergast, B. (2014) reproduced with permission, Copyright Massachusetts 
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Medical Society.  
 
2.1.3 Location of Calcification on Valve Leaflets 
The heart valve consists of a tri-laminar structure:  the ventricularis, spongiosa, and fibrosa. Each 
leaflet stratum has a distinct protein composition for the unique mechanical loading conditions 
experienced by each respective layer. The ventricularis side of the valve faces the left ventricle and 
is exposed to shear flow when the valve opens during systole. Rapid closure of the valve during 
diastole results in blood flowing in a “swirl”-like motion over the fibrosa. Examination of explanted 
disease valves exhibiting early calcific lesions show that the fibrosa is the predominant site of 
calcification [40]. Early lesions show sub endothelial thickening between the basement membrane 
and the elastic lamina, extracellular and intracellular lipids, mineralization, and disruption of the 
basement membrane over the lesion [41]. Regions of the fibrosa adjacent to these lesions showed 
disruption in extracellular matrix proteins and accumulation of lipids and calcification. Sites of 
increased mechanical stress are more likely to experience calcification [42, 43]. Figure 2.3 shows an 
immunohistological section of a disease valve. Notice the increased cell density compared to healthy 
native valves. 
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Figure 2.3 Cell aggregates within disease valve leaflet. The first column shows a healthy native 
valve. Cell density increases within the calcified aortic valve suggesting that CAVD is the result of an 
active tissue response to some stimulus. Image from [44], reproduced with permission.  
 
2.1.4 Valve Replacement 
Several types of valve replacements exist for patients, which include mechanical valves and bio-
prosthetic (tissue) valves. Tissue valves are created from bovine or porcine tissue. Valves made from 
bovine tissue are made from the bovine pericardium. Unlike the aortic valve whose structure is 
highly anisotropic due to different fiber alignment in the radial and circumferential directions, 
bovine pericardium is an isotropic material [45]. Porcine valves are taken from pig aortic valves. In 
addition, allografts from cadavers and autografts (pulmonary valve replaced to the aortic root) are 
also potential options [45]. All tissue valves require glutaraldehyde fixation to render the valves non-
immunogenic via collagen crosslinking which serves to stabilize the collagen fibers and reduce 
immunogenicity. Currently, no non-treated valves have achieved successful implantation [42]. 
However, glutaraldehyde fixation appears to make the valve susceptible to calcification as bio-
prosthetic valve calcification increases with severity with increasing fixative concentration [46]. The 
mechanisms of calcification of glutaraldehyde treated valves are likely different than those of CAVD.  
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The initial mechanical vale was the Starr-Edwards ball and cage prosthesis which was first used 
successfully in 1961 [47]. Several patients who had the original prosthesis design implanted are still 
alive today, and the ball and cage prosthesis is still available commercially in a slightly modified 
form. Other popular mechanical valve designs include the disc valve and the bileaflet valve. The first 
disc valve was created by Bjork-Shiley [47]. This prosthesis is comprised of a single disc coated in 
pyrolite carbon which tilts between two struts of the housing, typically made of stainless steel or 
titanium. Unfortunately, due to the combination of a slight design modification and change in 
manufacturing process, some generations of the Bjork-Shiley valve were prone to rupture, allowing 
the disc to escape, resulting in several hundred fatalities [47]. The Bjork-Shiley valve is no longer 
manufactured, but single disc valves continued to be available commercially through Medtronic and 
others. The third mechanical valve prosthesis design is the bileaflet valve. The first bileaflet valve 
was developed by St. Jude Medical in 1977  [47]. It has two semicircular leaflets which open and 
close creating one central and two peripheral orifices. Over 600,000 bileaflet valves have been 
implanted to date and is currently the most commonly implanted type of mechanical prosthesis in 
the world [47]. 
The disadvantage to a mechanical valve is that all designs alter the hemodynamic flow sufficiently to 
increase the risk of thrombolytic complications. This increased risk necessitates patients to take 
warfarin or another antithromboltyic agent to reduce thromboembolic complications such as stroke, 
pulmonary embolism, or heart attack [45]. As such, mechanical valves are not recommended for 
women of child-bearing age as currently there are no medical guidelines for correctly prescribing 
warfarin or other anticoagulation medication as all have negative consequences for fetal 
development [48, 49]. 
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Despite the increased quality of life, improved ability to complete activities of daily living, and 
prolonged lifespan for many patients, valve replacement has yet to become optimal and is 
associated with significant complications postoperative. Within 10 years, greater than 50% of 
patients experience complications with replacement valves [50]. Almost always, the complication 
requires urgent surgical intervention. The most common medical problems associated with aortic 
valve replacement include thromboembolic problems, infective endocarditis, paravalvular leak, 
intrinsic degradative dysfunction, and tissue overgrowth [51]. 
2.1.5 Calcification of  Bioprosthetic Replacement Valves 
Calcification is the most common type of failure of bioprosthetic heart valves. Calcific deposits result 
in decreased motion of the valves, causing tearing, resulting in regurgitation and the need for a 
second replacement valve [52]. For calcification to initially deposit onto the bioprosthetic valve 
leaflet from the blood stream, energy is required to achieve the phase transformation [53]. The 
presence of collagen fibrils, implant surface defects, and cell residues within the bioprosthetic valve 
all reduce the amount of energy needed for this phase transformation [54]. Additionally, the 
glutaraldehyde fixative used to reduce immunogencity of the bioprosthetic valve is toxic; it has been 
demonstrated that the chemical persists for many months, causing death of host fibrocytes and 
macrophages it comes in to contact with [52]. This too, increases the number of sites the calcium 
can nucleate. 
It is difficult to say whether mechanistically, the calcification pathways between natural valves and 
bioprosthetic valves are similar, as much remains unknown about both types of calcification [53]. 
Examination of the calcium deposits on valve leaflets of both natural heart valves and bioprosthetic 
valves by scanning electron microscopy shows similarly shaped calcification deposits. Elemental 
analysis of calcified areas by energy dispersive x-ray spectroscopy (EDS) shows approximately 
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equivalent calcium to phosphorous (Ca/P)  ratios for both calcified natural heart valves and calcified 
bioprosthetic valves (1.79 for native heart valves and 1.72 for bovine pericardium). These ratios of 
Ca/P are approximately what is expected for hydroxyapatite (HAP) found in bone. Stevens and 
colleagues analyzed mineralized nano-particles found on the surface of disease cardiovascular tissue 
with selected-area electron diffraction and showed that the crystallinity was higher than anything 
found within the body, including bone, suggesting different mineralization mechanisms in calcified 
valvular and vascular tissue, than osteogenesis [55] (to be discussed in more detail in chapter 4). 
2.2 Normal Aortic Valve Physiology and Function 
 
The aortic valve is one of four valves within the heart. As the heart is essentially a pump, the valves 
help prevent retrograde blood flow, as well as ensure pumping efficiency. The aortic valve is located 
between the left ventricle and the aorta. During systole, or heart contraction, the pressure inside 
the left ventricle exceeds that of the aorta, and the aortic valve opens. During diastole, the heart 
relaxes from its contracted state to allow for the filling of the left ventricle. When this happens, the 
pressure in the left ventricle pressure is lower than that of the aorta, and the aortic valve closes to 
prevent retrograde blood flow.  
2.2.1 Calculation of Aortic Valve Area 
Clinically, there are several metrics to evaluate efficiency of heart pumping and health of the valve. 
These include cardiac output, systolic ejection period, mean valvular pressure gradient, and heart 
rate. These metrics can be used to asses and estimate valve area and determine the degree of aortic 
stenosis. Determination of when and if a patient should get an aortic valve replacement  is mostly 
decided by the calculated aortic valve area. 
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There are three equations (which have different assumptions) and are used to calculate valve area 
from the aforementioned parameters. These include: the continuity equation, the Gorlin equation, 
and the Hakki equation. 
The continuity equation states that the flow in one area must equal the flow in a second area if 
there are no shunts between the two areas. The flow from the left ventricular outflow tract (LVOT) 
is compared to the flow at the level of the aortic valve. In echocardiography, the aortic valve area is 
calculated using the velocity time integral (VTI). The LVOT and LVOT VTI can be measured using 
pulse-wave Doppler, and the aortic VTI can be measured using continuous-wave Doppler. Once the 
values are obtained by the sonographer, equation 2.1 is used to calculate the valve area. 
????????????? ? ??????????????????????????????????????????????     Equation 2.1 
 
The Gorlin equation states that the aortic valve area is equal to the flow through the aortic valve 
during ventricular systole divided by the systolic pressure gradient across the valve multiplied by a 
constant. The flow across the aortic valve is computed by dividing the cardiac output 
(milliliters/minute) by both the heart rate (to give output per cardiac cycle) and  the systolic ejection 
period (seconds per beat), to give flow per ventricular contraction. 
????????????? ? ?? ???????????????? ??????????????????????????????????????????????????????????????  
Equation 2.2 
Where AV is the aortic valve, CO is cardiac output and HR is heart rate. 
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The Hakki equation shown in equation 2.3 is a simplified version of the Gorlin equation as in most 
patients the heart rate times the systolic ejection fraction *44.3 is approximately equal. 
????????????? ? ??? ??????????????????????????????     Equation 2.3 
2.2.2 Anatomy 
The normal aortic valve is comprised of three leaflets which co-adapt to form a barrier against 
retrograde blood flow. Although, three leaflets are considered normal for aortic valve anatomy, 
congenital conditions do exist where the aortic valve consists of two (bicuspid aortic valve) or even 
one leaflet. Patients with bicuspid aortic valves account for 50% of valve replacements for CAVD; 
this highlights the importance of mechanical factors and altered blood flow contributions of the 
disease. 
The valve leaflet is composed of three distinct layers: fibrosa, spongiosa, and ventricularis, and each 
layer has a different protein composition, which allows for its different mechanical properties. In a 
normal valve, the three layers remain stratified with valvular interstitial cells (VICs) being found 
uniformly throughout the valve; Figure 2.4 shows the different layers of the valve. In patients with 
CAVD, the stratified organization of the valve is completely disintegrated, with all extracellular 
matrix (ECM) proteins being found throughout the valve. 
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Figure 2.4. Schematic of tri-laminar structure of 
aortic valve leaflet. The ventricularis is mainly 
exposed to shear flow as the blood exits from the 
ventricle to the aorta. The ventricularis is 
composed mainly of a network of collagen and 
elastin fibers. The spongiosa or middle layer is 
believed to function as a lubricating layer and is 
composed of glycosaminoglycans. The fibrosa 
faces the aorta and is composed of type I and 
type III collagen fibers. Figure adapted from M.S. 
Sacks and A.P. Yoganathan (2007) with 
permission. 
 
2.3 Valvular Interstitial Cell Mechanobiology 
The following subsections appeared originally Cirka et al. "Mechanoregulation of Aortic Valvular 
Interstitial Cell Life and Death." Journal of long-term effects of medical implants 25.1-2 (2015). and 
are reproduced here with permission. 
There are two cell types in the valve: valvular endothelial cells (VECs) and valvular interstitial cells 
(VICs).  Both VECs and VICs appear to be sensitive to mechanical signals, as well as hemodynamic 
flow. A single layer of VECs line the surfaces of the aortic valve. VECs are distinct from endothelial 
cells populating the aorta. Additionally, VECs’ gene expression profiles differ with respect to which 
side of the aortic leaflet they are covering. VECs covering the fibrosa have upregulated proteins that 
are believed to promote calcification, while VECs lining the ventricularis side, which experience 
oscillating blood flow, have increased expression of Kruppel-like factor2 (KLF2), an 
“atheroprotective” transcription factor considered to downregulate calcification [56]. Additionally, it 
is believed that valvular endothelial cells can regulate valvular interstitial cell activation to the 
myofibroblast phenotype. VICs cultured in vitro often have high percentages of myofibroblast 
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activation (>99%); however, when cultured in the presence of VECs, the number of myofibroblasts 
decreases [57]. How this in vitro finding translates in vivo is still relatively unexplored. 
Valvular interstitial cells are a fibroblast-like cell that normally exists in the valve in its quiescent 
state [13]. When the valve is damaged, activation to the myofibroblast phenotype allows the cells to 
secrete matrix proteins, cytokines, and increase their cellular tension, analogous to a wound healing 
environment. Expression of alpha smooth muscle actin protein (αSMA) is an indicator of 
myofibroblast activation [15] and is often examined in studies assessing the VIC response to 
extracellular matrix composition and the mechanical cues of stiffness and stretch. In a healthy valve, 
approximately one percent of the cell population expresses αSMA. In a diseased valve, this number 
increases dramatically to 60% of the cell population. Myofibroblast persistence is believed to be a 
predominating factor in CAVD. Upon repair, the VICs deactivate and undergo numerous cellular 
processes including senescence and apoptosis, although the exact pathways remain unclear. The 
protein composition and cellular density of the valve changes over time.  The cellular density of an 
adult is approximately 10% of what it is compared to fetal valves [58]. Clearly signals regulating 
valvular interstitial cell fate are not only important for understanding pathology, but also normal 
tissue histomorphogenesis. 
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Figure 2.5. VICs are exposed to myriad mechanical forces in a dynamic environment in vivo. 
These forces include shear stress from the passing of blood through the valve, buckling stresses 
from when the valve opens and closes, and planar stress from when the valve is closed. Figure 
from [59] reproduced with permission. 
 
2.3.1 Cell-ECM and cell-cell connections 
Under normal physiological conditions, VICs do not usually come into contact with one another as 
they are embedded in large amounts of extracellular matrix. Focal adhesions on the cell serve as 
attachment points to ECM proteins. Focal adhesions grow larger when loaded, e.g. by pulling with 
microbeads [60, 61] or stretching the substrate [62]. With increasing tension, fibroblasts transition 
to proto-myofibroblasts; this phenotype expresses αSMA-negative stress fibers [63]. The 
myofibroblast phenotype is characterized by de novo expression of αSMA [64, 65]. Although shown 
in a different cell type than VICs, the tension generation capacity of myofibroblasts is much greater 
than that of fibroblasts due to αSMA actin incorporation into stress fibers [66]. It remains an open 
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research question if the integrins expressed by myofibroblasts differ from those expressed by 
fibroblasts, as transforming growth factor- beta (TGF-β), a potent myofibroblast activator, up-
regulates the expression of many integrins [67]. 
While a comprehensive comparative study of cell-cell junctions in fibroblasts and myofibroblasts has 
not been completed, cadherin expression likely differs between these phenotypes [63]. N-cadherin 
was the first cadherin to be identified in fibroblasts [68, 69]. Additional cadherins such as P-cadherin 
[70, 71], R-cadherin  [72], VE-cadherin [72, 73] and OB-cadherin (cadherin-11) [72, 74]  are 
expressed in fibroblasts. N-cadherin, cadherin-11, plaque proteins: α-and β-catenin, plakoglobin, 
and p120, together with minor amounts of protein p0071 are expressed by VICs. Cadherins likely 
play a role in valve diseases, as they are necessary for the aggregation of VICs as discussed in the 
‘Mechanoregulation of Calcification’ sub-section. 
2.3.2 Mechanical characterization of VIC phenotype 
As the cell cytoskeleton (CSK) is integral in mechanotransduction, characterization of VIC mechanical 
properties may provide insight into cellular mechanoregulation.  The cell Young’s modulus can be 
measured by micropipette aspiration (MA), atomic force microscopy (AFM) indentation, and 
magnetic bead twisting rheometry (MBR). Using atomic force mapping, VIC modulus has been 
shown to increase with culture on substrates of increasing modulus [75]. VIC modulus also increases 
during myofibroblast differentiation as shown by studies using micropipette aspiration [76]. This 
increase in modulus was not fully explained by substrate stiffness and appears to be the result of 
αSMA incorporation into the cytoskeleton.  Due to the viscoelastic nature of the biopolymer 
network of the CSK, the modulus is also dependent upon the loading rate of the pipette/probe 
during the measurement. However, negligible effects of viscoelasticity on VIC micropipette 
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deformation are reported over physiological timescales (0.05 s to 0.5 s), suggesting that the VIC 
cytoskeletal response is purely elastic in the physiological range [77]. 
The response of a cell to mechanical probing and thus the calculated modulus, is a complex function 
of both the intrinsic stiffness of the cytoskeletal elements, as well as the active tension in the 
cytoskeleton. Work by Stamenović and colleagues suggests that there is a positive correlation 
between cell modulus and cell prestress (i.e., cytoskeletal tension, as measured by traction force 
microscopy) [78, 79], but whether this correlation holds true for VICs and activated myofibroblasts 
remains to be resolved. 
2.3.3 Effect of substrate modulus on VIC phenotype and apoptosis 
Extensive experimental evidence suggests that VIC phenotype is sensitive to the elastic modulus of 
the substrate on which the cells are cultured [80, 81]. The substrate modulus is known to regulate 
the amount of tension a cell can generate [82].  When VICs are cultured on compliant substrates 
(less than 3 kPa), they have a rounded morphology with little αSMA incorporated into the 
cytoskeleton [81]. Spread area, which is correlated with cell generated tension in other cell types 
[82], [82][70] is also smaller for VICs on more compliant substrates. However, on high modulus 
substrates (greater than 10 kPa), VICs are elongated and spindle shaped with αSMA incorporated 
into the stress fibers [81].  
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Figure 2.6. Valvular interstitial cells (VICs) are mechanosensative. VICs expressed differential 
amounts of αSMA incorporation into stress fibers, an indication of the contractile myofibroblastic 
phenotype, when cultured on substrates of increasing modulus. Cell area is also correlated to 
substrate stiffness. Figure adapted from [81] with permission. 
 
Several research groups have attempted to identify a “transitional” stiffness, where VICs 
differentiate from quiescent fibroblast-like cells to highly contractile myofibroblasts [80, 81, 83]. 
Quinlan et al. activated VICs to the myofibroblast phenotype by culturing them for two days on stiff 
tissue culture plates before transferring them to collagen-coated polyacrylamide hydrogels. 
Identification of transitional stiffness was accomplished by using eleven different substrates with 
moduli that ranged from 0.15 kPa-150 kPa [81]. The transitional modulus was found to be 2.5 kPa-
7kPa [80, 81]. Anseth and colleagues also demonstrated that the activated VIC phenotype is 
reversible [80, 84]. Specifically, myofibroblasts were cultured for three days on photodegradable 
hydrogels and then irradiated to reduce the modulus from 32 kPa to 7 kPa.  Within two days after 
modulus reduction, myofibroblasts reverted to quiescent VICs without significant changes in cell 
viability [80, 84].  These data indicate that myofibroblasts can be dedifferentiated without inducing 
apoptosis, which has implications for the development of treatments of CAVD and fibrotic diseases 
as apoptosis has been identified in calcified diseased valves [11]. A better understanding of the 
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precise magnitude of stiffness and cell tension reduction required for phenotypic regulation is 
needed. For a brief review of studies examining the mechanobiology of VICS, please see table 2.2. 
Table 2.2- Review of studies examining the mechanobiology of valvular interstitial cells 
 
 
2.3.4 Cyclic stretch regulation of VIC phenotype and apoptosis 
As VICs are exposed to a highly dynamic environment in vivo, the effects of stretch and fiber 
anisotropy on VIC mechanoregulation are important to understand.  
Several bioreactors have been developed by different research groups which can replicate the 
strains and strain rates experienced in vivo for ex vivo whole-leaflet and whole-valve studies. 
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Balachandran et al. have demonstrated in whole valve cusps that cyclic stretch upregulates collagen 
production by VICs [85]. Studies with whole valves reveal a side-specific activation of VICs, with most 
αSMA expression being localized to the ventricularis [85]. VICs also appear to respond to local tissue 
stiffening by changing collagen biosynthesis [24]. VIC apoptosis has been shown to increase with 
cyclic stretch in a magnitude-dependent manner in ex vivo organ culture studies; however, 
physiological levels of stretch (10% and 15%) were shown to be preventative against apoptosis when 
compared to static controls. These studies suggest that the magnitude of cyclic stretch is an 
important regulator of both VIC phenotype and fate [86]. 
Anisotropy present within the valve layers may also regulate VIC function. Using a novel bioreactor 
design, Butcher and colleagues [87][75][77]investigated the effect of biaxial strain anisotropy on cell 
function in 3D collagen hydrogels. They found that increasing the anisotropy of the biaxial strain 
increases cellular realignment towards the direction of maximum principal strain, and that cell 
realignment precedes fiber reorganization [87]. The presence of cyclic strain decreases the 
expression of vimentin and αSMA as compared to unstretched controls, yet there were higher levels 
of apoptotic and proliferative markers in stretched samples compared to controls [87].  
Cyclic stretch has been shown in 2D experiments to regulate aspects of VIC phenotype including 
cytoskeletal rearrangement and gene and protein expression.   In particular, αSMA incorporation 
into stress fibers and collagen production, both hallmarks of the myofibroblast phenotype, are 
increased with the magnitude of stretch [24]. It has been shown in cardiac fibroblasts that stretch by 
ligand-coated ferromagnetic beads allows for αSMA incorporation into stress fibers [88]. 
Additionally, stretch magnitude has been shown to regulate genetic profiles. For example the lowest 
expression of inflammatory genes has been shown to be expressed with 15% equibiaxial stretch [89] 
[89][77][79]. Cyclic stretch has also been shown to induce VIC production of spheroid microparticles; 
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this production was cytosketal tension dependent and was abolished when RhoA/Rock was inhibited 
[90]. 
2.3.5 Integration of multiple mechanical signals 
Although the number of studies investigating the response of cells to matrix stiffness and stretch has 
increased rapidly over the past few years, very little is known about the relative importance of these 
mechanical signals or their interactions. Visual observations indicate that VICs on compliant 
substrates, which generally have a rounded morphology and small spread area when in isolation, 
are able to “generate tension against each other” and increase their spread area when in contact 
with other cells [81]. This observation highlights the importance of cell-cell contacts (cadherins) in 
the mechanoregulation process.  
 
Figure 2.7.  VICs are capable of integrating multiple mechanical cues. (a) VICs cultured on soft (0.3 
kPa) and stiff (50 kPa) PA gels cultured with and without cyclic stretch. (b) Effect of static and stretch 
culture on cell area for two substrate stiffness levels of culture. Figure adapted from [28], copyright 
Throm Quinlan. 
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Findings from recent studies, which incorporate a compliant PA gel on a flexible silicone culture 
substrate, indicate that VICs are able to integrate multiple mechanical signals from the substrate, 
including the local modulus and dynamic stretch, see Figure 2.7.  Using this method, we have 
demonstrated that VICs on stiff substrates decrease spread area slightly when subjected to cyclic 
equibiaxial stretch, possibly to maintain certain levels of homeostatic tension [28]. In contrast, VICs 
cultured on soft substrates increase in spread area when subjected to the same stretch stimulus. It 
remains to be determined if similar mechanosensory mechanisms are utilized by the cells for static 
inside-out sensing (of substrate modulus) and cyclic outside-in sensing (of stretch). Although cell 
area has been shown to be an adequate proxy for cell tension for some cell types [82], the 
relationship between fibroblast cell area and cell tension appears complex, with a possible 
dependency on TGF-β1 [91]. A shortcoming of cell area measurements is that if the cell generated 
traction-cell area relationship is not known, interpretation of mechanobiological data becomes 
imprecise. Future studies should include more robust measurements of cell tension, such as by 
traction force microscopy, rather than relying on cell area measurements alone. To date, little is 
known about cell tension changes in the presence of long-term cyclic stretch.  
2.3.6 Interactions between mechanical and soluble stimuli 
Substrate stiffness and stretch modulate the sensitivity of cells to soluble factors such as TGF-β1; 
therefore, mechanical and chemical stimuli must be studied simultaneously to determine potential 
synergistic interactions. For example, TGF-β1 and boundary stiffness act in concert to induce the 
myofibroblast phenotype in static 3D culture systems. With very compliant beams, TGF-β1 
supplementation (up to 5 ng/mL) does not change VIC-generated forces [92]. However, increasing 
boundary stiffness and TGF-β1 concentration together increase force-per-cell levels synergistically 
[92] Similar interactions have been reported in 2D systems.  The traction force generated by lung 
fibroblasts cultured on polyacrylamide gels reaches a plateau of 13 kPa without TGF-β1, yet 
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continues to increase for cells cultured in the presence of TGF-β1 [91]. These studies provide 
evidence for a cooperative mechanism between substrate and boundary stiffness and TGF-β. 
Studies employing cyclic stretch of porcine aortic valve leaflet tissue strips also indicate that stretch 
and TGF-β1 act in a cooperative manner to activate VICs. Merryman et al. [23] cultured strips cut 
from heart valves for 7 or 14 days in the presence of 15% equibiaxial stretch and 0.05 ng/mL TGF-β1 
or neither chemical nor mechanical stimuli.  The greatest number of myofibroblasts, as 
characterized by αSMA expression, were found in the group cultured simultaneously in the presence 
of stretch and TGF-β. 
When secreted by cells, TGF-β binds to the matrix in a latent form preventing its interaction with 
transmembrane receptors on the surface of the cells.  Recent evidence suggests that integrins may 
play a critical role in the process of releasing the active TGF-β from the latent complex.  This is 
accomplished by using a physical force to modify the protein configuration, allowing for releases of 
the molecule [93], shown schematically in Figure 2.8.  Additional mechanisms of latent TGF-β 
activation that have been identified include heat, pH, and reactive oxygen species [94]. The physical 
or chemical mechanisms which activate latent TGF-β have not been explored for VICs specifically, 
and further study may prove valuable for tissue engineering purposes as TGF-β is a key phenotypic 
regulator of this cell type. 
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Figure 2.8:  Effect of substrate stiffness and 
tension on release of latent TGF-β. Stiff 
substrates aid in release of latent TGF-β. As a 
cell pulls on the extracellular matrix, a 
conformational change is induced, releasing 
TGF- β molecules.  Compliant substrates do not 
allow for this conformational change. 
 
2.4 In Vitro Models of Calcific Aortic Valve Disease 
 
There are two believed mechanisms behind calcification seen in heart valves. These include ossific 
calcification (present in 13% of explanted valves) and dystrophic calcification (present in 83% of 
valves) [7]. In vitro models have been developed in order to replicate calcification that is observed in 
vivo [12]. However, no model currently simultaneously replicates ossific and dystrophic nodules as 
seen in some diseased heart valves. Ossific nodules have been created on both thick collagen gel 
substrates [16] and on 24 kPa polyacrylamide gels [95]. Dystrophic nodules are created by culturing 
VICs at high density in the presence of TGF-β1 on stiff substrates for a period of 5-7 days. Although 
both ossific and dystrophic nodules will stain positive for calcium, there are distinct phenotypic 
differences between the cells which comprise each nodule [10]. Dystrophic nodules have apoptosis 
co-localized with calcification in the center of the aggregate, while ossific nodules are living and will 
exclude propidium iodine. This is verified with mechanical characterization by atomic force 
microscopy; dystrophic nodules will have heterogeneous modulus throughout the aggregate, while 
ossific nodules have the modulus similar to that of a single VIC and no noticeable differences 
between the central and peripheral cells [95]. As dystrophic calcification is more prevalent, the 
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remainder of the discussion will focus on the mechanoregulation of dystrophic calcification. 
Representative images for the dystrophic model of calcification are shown in Figure 2.9. 
Figure 2.9. In vitro model of calcific aortic valvular disease. a.) Representative image of aggregates 
on day 7. Note that some aggregates are undergoing calcification within the central region as 
evidence by the white nodule. Other aggregates have yet to develop a nodule. These differences in 
time course make determining mechanisms behind calcification difficult. Scale bar = 100 µm. b.) 
Live/dead assay of aggregate. Cells within the central region of the aggregate undergo apoptosis and 
will then uptake ethidium homodimer-1 (red). Live cells exclude the dye and are stained with calcien 
(green). Scale bar = 100 µm. 
2.4.1 Mechanoregulation of calcification 
Cell tension has a clear connection to the rate and frequency of aggregation. Current culture 
methods require a high number of cells, the presence of TGF-β, and take on the order of a week to 
form aggregates; cyclic strain has been used in conjunction with TGF-β to accelerate the aggregation 
process. Merryman and colleagues cyclically stretched VIC monolayers for 24 hours [17] and found 
that cells cultured in the presence of TGF-β before or during stretch (but not after) were activated to 
the myofibroblastic phenotype. Although cyclic stretch alone did not activate VICs, the two stimuli 
together accelerated aggregation appreciably observed at 24 hrs compared to 1 week for static 
culture). Apoptosis and calcification have also been shown to increase in a stretch-dependent 
manner; 15% strain results in a 100-fold change over samples strained at 10% or static controls [90]. 
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Other methods of increasing cell tension include increasing expression of key cytoskeletal signaling 
proteins, such as RhoA and the ROCK pathway [96]. When RhoA/ROCK are upregulated, the rate of 
aggregation and number of aggregates observed increases [18]. On the contrary, when VICs were 
treated with ROCK inhibitors (H1152), there was reduced myofibroblast nodule formation as shown 
by a decrease in nodule number and area, reduced number of αSMA stress fibers, and an absence of 
apoptosis [18]. 
In addition to high cell tension, high cell-cell forces appear to be necessary for aggregate formation.  
Results from a recent study indicate that blocking cadherin-11 reduces intracellular tension in VIC 
monolayers and inhibits aggregation [97]. When cadherin-11 was inhibited using siRNA, VIC 
aggregation was also blocked.  Although these findings support the importance of high cell forces in 
aggregation, no direct cell-cell tension measurements have been made.  
2.4.2 Mechanoregulation of apoptosis 
Apoptosis, or programmed cell death, is associated with calcific deposits in CAVD, and is also known 
to be regulated by physical cues.  Apoptosis is a powerful mechanism for removal of excess cells 
following wound healing and during morphogenesis. Dysregulation of apoptosis can lead to fibrosis 
and cancer [98], but little is known how it may contribute to CAVD. Decreases in CSK tension initiate 
apoptosis in fibroblastic cells. Such conditions include 1) release of contractile cell-populated 
collagen gels from rigid anchors [99], 2) inhibiting adhesion to the ECM proteins [100], 3) low 
substrate modulus [33, 101, 102], and 4) restricted cell spread area [103] [104]. Although 
cytoskeletal tension is not generally measured with apoptosis, separate studies demonstrate 1) cells 
in free-floating gels generate minimal tension [105], 2) blocking integrin-ECM binding leads to a 
decrease in traction force [106], 3) cells with smaller spread area generate weaker traction forces 
[82, 107-109] , and 4) cells cultured on soft substrates generate lower traction force compared with 
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those cultured on stiffer substrates with identical ECM coating [33, 110]. Very little is known in 
particular about the sensitivity of VICs to these stimuli, and whether a stimulus that changes 
cytoskeletal tension will trigger a reversal of myofibroblastic phenotype to quiescent VICs or initiate 
apoptosis. More studies that take a quantitative approach to assess VIC tension are needed to 
determine the answer to this important question. 
2.4.3 The Apoptotic Pathway and Methods for Apoptosis Detection 
Apoptosis is a well-studied cell phenomenon that consists of a specific sequential series of events. A 
cell death event can be “triggered” by either external or internal signals. External cues, such as 
binding to lethal ligands, initiate the extrinsic pathway of apoptosis, and internal signals of cell stress 
initiate the internal pathway. Although the initial steps of these pathways are different, they 
converge  with a caspase cascade, as seen in Figure 2.10.  
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A dying cell exhibits several “hallmark” features, including initial cytoplasmic condensation, blebbing 
of the plasma membrane, and finally release of apoptotic bodies. 
Several methods of apoptotic detection exist and are typically grouped into early and late of 
apoptosis. Early detection methods use Annexin V, which binds to the biomarker protein 
phosphatidylserine (PS). Phosphatydylserine appears in the plasma membrane of apoptotic cells and 
is used as a signal for T-cells, signaling phagocytosis. This method can be used in vivo and is often 
used to assay the death of cancer cells and response to treatment. Late detection methods include 
TUNEL and caspase detection. TUNEL assays for DNA degradation by binding to DNA that has been 
nicked by the cellular enzyme terminal deoxynucleotidyl transferase. TUNEL inserts dUTPs, which 
can be detected a priori by antibody staining. Caspase detection methods exist for both initiator 
caspase (capase 8/9) and effector caspase (3/7). 
 
Figure 2.10. Apoptotic pathway is a well defined signaling cascade which can be initated by either 
extrinisic or intrinsic signals. Caspase 3/7 are cleaved at the final stage of apoptosis.  [111], 
Reproduced with permission  
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2.5 Traction Force 
 
Traction forces are created by the acto-myosin machinery of the cell. These contractile forces are 
transferred to the extracellular matrix at discrete points called focal adhesions. For an illustration of 
traction force generation, please see Figure 2.10. These forces create a stress and strain field in the 
surrounding extracellular matrix. The external stress and strain in the ECM in return modulate 
cellular functions such as extracellular matrix protein secretion and differentiation. Many disease 
states such as cancer, fibrosis, and hyper-tension all have traction force dysregulation. Traction 
forces are essential for all cellular processes which require adhesion to the extracellular matrix and 
tension within the cytoskeleton. This includes cell migration [112], cell differentiation, extracellular 
matrix assembly [113, 114], and cell proliferation. 
These forces were first described by Harris et al. [114] as wrinkles on a flexible silicone substrate. 
Dembo and Wang [115] later created a more accurate technique, which uses micro-fluorescent 
beads embedded in a flexible substrate with a known modulus (or “stiffness”). Polyacrylamide gels 
are the most frequently used material in the literature, but in theory, a hydrogel would be 
adequate.  The traction force is calculated using a combination of image analysis and finite element 
method calculations. For each cell, three images are captured. A phase image, showing the cell 
boundary, a fluorescent image of the microbeads below the cell, and a fluorescent image of the 
relaxed substrate after the cell has been trypsinized. Using the bead images, a displacement field is 
determined. Knowing the substrate modulus, the substrate stress can be calculated. From the phase 
image, cell boundaries and cell area can be determined. The substrate stress is then multiplied by 
the cell area and the cell traction force is determined. 
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Figure 2.11. Illustration of cell traction force 
generation against a substrate. The cell 
actin-myosin machinery connects to the 
extracellular matrix at discrete points known 
as focal adhesions. The focal adhesions 
comprise several types of proteins, such as 
integrins, which assemble together to form 
the focal-adhesion complex. Schematic 
originally appear in [116] and is reproduced 
here with permission. 
 
2.5.1 Traction Force Trends 
Traction force has been shown to correlate with cell spread area. As cells increase in size, cells are 
able to generate increased amounts of traction force [82]. Cell spread area , as well as the amount 
of traction force a cell is able to generate, increases as substrate stiffness increases [82]. 
Additionally, cell shape affects the amount of tension a cell is able to generate. With cell area held 
constant, the greater the cell elongates, the more traction force the cell is able to generate [107]. 
For example, for a rectangular cell and square cell of the same area, the rectangular cell will 
generate larger traction forces than the square cell. Fibroblastic cell types have increased traction 
force when cultured in the presence of growth factor TGF-β1. This effect was stronger as the 
substrate stiffness increased [91]. As stated previously, fibroblastic cells can differentiate into 
myofibroblastic cells in the presence of TGF-β1 by incorporation of the αSMA protein into the f-actin 
stress fibers [64]. A study by Chen et al. showed that traction forces are predictive of cell phenotype, 
which can be seen with myofibroblastic cells staining αSMA positive and generating increased levels 
of traction force, as see in Figure 2.12 [66]. 
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An elegant study by Han et al. used micro-contact printing on micro-posts to decouple the effects of 
cell area and focal adhesions [117]. As cells increase in size, they also increase in the number of focal 
adhesions. As traction forces are created at focal adhesions, it was unknown prior to this study if cell 
size or the number of focal adhesions was the primary contributor to traction force. As cellular focal 
adhesions can only form on a micro-post, the number of focal adhesions can be controlled by the 
number of micro-posts on which the cell is able to bind. By controlling the density of micro-posts, 
they were able to create two cell areas with the same number of micro-posts, as seen in Figure 2.13. 
Interestingly, despite the difference in size, cells generated identical levels of traction force, 
indicating that the number of focal adhesions determines the amount of traction force a cell is able 
to generate, and not the cell size. 
Figure 2.13. Combining micro-
contact printing with micro-posts 
allows for examination of the 
relationship between cell spread area 
and number of focal adhesions. Cells 
that had the same number of micro-
posts generate identical levels of 
traction force. Figure modified from 
[117] with permission. 
Figure 2.12. Myofibroblasts generate increased 
traction force. αSMA positive cells, indicating 
myofibroblastic phenotype, are capable of generating 
increased traction forces. Cell traction force is 
increasingly being recognized as a measure of cell 
phenotype. Figure adapted from [66] and reprinted 
with permission. 
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2.5.1.1 Measures of Cell Shape: 
Cell shape is an important regulator of cellular processes, such as traction force. Two measures of 
cell shape will be referenced in this thesis. These include form factor and elongation. Shape factor 
was first used by Chen et al. and is a measure of the number of cellular extensions. Form factor is 
calculated using the following formula: 
??????????? ? ?? ? ?????????????? 
Form factor values range from 0 to 1. Cells with many filiopodia and high elongation will have a 
shape factor closer zero. Cells that are perfectly circular will have a shape factor of 1. Shape factor 
gives some indication of the mechanical environment of the cell; cells that are cultured on soft 
substrates are often highly circular with low spread area, while cells on stiffer substrates will be 
more spread and have a lower shape factor. 
Elongation ratio is an indication of how elongated a cell is. It is determined by fitting an ellipse to the 
cell and taking a ratio of the major and minor axis of the ellipse using the following formula: 
???????????????? ? ????? ? ?????????? ? ????? 
where Amaj is the major axis of the ellipse and Amin  is the minor axis of the ellipse 
2.6 Simultaneous Measurements of Cell Traction with Stretch 
As studies that combine traction force with stretch have increased complexity and are technically 
very challenging, all the studies to date are of short duration (< 4 hours). While these studies have 
been short in duration, they have revealed that cell traction force changes rapidly with stretch, and 
the response depends upon a variety of factors, including the magnitude, type, duration, and 
direction of stretch with respect to cell orientation. On polyacrylamide gels, Fredberg and colleagues 
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observed that the traction force response to a single stretch depends upon the strain field. Under a 
homogenous strain field, cells decrease their traction force immediately, with a recovery over about 
15 minutes. On the contrary, when exposed to a non-uniform strain field, the traction force a cell is 
able to generate actually increases [118]. Sub-cellular measurements of traction force microscopy 
using micro-posts show that the area of the cell generating the traction force are not uniform, and 
occur primarily along the cell periphery. 
The duration of stretch also affects the traction force response; Fu and colleagues observed that 
cell-generated traction forces increase initially in response to a rapid step stretch of cells cultured on 
micropillar arrays, and then return to or fall below initial baseline values over the next 60 minutes as 
the stretch is held [119]. More recently, the same research group utilized micro-contact printed 
areas of various geometries and demonstrated that cell shape and orientation control the cell’s 
traction response to stretch [120]; notably, elongated cells oriented perpendicular to stretch 
exhibited little response to stretch, whereas those aligned with stretch exhibited large changes in 
traction force.  Mertz and colleagues stretched cells onto soft micro-pillars for four hours. Stretch 
waveforms were varied to determine if it is the stretch in general, the holding of the stretch, or the 
release of the stretch that cues a cell to elongate. Cells were initially rounded and then increased in 
size, area, proliferation, and traction force with time [29]. A complete summary of studies combining 
traction force is summarized in Table 2.3. 
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Table 2.3- summary of studies combining traction force with stretch 
 
2.7 Other measures of cell tension state 
 
Atomic force microscopy, magnetic bead twisting rheometry, and micropipette aspiration have all 
been used to assess cytoskeletal tension. Although not a direct measure of cell tension, these 
methods have been correlated with the amount of traction force a cell is able to generate. Using 
variations in cell stiffness to indicate changes in cell tension was first proposed by Wang and 
colleagues in 1996 [121]. In 2002, Stamenovic and colleagues showed linear correlation between cell 
tension, as measured by contractile moment, and stiffness measured by magnetic bead twisting 
rheometry, as seen in figure 2.14. 
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 Figure 2.14. Relationship between cell 
tension and cell stiffness. Cell stiffness 
is positively correlated with contractile 
moment, a measure of cell contractility, 
indicating that stiffness measurements 
may be used to determine tension state 
of the cell. Adapted from [78] with 
permission. 
 
2.8 Geometric Control of Cell Behavior 
 
Micro-contact printing involves “stamping” proteins in defined geometric shapes. Analogous to 
stamping with ink on the macro-scale, the stamps create protein islands of the desired geometry. 
Initial studies were done on glass coverslips, but it has since been combined with polyacrylamide 
gels and micro-posts as described above for concomitant studies of cell shape and traction force. 
Micro-contact printing has been used with both single cells and groups of cells. With single cells, the 
effect of cell shape and size on cell behavior has been investigated. Micro-contact printing of cell 
aggregates reveals differential behaviors with geometric location (i.e. periphery or center), which 
may give insight into spatial cues required in tissue morphogenesis. 
Studies in single cells have determined that there is a geometric component in apoptosis induction. 
Cells that had been restricted to 20 µm diameter circles underwent higher rates of apoptosis than 
cells on 50 µm diameter circles [103]. Cell shape also impacts lineage commitment of mesenchymal 
stem cells. By controlling cell geometry, differentiation of stem cells into a specific lineage 
commitment could be directed [122]; shapes that allowed for local areas of high cell tension (i.e. 
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pointed features between concave surfaces) promoted increased myosin activity that was 
associated with pathways of osteogenesis. Ablating the tension with various agents such 
blebbistatin and cytochalasin-D pushed cells towards adipocyte lineage commitment.  
Studies with aggregates of cells on micro-contact printed geometries have shown the proliferation 
rates vary with location within the aggregate. Chen and colleagues modeled micro-contact printed 
monolayers using a bi-layer model with a passive and contractile layer. Thermal strain was used to 
model contractility [123]. This model predicted areas with highest stresses to occur along the 
periphery of the geometry. Although simplistic, this model predicted proliferation behavior of 
bovine pulmonary endothelial cells on micro-patterned substrates as measured by BrdU 
incorporation.  Piccolo and colleagues examined YAP nuclear localization with multicellular 
aggregates and found that areas of high stress, such as along the micro-pattern perimeter, 
promoted YAP translocation to the nucleus [124]. Vunjak-Novakovic and colleagues examined MSC 
differentiation on large (1000 μm) rings (200 μm inner diameter) and found osteoblastic lineage 
commitment varied with location within the ring. This differentiation was primarily localized to 
regions where cell area was small yet cells still remained elongated (such as the inner edge of a ring 
and the regions next to the short edges of rectangles) [125]. The differentiation and proliferation 
activity observed was abolished with the use of cytoskeletal inhibitors, such as blebbistatin and Y-
27632. Combining these studies show the power of mechanical stresses in regulating multi-cellular 
behavior, and that cellular behavior within aggregates can vary due to the differences in mechanical 
stresses throughout the geometry. 
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 Figure 2.15. Mechanical Stresses predict cellular behaviors. 
Thermal cooling model of an annulus shows regions of high stresses 
localized primarily along the geometry periphery (D, G). Heat map of 
BrdU incorporation, a measure of proliferation, varies within 
geometry in agreement with predicted substrate mechanical stress. 
Cell proliferation varies with mechanical tension state highlighting 
the importance of multicellular mechanics in regulating individual 
cell behaviors. Figure adapted from [123], copyright PNAS. 
 
2.9 Rationale for quantitative methods 
 
Traction force was used as an overall metric to determine the contractile ability of a cell, or in the 
case of multicellular use, an aggregate. Traction force is most commonly used in the literature to 
measure cell tension, while other techniques such as atomic force microscopy measure “stiffness” 
which is an indirect measure of cell tension. Determining tension of a single cell within an aggregate 
is challenging, and in certain experiments stiffness was used as a proxy measurement for this 
reason.  Maximum substrate stress was used as a measure of peak stress applied to the substrate. 
Location of peak stress with respect to cell geometry was noted. For multicellular aggregates, 
location of peak stress with respect to position in the aggregate, was of interest. As cell shape and 
area can be indicative of phenotypic state, cell area was reported in Chapter 3. Shape factor and 
elongation was used to give an indication as to how many cellular filopodia (extensions) were 
present and the degree of polarization, respectively. Since cells can reorient with stretch and the 
rate of reorientation is cell type specific [126], the angle of orientation was also quantified. Alazarin 
Red S intensity was used as an indicator of calcium mineralization (reviewed by Merryman [10]). 
Caspase 3/7 activity was used to determine the presence of apoptosis within valvular interstitial cell 
aggregates. As a terminal measurement of cell death, calcein AM and ethidium homodimer-1 were 
used. The αSMA incorporation into stress fibers, YAP translocation to the nucleus [124, 127], and 
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vinculin size [128] were used as semi-quantitative immunohistochemistry markers of high cell 
tension states. 
2.10 Summary 
 
The valvular interstitial cell is a mechanosensitive cell type which expresses a range of phenotypic 
states from quiescent fibroblasts to highly contractile myofiboblasts. This range in phenotypes is 
affected by substrate stiffness and the presence of soluble factors. The amount of cell tension is 
influenced by the phenotypic state. Stretch, indirectly measured by cell area, has also been shown 
to affect cell tension. As the valve is a highly dynamic environment, understanding the traction force 
response to long-term cyclic stretch is of critical importance for understanding valvular interstitial 
cell tension and phenotypic regulation in physiologically relevant mechanical environments. The 
ability of these cells to undergo aggregation in vitro appears to be influenced by many things, such 
as cell tension, aggregation frequency increases in the presence of TGF-β1, increased Rho-pathway 
activity, being cultured on stiff culture surfaces, and cyclic stretch when cultured with TGF-β1. 
However, to date, no study has examined the distribution of tension within the aggregate, and 
induction of apoptosis and calcification. This is partly due to the random nature of the aggregation 
process. In order to facilitate investigation of the underlying disease mechanisms where valvular 
interstitial cells undergo apoptosis and calcification after aggregation, more reliable, repeatable, and 
controllable methods of aggregation must be established. 
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3.0 Abstract 
Mechanical stimulation is recognized as a potent modulator of cellular behaviors such as 
proliferation, differentiation, and extracellular matrix assembly. However, the study of how cell-
generated traction force changes in response to stretch is generally limited to short-term 
stimulation. The goal of this work is to determine how cells actively alter their traction force in 
response to long-term physiological cyclic stretch as a function of cell prestress. We developed a 
novel method to assess traction force following long-term (24 h) uniaxial or biaxial cyclic stretch 
under conditions of high cell prestress with culture on stiff (7.5 kPa) polyacrylamide gels (with or 
without TGF-β1) and low prestress by treating with Blebbistatin or culture on soft gels (0.6 kPa).  In 
response to equibiaxial stretch, valvular interstitial cells (VICs) on stiff substrates decreased their 
traction force (300 nN to 100 nN) and spread area (3000 to 2100 µm
2
). With uniaxial stretch, the 
cells had similar decreases in traction force and area and reoriented perpendicular to stretch. TGF-
β1 treated VICs had higher prestress (1100 nN) and exhibited a larger drop in traction force with 
uniaxial stretch, but the percentage changes in force and area with stretch were similar to the non-
TGF-β1 treated group.  Cells with inhibited myosin II motors increased traction force (41 nN to 63 
nN) and slightly reoriented towards stretch direction.  In contrast, cells cultured on soft gels 
increased their traction force significantly from 15 nN to 45 nN, doubled their spread area, 
elongated from an initially rounded morphology, and reoriented perpendicular to uniaxial stretch.  
Contractile moment measurements provided results consistent with total traction force 
measurements.  Combined, the results indicate that the change in traction force in response to 
external cyclic stretch is dependent upon the initial cell prestress. This finding is consistent with 
depolymerization of initially high-tension actin stress fibers, and reinforcement of an initially low-
tension actin cytoskeleton.  
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3.1 Introduction 
Cell traction forces are essential to numerous cell processes such as migration  [112, 129], adhesion 
[115], and extracellular matrix (ECM) assembly [113]. Cells generate traction forces through the 
actin-myosin machinery of the cytoskeleton which are transmitted to the surrounding extracellular 
matrix (ECM) via integrins. Cell traction forces produce stress and strain in the surrounding matrix, 
and the external stress and strain in the ECM modulate cellular functions such as ECM protein 
secretion [130] and differentiation [114]. Many disease states such as hypertension, fibrosis, and 
cancer result in the dysregulation of a cell’s ability to generate traction forces [131-133]; as such, 
traction force is an important functional readout of cell phenotype [134].  
Traction force is also a useful measure of a cell’s integrated response to physical and biochemical 
cues. Cell traction forces have been shown to be influenced by substrate stiffness [82, 91], 
restriction of both cell shape [107] and spreading [82, 117], ECM composition [135], and the 
presence of soluble factors [91]. Recently, rapid increases and decreases in traction force in 
response to stretch have been documented [118, 119]; however, the ways in which the traction 
forces are altered upon remodeling of the cytoskeleton in response to long-term external stretch 
remains largely unknown. Understanding the ways in which cell-generated forces change with long-
term cyclic stretch would provide insight into the regulation (or dysregulation) of cell tension during 
cell differentiation, proliferation, and apoptosis – biological events that occur over time-scales not 
currently investigated in combination stretch/traction force studies. 
Collectively, observations from a variety of studies indicate that many concomitant factors affect the 
ability of a cell to generate traction force in static culture. As substrate stiffness increases, the ability 
of cells to generate traction force increases [82, 91]. On stiffer substrates, spread area [117], cell 
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form factor (a function of cell area and perimeter) [107], and elongation [117] may also increase. 
These morphometric parameters affect the traction force that a cell is able to generate; it has been 
demonstrated that cells with larger spread area [117] and greater elongation [136] generate higher 
magnitudes of traction force compared to their respective controls. Stiffness, area, and cell shape 
relationships become even more complicated with the addition of dynamic stimulation. We have 
previously demonstrated that, with cyclic equibiaxal stretch for six hours, cells that are small and 
rounded in static culture on soft (0.6 kPa) substrates increase in area and elongation at levels similar 
to cells cultured statically on stiff substrates [137]. Additionally, increases in traction force and cell 
proliferation have been reported with short-term stretch on soft micropillar substrates [29]. 
The cell’s ability to generate traction force changes rapidly with stretch and depends on the 
magnitude, direction, type, and duration of stretch, as well as the cell's orientation with respect to 
the stretch direction. On polyacrylamide gels, Fredberg and colleagues observed that cell traction, as 
represented by the contractile moment, decreases precipitously in cells subjected to a rapid step 
and release of stretch [118, 138]. The recovery following the immediate loss of traction depends 
upon the uniformity of stretch. With a homogeneous strain field, the traction recovers to baseline 
over approximately 10 minutes, whereas with a non-homogeneous strain field, cells increase their 
contractile moment [138]. With multiple cycles of repetitive homogeneous stretch and release, the 
cells were not able to recover their baseline contractile moment within the 10-minute dwell time. 
Subcellular measurements of traction force utilizing stretch of micropillar arrays indicate that the 
cell traction response can vary with location within the cell, with the largest changes in traction 
force occurring along the periphery [139]. The duration of stretch also affects the traction force 
response; Fu and colleagues observed that cell-generated traction forces increase initially in 
response to a rapid step stretch of cells cultured on micropillar arrays, then return to or fall below 
initial baseline values over the next 60 minutes as the stretch is held [119]. More recently, the same 
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research group utilized micro-contact printed areas of various geometries and demonstrated that 
cell shape and orientation control the cell’s traction response to stretch [120]; notably, elongated 
cells oriented perpendicular to stretch exhibited little response to stretch, whereas those aligned 
with stretch exhibited large changes in traction force.  These pioneering studies indicate that the 
traction force changes rapidly with short-term stretch (<1 hr); however, extrapolating the 
cytoskeletal response observed in each of these studies to how the traction force will change with 
long-term cyclic stretch is not possible due to active adaptations of the cytoskeleton to stretch, such 
as alpha-smooth muscle actin incorporation into stress fibers and reorientation of the cell “away” 
from stretch.  
The goal of this work is to determine how cells alter their traction force in response to long-term 
physiological cyclic stretch.  We hypothesize that changes in traction force with stretch are 
dependent upon the cell prestress.  As defined in prior reports [140], cell prestress is the overall 
level of cytoskeletal tension under static conditions (prior to stretch). Cell prestress can be 
quantified by total traction force as we do herein, or by total contractile moment applied to the 
substrate, although it is understood that neither of these metrics have units of engineering stress. In 
the present studies, cell prestress was modulated by culturing valvular interstitial cells (VICs) and 
U2OS cells on tunable-modulus polyacrylamide hydrogels (7.5 kPa and 0.6 kPa) and treatment with 
TGF-β1 or Blebbistatin.  The hydrogels were attached to custom-designed PDMS wells and 10% 
biaxial or uniaxial stretch was applied with micro-controlled motors. After 24 hours of stretch, wells 
were removed from the stretch device and imaged for traction force measurements and analysis of 
cell morphology. 
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3.2 Methods 
3.2.1 Cell Culture 
Valvular interstitial cells (VICs) were chosen as a fibroblastic cell which is capable of alternating its 
prestress level with TGF-β1 supplementation [14]. VICs were isolated from porcine heart valve 
leaflets obtained from a local abattoir (Blood Farm, Groton, MA) within three hours of tissue harvest 
per published protocols [137]. Cells from passages 3-4 were used for all experiments. U2OS (human 
osteosarcoma) cells, generously donated by Dr. Roland Kaunas (Texas A&M University), were used 
as comparison cells to determine if there is  a cell-type specific traction force response with stretch.  
For all experiments, cells were seeded at a density of 2,500 cells/cm
2
 and cultured for 24 hours at 
37⁰ C, 10%  CO2, in standard media (1X DMEM, 10% FBS, and 1% antibiotic-antimycotic). To pre-
differentiate the VICs to the myofibroblast phenotype and thus increase the cell prestress, a subset 
of VICS were pre-treated with 5 ng/mL TGF-β1 (AcroBiosystems, Newark, DE) for five days prior to 
cell seeding. To inhibit myosin-II activity and reduce the cell prestress, a separate subset of cells 
were treated with 10 µm Blebbistatin (Sigma-Aldrich, St. Louis, MO) prepared according to 
manufacturer’s directions for one hour before stretching. Following addition to the wells, 
Blebbistatin remained in the media for the duration of the experiment.  
3.2.2 Stretch System and Culture Well Development 
A custom stretch system and compliant culture well system was developed with maximum optical 
clarity and uniformity in the strain field to apply long-term cyclic stretch to the cells (please see 
Supplementary Information for details). The stretch device consists of four micro-controlled stepper 
motors on a low-profile aluminum base that can be mounted on an inverted microscope or placed in 
a standard temperature and CO2-controlled incubator. The system is controlled by an open-source 
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Multi-Platform Integrated Development Environment (MPIDE) program which allows for stretch 
patterns, such as pure uniaxial stretch and uniaxial stretch of alternating direction each cycle, not 
available on commercial cell stretching systems (e.g., Strex,).   
Custom compliant culture wells were designed to circumvent limitations of commercially available 
systems for stretching cells which make traction force measurements challenging, namely: thick 
membranes and non-uniform strain fields in Flexcell© and Strex wells. The inverse molds for the 
custom wells were created with a thin metal spacer to form the bottom membrane. This allowed for 
the wells to be created in one casting of material, enabling the bottom to formed without prestretch 
(for more information on the design of the well, please see Supplementary Information).  The molds 
for the wells were drawn in Solidworks (Daussalt Systems, Waltham , MA) (Figure 3.1a) and 
machined out of polycarbonate sheets (Tap Plastics, Stockton, CA) using a CNC machine. The wells 
were optimized for uniformity of strain field using finite element analysis (ANSYS, Canonsburg, PA). 
Wells were cast with 16:1 base to cross-linker ratio of polydimethylsiloxane (PDMS, Sylgard 184 
Silicone Elastomer Kit, Dow Corning, Midland, MI) and strain patterns under various stretch 
regimens were validated using high-density displacement mapping software (courtesy of Dr. Glenn 
Gaudette, Worcester Polytechnic Institute) (Figure 3.1c). The custom well has an integrated bottom 
membrane which is sufficiently thin (<150 μm) to allow for quality images to be obtained even with 
attachment of a 70 μm thick polyacrylamide gel (details in the next sub-section).   
For all experiments, wells were stretched 10% (equibiaxial or uniaxial) at 1 Hz with a saw-tooth 
waveform for 24 hours in a temperature and CO2-controlled incubator. The well was then 
transferred to a microscope for traction force measurements in the zero-strain configuration. 
Measurements were completed approximately 15 minutes following cessation of stretch to allow 
for equilibration of cell-generated traction forces in the undeformed configuration. Static control 
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cells, cultured in identical wells that were not mounted on the stretch device, were analyzed in the 
same manner to serve as controls.  
 
Figure 3.1- Overview of method. (a.) Wells were created in a custom polycarbonate mold out of 
16:1 PDMS. (b) Polyacrylamide gels were attached to PDMS wells using previously published 
protocol.  After chemical treatment which activates silicone substrate, an unpolymerized droplet of 
polyacrylamide was placed onto well. A 22mm coverslip was placed onto droplet (1b, left) and a 
uniform gel thickness was acquired by capillary action. (1b, right) post-polymerization coverslip was 
removed. (c) Stretch wave form of strain field analysis. Color dots indicate where representative 
images of wells were taken, and are outlined for clarity. (d) Analysis region of uniaxial stretched gel 
for strain field analysis indicated with transparent red square. Longitudinal (εxx) and lateral (εyy) 
strain fields shown.  
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3.2.3 Tunable-Stiffness Traction Force Substrate Preparation 
For traction force measurements, polyacrylamide (PA) hydrogels were chosen as the compliant 
substrate as they are optically clear, have well-defined mechanical properties, and have an easily 
tunable modulus. To attach 70 µm thick PA to the PDMS wells, our previously published method was 
utilized with minor modifications [137].  Briefly, the PDMS surface was plasma treated then 
activated with a series organic solvents to facilitate PA bonding to the PDMS membrane, then 50 µl 
of PA solution was pipetted on the surface and cover slipped under continuous nitrogen flow. Even 
with these aggressive treatments, often when removing coverslips following polymerization, the low 
modulus gels (<1 kPa) stick to the glass coverslip and pull off the PDMS membranes. To facilitate 
more robust attachment, a thin (50 µm) PA gel with modulus of 7.5 kPa was attached to the gel first, 
and then 50 µl the low modulus (0.6 kPa) solution was pipetted onto the high modulus gel. 
Attachment was validated using different color fluorescent beads within the gels for verification of 
each layer.  
Next, to allow for traction force measurements, 0.2 μm fluorescent beads were embedded into the 
top surface of the gel. This was accomplished by evaporating 35 μL of a 0.5% solution of 0.2 μm 
fluorescent beads (Life Technologies, Grand Island, NY ) in 100% ethanol (Sigma-Aldrich, St. Louis, 
MO) onto 22 mm circular glass coverslips (VWR, Randor, PA). The beaded coverslip was placed on 
top of the unpolymerized top gel. The gels were allowed to sit undisturbed for 1 hour before the 
coverslips were removed.  
To facilitate cell attachment, PA gels were coated with 0.5 mg/ml solution of sulpho-SANPAH 
(Thermo-Fischer, Waltham, MA) and reacted under ultraviolet light as per [137]. A monomeric 
pepsin-extracted collagen solution (PurCol, Fremont, CA) of 3 mg/ml was diluted to 200 μg/ml in 1 
mL of 0.02 N acetic acid and was placed on the gels. The collagen solution remained on the gels 
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overnight at 4⁰C. As the process is not sterile, to avoid contamination, gels were treated with an 
antibiotic solution and rinsed with PBS prior to cell seeding. 
The modulus of polyacrylamide gels was measured by atomic force microscopy indentation at 1 
µm/s (Asylum AFM, 0.06 N/m cantilever, conical tip). Ten measurements were made over the gel, 
and two gels per stiffness were analyzed. A custom MATLAB (Mathworks, Natick, MA) script was 
then used to extract the Young's modulus from each curve by fitting the first 200 nm of indentation 
data to the Hertz model for a conical indenter. The extracted values were averaged to determine 
the mean modulus for each gel. 
3.2.4 Traction Force Measurements 
Images were captured using a Zeiss inverted microscope and CCD camera (Thornwood, NY). Using a 
motorized stage and Zeiss Axiovision software (v. 4.8.2 SP1), three images were acquired for each 
cell: a phase contrast image of cell, fluorescent image of beads within substrate beneath the cell, 
and a fluorescent image of beads in relaxed substrate when cell was removed via 0.25% trypsin with 
EDTA (Gibco, Grand Island, NY), see figure 3.2c. 6-20 cells per treatment/stretch condition were 
imaged in each the static control and stretched groups.  Please see table 3.1 for exact number.  Cell 
traction force present in table 3.1 is a population average and standard deviation, not a reflection of 
individual cells before and after stretch.  Due to the flexible nature of the PDMS membrane, the 
weight of the liquid media and trypsin caused slight image distortion.  A custom well holder was 
created with a No. 1 25 mm square coverslip (VWR, Logan, UT) to support the thin membrane 
during imaging (Figure 3.2b). 
A custom MATLAB program (Mathworks, Natick, MA) was created for image processing. Drift from 
the stage was removed by averaging the displacement of beads within small selected areas of the 
image corners. The images were then cropped around the cell of interest and cell boundaries were 
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manually selected. Bead displacements were calculated using mass particle image velocimetry (code 
available from MATLAB Central).  Substrate material properties, substrate dimensions, bead 
displacements, and the cell boundary were imported into ANSYS 14.0 (Ansys, Canonsburg, PA). 
Using FEA, stresses at the nodes under the cell were calculated. A custom MATLAB program was 
used to calculate total cell traction force magnitude, F, from the surface shear stresses, S, in the 
substrate and unit mesh area, da, using the following equations: 
 ?? ? ??????? ? ??????  (Equation 3.1) 
 ?????? ? ? ??? ? ???????  (Equation 3.2) 
Only stresses from nodes which lie within the cell boundary were integrated for the traction force 
calculation in (2). 
As a second measure of overall cell contractility, contractile moment was computed as described 
previously in [141].  
 ? ? ??? ????  (Equation 3.3) 
Where Mxx is the combination of the traction forces in the x-direction weighted by their coordinates 
in the x-direction and Myy  is the combination of the traction forces in the y-direction weighted by 
their coordinates in the y-direction.  As defined, the net contractile moment is negative for a cell 
that is pulling inward and positive for a cell that is pushing outward.  The angle of principle stress 
was also computed as described in [141]. 
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Figure 3.2. Overview of traction force measurements. (a) Time course schematic of experiment. All 
stretch experiments were at 10% magnitude (either uniaxial or biaxial stretch). At 24 hours, stretch 
was stopped and the well was removed from the stretch device and placed in microscope viewing 
dish for image acquisition. Wells were in original conformation during the image acquisition process. 
(b) Image acquisition set up, side view. (c) Representative images of traction force calculation. Phase 
image of cell were acquired as well as a fluorescent image of beads embedded within the 
polyacrylamide gel. Green and red colorizations show the stressed and relaxed (cells trypsinized) 
substrate, respectively. Using a particle tracking algorithm, bead displacements were calculated. 
Finally, knowing the modulus of the substrate and the bead displacements, a stress map of the 
substrate was created. 
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3.2.5 Orientation and Area Measurements 
Phase images were acquired at 24 hours, and cell morphological measurements were made using 
ImageJ [142]. To determine alignment angle relative to the stretch axis, a line was fit through the 
long axis of the cell nucleus. For angles over 90 degrees, the supplementary angle is reported due to 
symmetry. A minimum of 90 cells from each group were measured. Cell area, perimeter, and major 
and minor axis dimensions were measured, and form factor [137, 143], an indication of the number 
of cellular extensions, and elongation [144] were calculated using the following formulas: 
??????????? ? ????????????????? (Equation 3.4) 
?????????? ? ??????????????????????? (Equation 3.5) 
where Amaj  and Amin are the major and minor axes of a fitted ellipse, respectively. 
3.2.6 Statistics 
All values reported are mean ± standard deviation. Differences in metrics between static and stretch  
were compared for each treatment using two-tailed student t-tests assuming equal variance. Due to 
dissimilarity in the baseline levels between treatment groups (e.g., TGF-β1, Blebbistatin, soft, stiff), 
these treatment groups were not compared statistically.  A p-value less than 0.05 is considered to be 
statistically significant. Each stretched group was compared to its respective control with a student 
t-test using Sigma-Plot v. 11.0  (Systat Software, Inc., San Jose, California). Angle was measured with 
respect to stretch direction, stretch direction was defined as 0 - 180⁰. 
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3.3 Results 
To assess the effect of long-term stretch on traction force, we first cyclically stretched the cells 
equibiaxially on stiff substrates to reduce effects of stretch avoidance by cell reorientation. The 
maximum substrate stress decreased significantly with stretch, as did the overall cell traction force 
and contractile moment (p<0.05). As our current experimental set up does not allow for tracking 
individual cells over time, traction force measurements reported herein are population averages of 
stretched cells compared to a separate, paired control group of statically cultured cells. 
Representative stress plots for cells from each culture condition are shown in Figure 3.3. Figure 3.4 
shows the relative (%) changes in cell traction force, cell area, and contractile moment for each 
experimental group as compared to their respective controls. Figure 3.5 shows cell elongation and 
average form factor changes with long-term cyclic stretch and Table 3.1 lists the population 
averages as numerical values for all the aforementioned variables.  Following cyclic equibiaxial 
stretch, cells appeared to have less cellular extensions than respective controls and average cell area 
was smaller (n.s.). The average form factor was significantly larger in stretched cells indicating that 
cyclic equibiaxial stretch induced cells to adopt a more rounded phenotype (Figure 3.5).  As 
expected, there was no preferential angle of orientation for VICs under cyclic equibiaxial stretch; 
both static culture and stretch cells exhibited a random orientation (Figure 3.6). 
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Figure 3.3. Overview of experiments. VICs were cultured on 7.5 kPa substrates unless otherwise 
indicated. Pre-treatments are indicated on the representative static stress map. Type of stretch 
indicates whether uniaxial or biaxial stretch was used for a given experiment. For cells cultured 
under high prestress conditions, mean traction force, mean contractile moment, mean cell area and 
mean maximum substrate stress all decreased with stretch. Mean form factor increased for both 
equibiaxially stretched cells and TGF-β1 pre-treated cells when uniaxially stretched indicating a 
decrease in extent of cell extensions. The opposite was true for cells under low prestress conditions: 
mean traction force, mean maximum substrate stress and mean cell area all increased when cells 
were stretched compared to static control cells. Scale bar = 50 μm.  
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Figure 3.4. Cell traction force and area change with long-term cyclic stretch. (a) % change in 
cell traction force was normalized to respective controls for each treatment group. Error bars 
reflect raw stretch traction force values divide by the mean of the controls then multiplied by 
100%. Cell traction force decreases with biaxial stretch, uniaxial stretch, and uniaxial stretch 
with TGF-β1 pre-treatment (TGFβ) on a 7.5 kPa substrate. Cell traction force increases with 
stretch slightly when cells were pre-treated with 10 µM Blebbistatin (Bleb) prior to stretch and 
with cells that were stretched on a soft substrate. (b) % change in cell area was normalized to 
respective controls for each treatment group. Error bars reflect raw stretch cell area values 
divide by the mean of the controls. Cell area decreases with biaxial stretch, uniaxial stretch, and 
uniaxial stretch with TGF-β1 pre-treatment on a 7.5 kPa substrate. Cell area with stretch when 
cells were pre-treated with 10 µM Blebbistatin prior to stretch and with cells that were 
stretched on a soft substrate. (c) % contractile moment followed same trends as traction force, 
the average contractile moment decreasing significantly for cells under high prestress. For cells 
under low prestress, there was an increase in average contractile moment with stretch. * 
indicates significance when compared via student t-test to respective static controls (p<0.05).  
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Figure 3.5. Cell shape and elongation changes with long-term cyclic stretch. (a) elongation 
ratio was unaffected by stretch with most treatment conditions, except with culture on a 
soft (0.6 kPa) gel (b) Form factor increased with biaxial stretch and uniaxial stretch with 
TGF-β1 (TGF β) as cell perimeter decreased with depolymerization of many cellular 
extensions in the direction for stretch.  Form factor decreased with stretch on a soft 
substrate as cells elongated from a circular morphology. * indicates p<0.05 
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Figure 3.6. Cells reorient with 24 hour stretch regardless of substrate stiffness. Angle of orientation 
for static and stretched cells represented as 0-90° histograms. Angle of orientation was measured 
with respect to the stretch direction (0°-180°). Cells that oriented perpendicular to stretch had an 
angle of orientation of 90°.  
 
We then investigated if VICs would maintain their level of traction force when allowed to reorient 
away from the direction of stretch (the membrane is essentially static perpendicular to the stretch 
direction). Despite orientation to the direction of zero stretch, cyclic uniaxial stretch caused a 
significant decrease in maximum substrate stress and traction force.  The decrease in traction 
relative to matched static controls for uniaxial stretch was somewhat lower than for equibiaxial 
stretch (43% and 67% decrease, respectively). The average contractile moment also decreased 
significantly with stretch, though it was slightly less than for equibiaxially stretch (65% and 76%, 
respectively).  The average cell area decreased significantly with stretch, but no significant changes 
in average elongation ratio or form factor changes were measured.  
In the presence of TGF-β1, VICs cultured on stiff substrates differentiate into myofibroblasts with α-
SMA positive actin stress fibers [14] which can withstand high forces; thus, a 5-day pre-treatment 
 Ch. 3: Altered traction force with long-term stretch 
65 
 
with TGF-β1 was used to increase the cell prestress. VICs cultured under static conditions with TGF-
β1 pre-treatment generated two and a half times the maximum substrate stress and traction force 
as the untreated static controls (see Table 3.1 for numerical values) and appendix B for the 
distributions). These cells also had a greater average cell area and appeared to have more cell 
extensions under static conditions when compared to untreated VICs under static conditions. 
Despite the ability of the actin cytoskeleton to withstand tension with TGF-β1 treatment, these cells 
exhibited a significant decrease in the cell traction force after 24 hours of uniaxial stretch similar to 
the untreated cells (Figure 3.4). Areas of locally high stress that concentrated under the cellular 
extensions in statically cultured cells were not apparent with stretched cells, and there was a 
decrease in maximum substrate stress following stretch (n.s.). Average contractile moment 
decreased significantly with stretch.  Average cell area decreased significantly with stretch, likely 
due to the decreased number of cellular extensions as indicated by the significant increase in form 
factor (Figure 3.5). The average elongation ratio of the cells was not significantly altered by stretch. 
Like non-treated VICs, TGF-β1 pre-treated cells were oriented perpendicular to stretch direction, 
and there was no statistical difference in orientation between untreated VICs and VICs pre-treated 
with TGF-β1 after 24 hours of cyclic uniaxial stretch.  
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Table 3.1- the mean average stress for a group can be approximated within a few % error by dividing 
the mean traction force by the mean cell area. 
 
Table 3.1. Summary of experimental results.  Experimental details given in columns, 
including number of cells analyzed in each group, as well as measured values for cell area, 
traction force, contractile moment, maximum substrate stress, form factor, elongation ratio 
and average angle of orientation. Data presented as mean ± standard deviation and 
represent a population average and not a calculation from individual tracked cells. * 
indicates significance compared to static control, student t-test (p<0.05) 
Following the observation that the cells reduced their traction in response to long-term stretch, we 
sought to determine if stretch could increase cytoskeletal tension for cells below their optimal 
cytoskeletal tension level.  Cell prestress was decreased in two ways.  First, Blebbistatin, a myosin II 
inhibitor, was used as a chemical means of decreasing the cytoskeletal tension prior to stretch. VICs 
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treated with Blebbistatin generated about ~25% of the traction force of static, untreated VICs.  
Although not significant, maximum substrate stress and cell traction force increased with cyclic 
uniaxial stretch. The average contractile moment increased its magnitude significantly with stretch 
(Figure 3.4).  Additionally, the contractile moment for some control Blebbistatin treated VICs and all 
stretched Blebbistatin treated VICs was positive. The Blebbistatin treated VICs had outward 
displacement vectors near the cell periphery.  This non-intuitive finding may possibly indicate 
outward forces due to polymerization of actin stress fibers and/or non-recoverable stretch in the 
stress fibers which push outward upon cessation of cyclic stretch. In these cells, the myosin II motors 
were inhibited an unable to provide necessary inward contractile force (see representative images 
in Appendix B, supporting information). VICs treated with Blebbistatin had a smaller spread area, 
though they remained elongated, exhibiting a very thin, spindle shape. Average cell area increased 
significantly with stretch (Figure 3.4), while average form factor and average elongation ratio (Figure 
3.5) were not statistically different for static and stretched Blebbistatin-treated VICs. Blebbistatin-
treated cells had a slight, yet significant, orientation parallel to the stretch direction.  
Second, as a mechanical means of reducing prestress, VICs were cultured on low modulus (0.6 kPa) 
polyacrylamide gels (termed “soft” herein in accordance with mechanobiology literature).  Cells 
statically cultured on these soft substrates had a circular morphology with low traction force and 
low maximum stress values (Figure 3.3). With uniaxial stretch, the traction force and cell area 
increased significantly (Figure 3.4) and the maximum stress increased slightly (n.s.). The mean 
contractile moment was positive for cells cultured on soft substrates with stretch compared to static 
controls which had a negative contractile moment (Figure 3.4). The positive contractile moment for 
the stretched cells on soft may indicate that the cells are spreading outward, as evidenced by the 
increase in mean cell area, due to dynamic stimulation.  VICs became elongated with a significant 
increase in the average elongation ratio.  The average form factor significantly decreased, and 
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average elongation significantly increased (Figure 3.5), indicating a transition to a more polarized 
cell phenotype. Similar to VICs cultured on stiff substrates, VICs on soft substrates had a statistically 
significant orientation away from the direction of stretch (p<0.05). There was a uniform distribution 
of angles for static cells, whereas the average angle for stretched cells was 70 degrees relative to the 
axis of stretch (Figure 3.6). As orientation away from stretch on a soft substrate contradicted 
previous findings by Kaunas and colleagues with U2OS cells (human, osteosarcoma) cultured on soft 
collagen substrates [30], an additional study with U2OS cells on soft substrates was done to 
compare orientation responses on soft (0.6 kPa) and very stiff (1 MPa) substrates. Similar to VICs, 
U2OS cells reoriented away from stretch when cultured on both the soft and stiff substrate 
(appendix B, supporting information). After cyclic uniaxial stretch, U2OS cells on soft substrates 
were equivalent in size to stretched U2OS cells on 1 MPa substrates. An additional experiment was 
conducted on U2OS cells to ascertain how cells integrate stretch signals over time in the PDMS 
culture wells. U2OS cells were subjected to three patterns of stretch: 10% uniaxial stretch, 10% 
equibiaxial stretch, or alternating uniaxial stretch (10% uniaxial x-direction stretch, followed by 10% 
uniaxial y-direction of stretch). The cytoskeleton of alternatingly uniaxial stretched groups appeared 
diamond in shape with peaks at approximately 45 degrees from the directions of stretch; see 
appendix B, supporting information. 
3.4 Discussion 
In this study, we tested the hypothesis that changes in cell-generated traction forces in response to 
long-term cyclic stretch are dependent upon the prestress in the cell. We developed and 
implemented a system capable of measuring traction force generated by cells cultured on 
substrates with tunable elastic modulus.  Following cyclic stretch for 24 hours, decreases in traction 
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force in cells with high prestress (for the particular cell phenotype) and increases in traction force 
for cells with low prestress were observed. This behavior, along with reorienting away from uniaxial 
stretch, is consistent with maintaining homeostatic cytoskeletal tension during dynamic stretch, i.e., 
if the cytoskeletal tension is at a maximal level in static culture, it is reduced to accommodate 
dynamic stretch by retraction of cellular extensions and/or reorientation, whereas if it is below the 
maximal level (e.g., on a soft substrate), the cytoskeletal tension is increased toward its optimal 
level. The method and data presented herein can be used to validate future mathematical and 
phenomenological models of cell reorientation and cell shape changes with stretch based upon 
cytoskeletal tension. 
3.4.1 Effects of stretch on cytoskeletal structure and mechanics 
Rapid cytoskeletal remodeling with stretch has been observed with metrics other than traction force 
including immunofluorescence, storage modulus, and cell spread area. Early work by Pender and 
McCulloch showed rapid changes in the cytoskeleton with stretch using immunflourescence; F-actin 
in gingival fibroblasts is reduced by 50% at 10 s after stretch, but increases more than 100% at 50 s 
after stretch [145]. Further, Costa et al. observe that release of stretch causes human aortic 
endothelial cells cultured on pre-stretched silicone membrane to depolymerize stress fibers in the 
direction of stretch release when release rates were greater than 5% stretch per second, and rapid 
remodeling was observed within 60 s of release of stretch [146]. In response to transient stretch-un-
stretch, human bladder smooth muscle cells rapidly disassemble F-actin [118].  In parallel to changes 
in the actin cytoskeleton, cell mechanical properties also change with stretch.  Fredberg and 
colleagues demonstrated that human airway smooth muscle cells abruptly soften (as measured by 
G’ decrease) with transient equibiaxial stretch with cell stiffness recovery over ~10 minutes [138]. 
This behavior was interpreted as “fluidization” and “resolidification” of the cytoskeleton [147]. 
Throm et al. demonstrated cytoskeletal remodeling (via an increase in cell spread area) of VICs when 
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they were cultured on 0.6 kPa substrates and stretched equibiaxially at 1 Hz for 6 hours [137]. 
Although traction force was not measured in these studies, these works support rapid cytoskeletal 
remodeling with stretch which would likely lead to changes in cellular forces. 
3.4.2 Effects of long- and short-term stretch on cell traction force 
Prior to this study, changes in cell traction force have been measured with stretch on short 
timescales (less than one hour) using stretch and release as well as stretch and hold experimental 
designs. Navajas and colleagues [148] rapidly stretched epithelial cells cultured on collagen gels.  
They observed an initial passive increase in traction force with stretch (with 5.5% and 11% stretch); 
with release of stretch, there was a significant decrease in traction with recovery over 10 minutes. 
Fredberg and colleagues applied a transient homogeneous strain field and, in contrast to Gavara, 
found that the contractile moment decreased rapidly following stretch and recovered over a period 
of approximately 10 minutes [138]. Fu and colleagues applied an instantaneous step-stretch 
(without release) to smooth muscle cells cultured on a micropillar device and observed the cell-
generated forces for one hour [119]. Cells increased their traction force within the first half hour of 
observation and decreased to below baseline after 60 minutes. Although the time-course of these 
studies is not long enough to observe cytoskeletal adaptation to stretch involving protein 
incorporation (such as αSMA which has been reported to take 72 hours [64]), these studies shed 
light on the passive transfer of load within the cytoskeleton and the ways in which the rapid 
reorganization of the existing cytoskeletal proteins translates into the evolution of localized active 
cell-generated traction.   
Several theories have been developed which predict that cell tension is either maintained or 
increased with stretch [149]; however, no combination studies of simultaneous traction force and 
stretch have reached long enough time scales to allow for changes in protein expression and 
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differentiation which many groups report with stretch [26]. Many studies have observed 
reorientation with stretch; however, substrates outside of the physiologically relevant range of 
stiffness are generally utilized [150-152]. To date, the only study of simultaneous cell reorientation 
and traction force has been done with very slow tidal stretches [141]. Human embryonic vascular 
endothelial cells were subjected to a trapezoidal waveform (~1 s loading, 3 s hold, ~ 1 s unloading) 
every 49 seconds for two hours. There was an initial drop in cell tension at approximately 50 
minutes into the experiment. Once cells reoriented perpendicular to stretch, they report that cells 
recover their full contractile moment in contrast to the depressed traction exerted by the cells on 
our stiff substrates following 24 hours of stretch at 1 Hz.  The difference in frequency or length of 
culture may be responsible for the differences: repeated rapid stretching for an extended duration 
may changes protein levels so that VICs become less contractile, which has been shown with 
pulmonary fibroblasts [26] as well as vascular smooth muscle cells (Marsha Rolle, Worcester 
Polytechnic Institute, personnel communication).   
 Changes in traction force with stretch are heterogeneous within and between cells. Fu and 
colleagues observed the largest changes in force along the cell periphery [119, 139]. We also found 
that the stresses under cellular extensions at the periphery of the cells cultured on stiff substrates 
had the most markedly decreased following stretch. In contrast, on very soft substrates, cells were 
rounded in static culture and elongated and created areas of high substrate stress under the cellular 
extensions. The ways in which the peripheral tension fluctuations due to external loading are 
translated into a global cell response, such as cell reorientation and cell shape are still unknown.  In 
terms of cell-to-cell difference in the response to stretch, Gavara et al. reported highly variable 
changes in traction between cells upon release of equibiaxial stretch [148]. The authors attributed 
these differences to biological variations in the initial traction force (i.e., prestress). Epithelial cells 
with low initial traction force had greater recovery of traction force and recovered to baseline levels, 
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but cells with high initial traction force did not recover their ability to generate traction on the 
collagen substrate over the 10-minute timespan measured. Matsumoto and colleagues found 
biological variability in how smooth muscle cells respond to two cycles of slow stretch [139]. Cells 
either increased their traction force following the first cycle of stretch (termed an active myogenic 
response) or decreased their traction force following the first cycle of stretch (a passive response). 
The baseline traction force (i.e., prestress) was similar between groups, and the authors did not 
discuss a mechanism that would account for the differences. We also saw variability in traction force 
with stretch, with the greatest differences on the soft (0.6 kPa) substrates. Although the average 
traction force was greater for the stretched cells, several of the stretched cells on soft substrates 
had lower traction forces than did the average for static control cells. These cells were as elongated 
as those that generated higher tractions.  
3.4.3 Changes in traction force and spreading with stretch depend upon initial prestress 
Combined, our results indicate that the traction force response to long-term cyclic stretch is 
dependent upon the cell prestress level. In the presence of TGF-β1, the cell incorporates αSMA into 
the actin stress fibers and increases contractile activity.  The cell is thus able to generate more 
tension (>1000 nN); however, when cyclically stretched beyond homeostatic tension level for long 
duration, the cytoskeleton is remodeled by retraction of cellular extensions and/or reorientation 
away from stretch, resulting in a decrease in traction force.  The actin cytoskeleton of U2OS cells 
appears to have a lower homeostatic tension level compared to VIC cells cultured upon the same 
substrate stiffness (7.5 kPa), (Figure 3.3). However, U2OS cells reorient similar to the VICs and 
decrease traction force indicating that stretch increased homeostatic tension  despite starting at a 
relatively low prestress (~100 nN) when compared to VICs (~500nN). Our results indicate that initial 
prestress is dependent upon cell type.  In contrast to cells on stiff substrates, VICs cultured on soft 
substrates and those with inhibited myosin-II motor activity generate submaximal cytoskeletal 
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tension when cultured statically.  The traction force increased in these cells with long-term cyclic 
stretch, yet not to the level of cells culture on stiff substrates (either static or stretched). Sheetz and 
colleagues observed similar spreading of fibroblasts cultured on soft micropillars that were cyclically 
stretched equibiaxially [29]. 
In contrast, Krishnan et al. found that changes in cell traction in response to homogeneous stretch 
are not dependent upon substrate modulus (and thus initial cell prestress level) [138]. Their 
reported results indicate that in response to a transient equibiaxial stretch, the contractile moment  
is decreased to 20% of its initial value then recovers to initial levels within three minutes regardless 
of the modulus of the substrate (1, 4, or 6.2 kPa). The soft substrate utilized in our experiments has 
a somewhat lower modulus (0.6 kPa) resulting in a rounded cell morphology; this distinct 
morphological change was not reported by Krishnan et al.  
3.4.4 Reorientation of initially spread cells and the effect of prestress 
Both VICs (Figure 3.6) and U2OS cells (see Supplemental Figure 3.5) cultured on stiff substrates 
orientated away from the direction of uniaxial stretch in agreement with the literature for a variety 
of cell types [126, 153-156].  With equibiaxial stretch, the decrease in spread area was significant for 
both VICs and U2OS cells and, as expected, neither cell type reoriented. Alternating uniaxial stretch 
resulted in diamond-shaped cells with stress fibers at approximately ± 45° from the alternating 
directions of stretch. These data provide additional support for the theory that stress fibers exposed 
to high magnitude stretch depolymerize and that those with low tension are reinforced with stretch 
(appendix B, supporting information). To our knowledge, this is the first time that an alternating 
uniaxial stretch regimen has been utilized. 
It is possible that the rate of reorientation with cyclic stretch is related to the amount of cell 
prestress. Specifically, lower cell traction force and associated weaker substrate adhesion, we 
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predicted that cells would reorient more readily, and with higher traction forces to a lesser extent. 
Differences in reorientation was found between the two cell types we tested. U2OS cells, which on 
average generate less than a third of the overall traction force of VICs (Table 3.1) , were shown to 
reorient to a greater degree than VICs over 24 hours of uniaxial stretch (Figure 3.6 and appendix B, 
supporting information). Like VICs, U2OS cells had statistically lower traction force and statistically 
smaller area with stretch (Table 3.1). Differences in reorientation rate have been reported between 
cell types in the literature, but the relationship with traction force has not been measured 
simultaneously [126]. It was surprising that TGF-β1 treated VICs (myofibroblasts), which generate 
more than double the traction force of non-treated VICs and have mature focal complexes [157], 
reoriented to a similar extent as the untreated VICs and had an equivalent relative decrease in cell 
area with cyclic stretch.  Thus, it appears that degree of reorientation is more strongly associated 
with cell type than prestress . One possible explanation as to why TGF-β1 pre-treated VICs were still 
able to reorient is that stretch may also act to modulate phenotype in mechanosensitive cells 
reverting them to less contractile phenotype [26] and allowing them to reorient, although more 
experimentation needs to be done to test this hypothesis. 
Culture in the presence of Blebbistatin, a myosin-II motor inhibitor, resulted in cells with lower 
prestress. VICs that had been treated with Blebbistatin reoriented parallel to stretch. This 
observation is in agreement with comparable studies of Blebbistatin and stretch on PDMS 
substrates in the literature [144]. It has been proposed that myosin-II cross-bridge cycling helps 
maintain stress fiber tension, and stress fibers depolymerize when they are not at their homeostatic 
level of tension [158].  However, with myosin-II inhibited, the stress fibers are below their ideal 
tension level. With uniaxial stretch, stretch fiber tension is passively increased by the dynamic 
stimulus in the direction of stretch. Active tension generation by the cell is decreased with myosin-II 
inhibited, but stress fibers are able to form likely by using the passive tension generation of the 
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stretch. This would explain why the Blebbistatin treated cells orient parallel to stretch and not 
perpendicular. As Blebbistatin can affect some myosin-II independent processes [159], future work 
to determine myosin’s contribution to stress fiber tension and cell reorientation should also include 
myosin light chain inhibitors ML-7 and ML-9. Interestingly, approximately half of the Blebbistatin-
treated control cells and all of the Blebbistatin-treated stretched cells had a positive contractile 
moment, indicating outward (away from the cell body) forces. Outward pushing forces have been 
reported by Sheetz and colleagues for cells that had been stretched when the membrane returned 
to its original confirmation [29]. To our knowledge, this is the first reported finding of outward 
pushing forces in Blebbistatin treated cells and in any non-stretched cells. A possible explanation for 
the outward displacements by these cells is the outward polymerization of actin stress fibers while 
the myosin motors are inhibited and unable to provide an inward (contractile) force. These 
contractile moment values are above the level of noise in the measurement, and U2OS cells had 
similar measured cell traction force magnitudes but negative contractile moments (indicating 
inward, towards the cell body displacements).  
3.4.5 Reorientation and spreading of initially rounded cells with long-term stretch 
Both VICs and U2OS cells reoriented away from the direction of stretch when cultured on soft 
substrates.  Results of similar experiments reported by Kaunas and colleagues showed that cells 
reorient parallel to the direction of stretch when cultured on soft collagen gels (10% uniaxial at 1 Hz 
for 3 hours) [30]. This finding raises questions about the time-course of cell spreading and 
reorientation on soft substrates, whether the cells first spread out and then reorient, and what 
mechanism is allowing cells to maintain their area on soft substrates once they have reoriented (as 
in theory, the angle of zero strain should have no mechanical stimulation). An additional study of 
cell reorientation on soft substrates showed no reorientation with 16 hours of stretch; however, this 
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study was done at mHz frequencies and low strain amplitude (3%). Cell reorientation has been 
shown to be dependent on frequency [30, 160]. 
Many models have been developed to examine the mechanisms of cell reorientation and stress fiber 
dynamics with cyclic stretch [160-162]. Few models can predict the reorientation behavior of cells 
cultured on the soft (0.6 kPa) substrates. The Wei model [162], a polymerization based model, 
predict cell reorientation if the cell is not elongated (as is the case with the soft substrate) but does 
not include a term for matrix stiffness and is not predictive of an already elongated cell (as is the 
case for cells cultured on the 7.5 kPa gel). Stamenovic et al. developed a model incorporating the 
phenomena of cytoskeletal fluidization and resolidification in response to cyclic stretching [149]. 
This model accurately predicts the increase in cell traction force and cell lengthening we observed 
with stretch on soft 0.6 kPa substrates.  To our knowledge, there is no model that can 
simultaneously predict the prestress dependent behaviors of traction force and elongation with 
reorientation in the cells cultured on soft and stiff substrates.  
3.4.6 Limitations and future studies 
As traction force, reorientation, and cell morphology were only assessed after 24 hours of stretch, 
we cannot comment on the time-course of changes in these metrics during stretch or following 
cessation of stretch.  In the future, tracking the same cells over time on both the soft and stiff 
substrates presented here would be ideal. This will help to better address how traction force 
changes as a measure of prestress, cell orientation with respect to stretch direction, and total strain. 
Additionally, it will allow the study of cell elongation and reorientation on the very soft substrates. 
We also did not measure changes in protein expression (e.g., αSMA) which may explain changes in 
traction force with long-term stretch. Although not studied in VICs, reversal of the myofibroblastic 
phenotype in the presence of stretch was shown with lung myofibroblasts [90].  We believe that 
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traction force can be used as a powerful functional indicator of cell phenotype than can add to 
biochemical metrics (protein synthesis, gene expression). 
3.5 Conclusions 
Here, we report the first traction force measurements after 24 hour cyclic stretch. We observed that 
the traction force response to stretch is dependent upon initial cell prestress. The cell traction force 
decreased with long term cyclic stretch when the cell prestress levels were high, while traction force 
increased when cell prestress levels were low. The decrease in traction force with stretch was larger 
in the case of equibiaxial stretch than uniaxial stretch, as cells were unable to undergo reorientation.  
Cell prestress levels were further increased with culture in TGF-β1. However, TGF-β1 treated cells 
still decrease traction force following long-term stretch. From these observations, we conclude that 
although TGF-β1 increases cell prestress, 10% stretch exceded the maximal cytoskeletal tension, 
initiating the process of cytoskeletal reorganization. Decreasing prestress levels either chemically 
with blebbistatin or by culture on soft substrates resulted in increasing traction force with stretch. 
We conclude that when cell prestress is low, mechanical stimulation may serve as means to increase 
cytoskeletal tension. The methods and data from this study will enable the development and 
validation of models of cell reorientation and cell spreading with stretch which take into account cell 
prestress. To our knowledge, this study is the first study to measure cell reorientation and traction 
force with stretch at frequencies and stiffness levels relevant to the cardiovascular system.  
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4.0 Abstract 
Calcific aortic valvular disease (CAVD) is the most prevalent valvular pathology in the United States, 
necessitating nearly all aortic valve replacements in the industrialized world. Despite the high 
incidence of CAVD, much remains elusive about the mechanisms initiating the disease. Hindering 
development of preventative treatments is the lack of adequate animal models for CAVD, as well as 
limited insights of factors initiating disease onset provided by the examination of explanted calcified 
valves. Although an in vitro model exists, its utility is limited as calcifications form randomly and are 
of variable sizes without a consistent time-course. In this chapter, we introduce and validate a high-
content method for studying CAVD in vitro. By utilizing micro-contact printing, we are able to re-
create dystrophic calcification seen in vivo characterized by valvular interstitial cell aggregates with 
myofibroblastic activity, calcium-positive mineralization, and cell death. This method was highly 
repeatable with consistent apoptotic activity and calcification seen throughout multiple trials of 
one-week time-courses. X-ray micro-analysis revealed details behind calcification within the micro-
contact printed aggregates. Further, micro-contact printing enables the study of the effect of 
cytokines, substrate stiffness, and pharmocologics on calcification which is not possible using the 
current in vitro model as high cell tension is needed to initiate the aggregation and subsequent 
calcification. Finally, micro-contact printing enables biophysical characterization of valvular 
interstitial cell aggregates via traction force microscopy which was previously impossible.  
4.1 Introduction 
Calcific aortic valvular disease (CAVD) is the most prevalent valvular disorder in the United States, 
affecting 81 million Americans [2]. The prevalence rises to 9.8% in octogenarians [3]. The increase in 
incidence of CAVD with age leads many people to believe that it was the result of the passive 
degeneration of the valve, but recently it has been shown to be a cell-mediated phenomenon. CAVD 
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results when calcifications form on the aortic heart valve leaflets, inhibiting normal function, leading 
to stenosis and regurgitation. The number of patients with CAVD is expected to increase 
exponentially in the coming decade as the population ages. Valve replacement surgeries have been 
increasing in the United States over the last several decades; a total of 95,000 aortic-valve 
replacements were performed in the United States in 2010, the majority of which were necessitated 
by CAVD [1, 163]. To date, there are no pharmaceutical interventions to halt, slow, or reverse the 
progression of CAVD.  
Several hypotheses exist as to the mechanisms behind calcification. These include passive 
calcification of the collagen fibers, calcification via active cellular mineralization via differentiation to 
osteoblastic phenotype, calcification associated with cell death, as well as aggregation on calcium 
micro-particles into hydroxyapatite structures. Examination of explanted valves reveals two 
mechanisms of calcification: osteogenic calcification, observed in 13% of diseased valves, and 
dystrophic calcification which is more common and present in 83% of explanted valves [7]. By 
definition, osteogenic mechanisms are “active” cellular processes in which osteoblastic cells lay 
down hydroxyapatite, which has highly organized molecular structure [9]. Dystrophic calcification 
involves cell death. Unlike osteogenic calcification, dystrophic calcification is not organized [8]. The 
mechanisms by which cells initiate death within dystrophic calcification are currently unknown. 
Currently, CAVD remains challenging to study as there are no adequate animal models which can 
replicate the calcification seen within human valves [10]. Study of diseased explanted human valve 
cusps only reveals end-stages of disease and does not indicate disease progression. From these 
studies it is difficult to identify pharmacological targets for early treatment and intervention. A two-
dimensional in vitro model for dystrophic calcification has been developed to replicate the cell death 
and calcification seen clinically. This model involves seeding valvular interstitial cells (VICs) at high 
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density (60,000-100,000 cells/cm
2
), often in the presence of TGF-β1. VICs then undergo aggregation. 
Following aggregation, cells within the center of the aggregate apoptose and calcification ensues 
[12]. 
The current 2-D in vitro model, although simplistic, has revealed a significant amount of information 
about the extracellular, chemokine, and mechanical signals which affect aggregation. Notably, 
factors which appear to increase intracellular tension also increase rates of aggregation. Increased 
aggregation rates are observed with culture in the presence of TGF- β1 [12], on stiff surfaces [16], on 
fibrin-coated surfaces [9], and in conditions that combines TGF- β1 and cyclic mechanical strain [17]. 
However, how the aggregation of VICs progresses into calcification remains incompletely 
understood as currently there is no method for separating the aggregation process from the 
calcification process.  
A major challenge in understanding how cell death initiates within VIC aggregates is the large 
variability seen within rates of VIC aggregation. Table 1 shows the reported values found in 
literature for aggregate size. In vitro, aggregates take a week or more to form, form randomly and 
variably, and have a distribution of sizes which makes examining the mechanisms of pathology 
difficult. Different time-courses for aggregation and subsequent calcification have been reported for 
controls in papers which use the same methodology for aggregate development [9, 18]. In addition, 
a range of sizes have been reported in the literature [9, 18] for control aggregates formed under the 
same conditions. Furthermore, all in vitro models to date rely on the aggregate formation to study 
apoptosis and calcification.  In order to better study the mechanisms of pathology, a method must 
be developed to separate the two phenomena.  
The goal of this study is to validate a novel method for creating the in vitro model of calcific aortic 
valve disease, allowing for the regulation of parameters such as aggregate size, substrate stiffness, 
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and cytokines for high-content analysis of effects on apoptosis initiation and dystrophic calcification 
within valvular interstitial cell aggregates. Our approach is to use micro-contact printing on 
polyacrylamide gels to control aggregate formation to a defined size. Not only will this method 
enable studies into the factors contributing to apoptosis and dystrophic calcification in VIC 
aggregates in vitro, this method also offers the potential to be used as a high-content mechanism for 
screening promising therapeutics. Aggregate size can be varied, allowing for study of aggregate cell 
number and the effect on apoptosis. As aggregate size increases, so too does number of cells within 
the aggregate as well as the number of cell-cell contacts. Cadherin-11 has been shown to be 
essential for aggregate formation [97], as well as having been found in disease valves [97]. In 
addition, modulus of the polyacrylamide gels can be varied allowing for the study of how substrate 
stiffness affects apoptosis and calcification, as currently it is believed that dystrophic calcification 
initiates only on stiff substrates [16]. Finally, micro-contact printing enables the study of cytokines 
and their effect on cell apoptosis and calcification as TGF- β1 is not required to induce aggregation. 
Although TGF-β1 is found in diseased explanted valves, it is uncertain if high TGF-β1 levels initiate 
and perpetuate the disease or if high levels of TGF-β1 are a result of calcific aortic valvular disease 
[12]. 
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Table 4.1 Mini-review of literature for studies employing in vitro model. Notice micro-contact printing 
method allow to control size of aggregates, as well as increases number of aggregates by an order of 
magnitude 
 
4.2 Materials and Methods 
4.2.1 Micro-Contact Printing Stamp Design 
A 2-D computer-aided design (CAD) software, DraftSight (Dassault Systems), was used to create a 
stamp master design. The stamp master design consisted of twelve stamp templates, each with 
circles of a specific diameter that correspond to sizes of aggregates reported in literature[9, 17, 18, 
164]. The CAD drawing was sent to CAD/ART services for the formation of a high resolution (20,000 
dots per inch) photomask, which was then used to create a master stamp silicon wafer utilizing 
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standard photo-lithography methods with assistance from Dr. Dirk Albrecht (WPI). Subsequently, 
PDMS stamps were synthesized by placing the silicon wafer in a 100 mm petri dish and pouring 100 
g of 10:1 polydimethylsiloxane (Dow Corning) over the wafer. The petri dish was then placed under 
house vacuum for one hour, until all bubbles had been removed from the PDMS solution. 
Afterwards, the solution was allowed to polymerize for three hours in an oven at 65⁰ C. Stamps 
were removed from the wafer once the PDMS had cooled to room temperature.  
4.2.2 Tunable-Stiffness Substrate Preparation 
Polyacrylamide (PA) gels were chosen as the substrate for the model, as they are optically clear, 
have a tunable modulus over several orders of magnitude, and have been used successfully for 
micro-contact printing in the literature [107, 165, 166]. 22 mm glass cover slips (Ted Pella) were 
activated for polyacrylamide attachment by soaking in a 1.5% (aminopropyl)trimethoxysilane 
solution (Sigma-Aldrich) for 30 minutes, rinsing with diH2O, and incubating in 0.5% gluteraldehyde 
solution (Sigma-Aldrich) for three hours at 4°C. The activated coverslips were then dried using 
vacuum aspiration. Four different stiffness values of PA gels (9.6, 19.2, 38.4, and 76.8 kPa) were 
formed by varying the concentration of acrylamide and bis-acrylamide (BioRad) as described by 
Quinlan, et al. [81]. Once the un-polymerized gel solution was made, 50 μL were pipetted onto each 
glutaraldehyde-treated coverslip. The droplet was then sandwiched with an untreated coverslip to 
allow for uniform gel distribution by capillary action. After gel polymerization, the two coverslips 
were separated using a standard razor blade, with the polyacrylamide gel remaining affixed to the 
glutaraldehyde-treated glass slide. 
4.2.3 Micro-Contact Printing 
Polyacrylamide gels were functionalized prior to protein micro-contact printing by submersion in a 
solution of 55% hydrazine hydrate (stock solution purchased from: Sigma-Aldrich, St. Louis, MO) for 
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two hours. As hydrazine hydrate is reactive with most plastics and metals, a ceramic rack from 
Thomas Scientific was used to arrange the coverslips. After soaking in hydrazine hydrate, the 
ceramic rack was transferred to a solution of 5% glacial acetic acid (Sigma-Aldrich) for one hour to 
neutralize the PA gels, and finally submerged in diH2O for an additional hour. 
An overview of the sample preparation is shown in Figure 1. Collagen protein solution was prepared 
by conjugating 1 ml of collagen at concentration of 100 µg/ml (Advanced Biomatrix) with Alexa 
Fluor-488 succinimidyl ester (Thermo-Fischer) in 9 mL of 50 mM sodium acetate buffer, and 3.6 mg 
of sodium periodate crystals. Once complete protein transfer was observed, the fluorescent 
collagen labeling step was omitted.  
Prior to protein incubation, PDMS stamps were thoroughly rinsed with diH2O, 100% ethanol, and 
diH2O. The stamps were incubated with protein solution for 45 minutes, while the functionalized PA 
gels were dried completely in a desiccator under vacuum. Excess protein on the PDMS stamps was 
removed using a nitrogen gun. Each stamp was then placed gently on top of a polyacrylamide gel 
and left to sit for two minutes within a 60⁰ C oven, which we found were the best conditions for 
complete protein transfer.  
As sample preparation is not sterile, following micro-contact printing gels were treated with an 
antibiotic/antifungal cocktail in 1X PBS overnight containing 100 μg/mL penicillin–streptomycin 
(MediaTech), 2.5 μg/mL amphotericin B (Corning), 10 μg/mL ciprofloxacin (Alfa Aesar), and 100 
μg/mL gentamycin (Alfa Aesar) described by Clement et al. [167]  Aggregates formed by this method 
were highly repeatable < 4% variability in area (see supplemental information). 
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Figure 4.1: Overview of micro-contact printing on tunable modulus substrate. Master of inverse 
stamp design is created using standard photolithography methods. 10:1 PDMS is poured over stamp 
and allowed to polymerize. Stamps are coated with collagen (shown in fluorescent green). PA gel is 
treated with series of hydrazine hydrate, acetic acid, and diH2O to allow protein to bind. Stamp is 
inverted onto PA gels. Protein is transferred to substrate. VICs are cultured on these circles forming 
the engineered aggregates. Inset a) Micro-contact printed collagen circles fluorescently labeled on a 
38 kPa polyacrylamide gel. b) Micro-contact printed aggregate stained for αSMA (red), f-actin 
(green), and nuclei (blue). αSMA incorporates into stress fibers indicative of myofiboblastic 
phenotype present in dystrophic calcification. c) Caspase 3/7 activity present within central region 
aggregates indicating cell death via apoptotic pathways. 
4.2.4 Cell Culture 
Valvular interstitial cells (VICs) were isolated from porcine heart valve leaflets obtained from a local 
abattoir (Blood Farm, Groton, MA) within three hours of tissue harvest per published protocols 
[168]. Cells from passages 3-7 were used for all experiments. Cells were seeded at densities 
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consistent with literature to encourage monolayer formation and complete cell coverage of the 
micro-contact printed area (12,500 cells/cm
2
). Media was changed every 4 days. 
Transforming growth factor-beta 1 (TGF-β1, Sigma-Aldrich) was used as a pre-treatment for some 
experiments to encourage differentiation to a highly contractile myofibroblastic phenotype [12]. In 
this scenario, 5 ng/ml of TGF- β1 was added to the media for five days prior to seeding cells onto 
micro-contact printed hydrogels. 
Pravastatin (Sigma) was used in a subset of cells to demonstrate potential to be used to as a 
pharmaceutical screen. Cells were treated with 100 μM Pravastatin for five days. Cells were seeded 
onto samples as described above. Pravastatin treatment continued for three days. 
To inhibit apoptosis in a subset of samples, VICs were pretreated with 20 μM ZVAD-FMK (ApexBio) 
for five days prior to seeding. ZVAD-FMK treatment continued for three days for VICs in culture. 
4.2.5 Caspase Activity 
Caspase 3/7 activity was used as a measure of apoptosis detection. CellEvent® Caspase 3/7 Green 
ReadyProbes® Reagent (Thomas-Scientific) was used according to the manufacturer’s guidelines. As 
a positive control, cells were treated with 1 µM staurosporine (Apex Bio), a broad spectrum protein 
kinase inhibitor, for 48 hours. Caspase 3/7 activity was quantified using a custom MATLAB 
(MathWorks, Natick MA) program. The perimeter of the aggregate of interest was outlined manually 
in a phase image. The marked phase image and corresponding fluorescent image were then used as 
inputs in the MATLAB program. The program then subtracted the background pixel intensity of the 
fluorescent image from the area of interest and converted the pixels within the aggregate to either 
Caspase 3/7 positive (white pixel) or negative (black pixel). The threshold of pixel intensity can be 
adjusted by the user to accurately dictate Caspase 3/7 positive or negative pixels. The total number 
of Caspase 3/7 positive pixels are then computed, and the program outputs the total number of 
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positive pixels as well as the aggregate area for further analysis.  For an example of caspase analysis, 
please see supplemental data. 
4.2.6 Immunohistochemistry 
Cells were fixed with 4% Paraformaldehyde (USB Products) for fifteen minutes and permeabilized 
with 0.25% Triton-X (Calbiochem). Cells were blocked with 1.5% goat serum (Invitrogen) and stained 
for alpha smooth muscle actin (Sigma). Cells were counter stained with Alexa-fluor 488 phalloidin 
(Thermo-Scientific) and Hoechst (Thermo-Scientific). Antibodies used: anti-αSMA (Sigma, A2547). 
To allow for imaging, coverslips were affixed to glass slides using SHUR/Mount™ Toluene-Based 
Liquid Mounting Medium (Ted Pella). Prolong-gold (Life Technologies, Grand Island, NY) was then 
added to the polyacrylamide gel. 
Images for time-course imaging of caspase activity were acquired using a using a Zeiss inverted 
microscope and CCD camera. Z-stacks of micro-contact printed aggregates were also acquired at 63x 
magnification with a confocal microscope (Leica Microsystems). 
4.2.7 Calculation of Average Cell Area  
Average cellular area was determined on day seven by staining for nuclei with Hoechst and f-actin 
with phalloidin (see above methods). Aggregate area was determined using image J. Number of 
nuclei were counted. Average cell area was calculated by dividing the aggregate area by number of 
cells within the aggregate. 
4.2.8 Calcium Staining 
Calcium nodules were assayed by using Alazarin Red S dye (Fischer Scientific). Samples were fixed as 
described above, and 20 μL of dye was placed on the sample for two minutes. Samples were then 
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rinsed with copious amounts of diH2O to remove excess stain. Positively stained nodules were 
confirmed by visible red-orange color [169]. 
4.2.9 Traction Force Microscopy 
Polyacrylamide gels for traction force measurements were fabricated as described above with the 
following exception: prior to gel polymerization, a glass coverslip (Ted Pella, Redding, CA) was 
prepared imbedded with fluorescent microbeads. This coverslip was used instead of the plain glass 
coverslip mentioned above and allowed for deposition of fluorescent microbeads within the top 
surface of the gel. To create these bead glass coverslips, 0.5% fluorescent bead solution (Invitrogen) 
was prepared in 100% ethanol. Coverslips were cleaned and treated with nitrogen plasma (SPI) for 
30 seconds to ensure a hydrophilic surface. 35 μL of bead solution was then pipetted onto the glass 
coverslips and evaporated at 150⁰C in a vacuum oven under house vacuum for 30 seconds. 
To ensure optimal image quality, the amount of material from sample surface to the microscope 
objectives was reduced by removing a 20 mm diameter hole from 60 mm petri dishes using a metal 
tissue biopsy heated with a Bunsen burner.  
The coverslip sample was then glued into the petri dish using Norland Optical Glue 68 (Norland 
Adhesives). As sample preparation was not sterile, gels were treated with antibiotics as described 
above. 
Images and aggregate traction force calculation were acquired using methods previously described 
in Chapter 3. 
4.2.10 Image Analysis 
Time course heat maps of caspase activity were created using a custom MATLAB program 
(Mathworks, Natick, MA). Phase images and fluorescent images of the caspase signal were taken at 
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40x using a Zeiss inverted microscope and CCD camera (Thornwood, NY). The program allowed users 
to identify the aggregate center from the phase contrast image. The caspase image was translated 
so that all the aggregate centers were in the identical pixel location. Peak caspase signals were then 
averaged over 40 aggregates for each time-point measured. 
4.2.11 Scanning Electron Microscopy and X-ray Micro-Analysis 
For SEM-EDS analysis, micro-contact printed samples were fixed in 2.5% gluteraldehyde in 0.1M 
sodium cacodylate buffer solution for 1 h at room temperature and 24 h at 4⁰C. Samples were 
subsequently washed three times with sodium cacodylate buffer. Samples were then dehydrated by 
a series of ethanol washes (30%, 50%, 70%, and 95% ethanol) for 15 min each. Dehydration was 
completed with two 15 min washes with 100% ethanol. Samples underwent critical point drying in 
liquid CO2. The polyacrylamide gels on cover slips were then mounted to aluminum stubs with silver 
conductive paste and coated with carbon to electrically ground the hydrogel matrix. The specimens 
were examined using an FEI Quanta 200 field emission scanning electron microscope (SEM) 
equipped with an Oxford-Link X-ray analyzer for X-ray microanalysis. All scans were done at 10 KV, 
images were taken at various magnifications for viewing apoptotic cells, calcifications, as well as 
intra-cellular and extra-cellular vesicles. 
4.2.12 Statistics 
Data presented are the mean and standard deviation, unless otherwise indicated. Statistical 
significance was determined between treatments with appropriate test using Sigma-Plot v. 11.0 
software (Systat Software, Inc., San Jose, California).  A p-value of less than 0.05 was considered 
statistically significant. 
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4.3 Results 
4.3.1 Dystrophic Calcification is Present in Micro-Contact Printing Aggregates 
Dystrophic calcification is currently believed to be mediated by highly contractile myofibroblastic 
cell aggregates which undergo apoptosis and calcify. This apoptosis and calcification initiates in the 
central region of the aggregate and spreads radially outward over time. The myofibroblastic 
phenotype is characterized by α-SMA-positive stress fibers. Our α-SMA staining confirmed that the 
myofibroblastic phenotype is present within our micro-contact printed aggregates (See Figure 4.2). 
Caspase 3/7 detection reagent indicated that cells within the central region of the micro-contact 
printed aggregates were undergoing apoptosis (Figure 4.1c); live/dead staining verified that the cell 
death occurred initially in the center of the aggregates similar to the current in vitro system (see 
Supplemental Data, Figure 3). 200 μm diameter micro-contact printed aggregates on 38.2 kPa PA 
gels formed calcifications within 4 days, with apoptotic activity present at 24 hours. Calcification, as 
measured by positive staining of Alizarin Red S, was replicated with high fidelity in this model (Figure 
2a). Average number of aggregates calcified at one week was 67.8 ± 0.5 (mean ± SEM) as 
determined by five consecutive trial runs of one-week duration. To determine if cell death was 
mediated by the apoptotic pathway, a subset of aggregates were cultured with Z-VAD-FMK. Cells 
were treated with Z-VAD-FMK for three days prior to being transferred to the micro-contact 
patterned PA gels. Z-VAD-FMK reduced the number of calcifications by about 75% compared to 
untreated controls (Figure 4.1c).  Combined these findings suggest that dystrophic calcification is 
present in micro-contact printed aggregates and apoptosis is the mechanism of cell death. 
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Figure 4.2 Myofibroblastic phenotype, as indicated by α-SMA incorporation into stress fibers is 
present in micro-contact printed valvular interstitial cell aggregates. a) Representative staining in a 
400 µm diameter aggregate  cultured on 38 kPa gel. Overlay and separate channels showing high α-
SMA incorporation along aggregate periphery. scale bar = 100 µm. b) 200 µm diameter aggregate  
cultured on 38 kPa gel. Overlay and separate channels showing high α-SMA incorporation along 
aggregate periphery. scale bar = 100 µm. 
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Figure 4.3: Micro-contact printing method for in vitro model of calcific aortic valvular disease 
results in calcification with high fidelity. a) Aggregates that stain positive for Alazarin Red S, an 
indicator of calcification, were replicated with high fidelity during different trials of our experiments. 
On average, 67% aggregates of 200 μm diameter aggregates on 38.2 kPa PA gel stained positive for 
calcification at one week. This was repeated in five separate one week time course experiments. b) 
Calcification may be mediated by apoptosis as decreasing caspase activity with Z-VAD-FMK, a pan 
caspase inhibitor, resulted in ~65%  less calcifications, statistically significant by student t-test 
p<0.05. Although calcification did not decrease to zero with Z-VAD-FMK, the reduced amount of 
calcification is consistent with reduction seen by other groups using this inhibitor [16]. c) 
Repeatability of time-course of apoptosis within valvular interstitial cell aggregates as measured by 
% of aggregate positive for caspase activity. n=100 aggregates per time-point, repeated three times. 
Data presented mean ± SEM. 
 
4.3.2 Scanning Electron Microscopy and X-ray Microanalysis 
X-ray micro-analysis was used as a second measure of calcification. Micro-analysis revealed that 
calcification is present in several forms within the aggregate, and may indicate multiple mechanisms 
of calcification. False colorization density maps were created by overlaying the electron image and 
backscatter image. Inspection of areas of high density as determined by backscatter image showed 
high mineral content with calcium present. Mineralized nanoparticles, which appear to be 
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exocytosing from the cell as extracellular vesicles were observed with trace amounts of calcium 
(0.03%). Particles of size range 100-450 nm were observed “clustering” on the apical aggregate 
surface in the central region of the aggregate (Figure 4.6c). These nano-particle clusters were seen 
on several aggregates that were examined. Rounded cells were observed in the center of several 
aggregates examined. These cells had approximately three-fold higher calcium density then the 
aforementioned nanoparticles. Calcium likely took the form of calcium oxide within these cells 
(Figure 4.4, Figure 4.5) Rounded cells with large numbers of mineralized, calcium positive 
nanoparticles within the cells were also found in several aggregates that were examined (Figure 4.4 
and Figure 4.5). Dense mineralized particles have been previously reported to have been found in 
diseased aortic valves (Figure 4.6c). It remains an open research question if mineral content of 
nanoparticles is similar between in vivo calcium nanoparticles, and those that are seen in our in vitro 
model. To our knowledge, this is the first report of mineralized nanoparticles within aggregates in 
vitro, although whole nodules have been examined via X-ray microanalysis methods [95]. 
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Figure 4.4: Rounded cells in center of aggregate contain mineralization with calcium. a) Density 
dependent scanning electron image created from overlaying the electron image with the 
backscatter image. Regions that are more dense, and more likely to contain mineralization show in 
red. b) Electron image imported for X-ray microanalysis. Region of interest selected with magenta 
box. c) Elemental composition of selected region. Weight % is indicative of how much ROI chemical 
makeup is the selected element, formula gives most likely formulation for each element found. d) 
Elemental spectrum from ROI used to calculate weight percent of the elements. 
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Figure 4.5: Rounded cell with internal accumulation of mineralized nanoparticles. a) Density 
dependent scanning electron image created from overlaying the electron image with the 
backscatter image. Regions that are more dense, and more likely to contain mineralization show in 
red. b) Electron image imported for X-ray microanalysis. Region of interest selected with magenta 
box c) Elemental composition of selected region. Weight % is indicative of how much ROI chemical 
makeup is the selected element, formula gives most likely formulation for each element found. d) 
Elemental spectrum from ROI used to calculate weight percent of the elements. 
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Figure 4.6: Cell originating mineralized nanoparticles may be involved in CAVD in vivo. a) SEM 
density images, red indicates material of higher density, green is background organic material. 
Dense nanoparticles apparent in cell body of cells within a micro-contact printed aggregate as 
indicated by white arrows b) Accumulation of mineralized nano-particles on top of micro-contact 
printed aggregate as indicate by white arrows. Particles may be serving as nucleation sites for 
additional calcium deposition. c) Dense particles may be involved in earliest stages of CAVD in vivo. 
Mineralized particles are found in valves which do not yet exhibit disease at macroscopic level. Scale 
bar 3 µm. Image obtained from [55], reproduced with permission.  
4.3.3 Apoptosis and Calcification Occurs in Aggregates of All Sizes 
A range of aggregate size has been reported in the literature for studies utilizing the in vitro model 
(Table 1); however, no study to date has investigated the effect that aggregate size may have on cell 
apoptosis and dystrophic calcification. In addition, it is not known if there is a minimum aggregate 
size required for pathological calcification. Aggregate size was varied by using 50 μm, 200 μm, 300 
μm, and 400 μm diameter circles. Both the 50 μm and 200 μm exhibited caspase within 24 hours. 
300 μm and 400 μm aggregates exhibited little apoptosis 24 hours after seeding.  
Presence of calcium was confirmed in all aggregate sizes at both 1 week and 2 week time-points 
(Figure 4.7). Calcium staining appeared more intense at two weeks compared to the one week time-
point for all aggregate sizes, indicating ongoing mineralization (Figure 4.7, b-i). The number of 
aggregates that stained positive for calcium increased with time, as did the size of calcifications 
within the aggregates. Percent of aggregate area encompassed by calcium mineralization varied 
with aggregate size. For smaller aggregates (<200 µm diameter), calcium staining encompassed the 
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whole aggregate while the majority of larger aggregates (>200 µm diameter) had positive staining of 
calcifications localized within the central region. Presence of calcium corresponded with regions of 
caspase 3/7 activity (Figure 4.11a, caspase heat maps). 
 
Figure 4.7: Calcification occurs in all aggregates, regardless of size. a) Micro-contact printed aggregates 
of all sizes were calcified at two weeks. (b-e) Alazarin Red S, a stain for calcium, in 50 μm, 200 μm, 300 
μm, and 400 μm micro-contact printed aggregates at one week time-point. (f-i) Alazarin Red S staining 
became more intense with time in culture, indicating continuing mineralization. Scale bar = 200 μm 
 
Number of cells within the aggregates increased with aggregate size. Cell area, measured by taking 
total aggregate area and diving by the number of cells, was unchanged between aggregates of 
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different diameters. However, VICs within micro-contact printed aggregates had much smaller cell 
area than VICs within a monolayer formation (supplemental data). 
4.3.4 Aggregate Traction Forces Scale with Size and Substrate Modulus 
To determine if differently sized aggregates have different mechanical environments that may 
contribute to pathology, traction force was measured. Total overall traction force of aggregates 
increases with aggregate size and substrate stiffness. Stress maps of tractions revealed that the 
highest measured substrate stress transfer was at the aggregate periphery (indicated by red 
colorization of stress maps). Interestingly, aggregates on the same substrate stiffness but varying 
diameters had approximately the same average stress (Figure 4.8). Maximum substrate stress was 
positively correlated with aggregate diameter. 
Traction force was then investigated for aggregates cultured on varying moduli of polyacrylamide 
gels. Aggregates generated increasing amounts of traction force with increasing substrate stiffness. 
Average substrate stress and maximum substrate stress was positively correlated with substrate 
moduli. Despite varying moduli of polyacrylamide gels, distribution of tension appeared similar with 
highest measured substrate tractions around the periphery of the aggregate. The greatest increase 
in measured average stress and substrate stress was on the 76.4 kPa gel (Figure 8). Interestingly, 
calcification was not correlated with overall traction force, average substrate stress, or maximum 
substrate stress (Figure 4.9) suggesting that distribution of tension may be more critical to pathology 
initiation than actual measured mechanical environment. However, more research is needed to 
confirm this hypothesis. 
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Figure 4.8: Aggregate overall traction force increases with aggregate size. (a-d) substrate stress 
maps for VIC aggregates cultured on 38.2 kPa PA gel. Areas of highest substrate stress were localized 
to the periphery of the aggregate. (e) Overall traction force increased linearly with aggregate 
diameter. (f) Interestingly, average stress within the aggregates was approximately equal between 
aggregates of all sizes (g) Maximum substrate stress was positively correlated with aggregate size. 
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Figure 4.9: Aggregate overall traction force increases with substrate stiffness. (a-d) stress maps of 
traction of aggregates on increasing stiffness of polyacrylamide gel. Highest traction forces were 
primarily localized to the periphery of the aggregate, potentially indicating different mechanical 
environments between center and edge cells. e) Overall traction force increased with substrate 
stiffness, as did the magnitude of average stress (f), and magnitude of maximum stress (g). 
 
4.3.5 Substrate Modulus Threshold for Calcification 
As VICs are mechanosensitive cells and have increased myofibroblastic activity on stiffer substrates 
[80, 81, 84], micro-contact printed circles were created on varying moduli of polyacrylamide gels to 
determine if stiffer substrates induce greater calcification as myofibroblastic activity is higher. 
Additionally, substrate modulus has been proposed to dictate mechanism of calcification with softer 
substrates favoring osteogenic calcification (calcium nodules with an absence of cell death) [16, 95]. 
Caspase 3/7 activity was observed on all substrates moduli tested, indicating apoptotic activity (and 
dystrophic calcification) is present. Micro-contact printed aggregates on all substrate moduli tested 
stained positive for calcium as determined by Alizarin Red S (Figure 4.10).  Substrate modulus 
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appeared to create a threshold for calcification, above 9.6 kPa, no increase in aggregates staining 
positive for calcification was observed. This could also indicate the myofibroblastic phenotype 
reaches maximum activity above 10 kPa which corresponds to transitional stiffness for VICs in the 
literature [80]. 
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Figure 4.10: Calcification occurs in 200 μm diameter aggregates on all moduli of PA gels tested. a) 
Threshold effect of substrate stiffness appear to occur on polyacrylamide gels of moduli stiffer than 
10 kPa. This threshold level agrees in literature with reported values of the transitional stiffness for 
VIC myofibroblastic differentiation. (b-e) 10x phase images of aggregates positive for Alizarin Red S 
staining on all moduli tested. 
 
4.3.6 TGF-β1 is Not Required for Apoptosis or Calcification 
Many groups using the current in vitro model supplement cultures with TGF- β1 to increase 
aggregation and calcification response. As micro-contact printing circumvents the need for the cells 
to aggregate, treatment of micro-contact printed VICs with TGF- β1 would identify this cytokine’s 
effects on apoptosis and calcification post aggregation. Cells were pre-treated with TGF-β1 for five 
days, and then were continued to be cultured in the presence of TGF-β1 for one week. TGF-β1 
treated aggregates had slightly less caspase activity (as measured by % of aggregate positive for 
calcium). Heat maps of caspase activity showed highest activity in central regions of aggregates. 
These heat maps averaged multiple aggregate caspase data together by taking the mean pixel 
intensity at each location. Number of aggregates averaged to generate each image is given below 
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each respective heat map. TGF-β1 heat maps appeared to have more punctate caspase activity, 
while control aggregates had large clusters of caspase activity, potentially indicating multiple cells 
undergoing apoptosis simultaneously (Figure 4.11). TGF-β1 treated aggregates appeared to have 
slightly increased mineralization as Alazarin Red S staining was more intense then respective 
controls at one week. Number of aggregates positive for Alazarin Red S was slightly higher in those 
that had been treated with TGF-β1 (Figure 4.11), though this was not significant, indicating that TGF-
β1 is not required for calcification. 
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Figure 4.11: TGF-β1 increased mineralization activity, but did not increase caspase 3/7 activity. a) 
Time course of caspase 3/7 activity in 200 μm diameter aggregates on 38.2 kPa polyacrylamide gel. 
b) Time course of caspase 3/7 activity in 200 μm diameter aggregates on 38.2 kPa polyacrylamide 
gel treated with TGF-β1. Images of aggregates were acquired at 40x, centered using a custom 
MATLAB script, and “stacked.” Average pixel intensity at each location was taken to create heat 
map. Red indicates most prominent caspase 3/7 activity. c) Alazarin Red S staining in 200 μm 
diameter aggregates on 38.2 kPa polyacrylamide gel and d) 200 μm diameter aggregates on 38.2 kPa 
polyacrylamide gel treated with TGF-β1. e) Samples treated with TGF-β1 had a slight increase in 
number of aggregates staining positive for calcium. 
 
4.3.7 Pravastatin Did not Decrease Calcification  
As a proof-of-concept for utilizing this system as a high-content in vitro screen for drug analysis, 
pravastatin was used to pre-treat a subset of VICs which were then seeded into micro-contact 
printed protein circles forming aggregates. Statins have been used in several clinical trials in hopes in 
reversing calcific aortic valve disease, but without success. In our model, pravastatin failed to 
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decrease apoptotic activity or calcification within micro-contact printed aggregates indicating that 
pravastatin is not a valid treatment therapy once aggregates have already formed (Figure 4.12).  
 
 
Figure 4.12: Pravastatin did not reduce apoptotic activity or % of aggregates which stained 
positive for calcification. a) Time-course of apoptotic activity between control aggregates and 
aggregates that had been treated with pravastatin were almost identical, suggesting that pravastatin 
does not reduce apoptotic activity within micro-contact printed in vitro model. b) Pravastatin did not 
reduce number of calcifications as determined by orange staining with Alazarin Red S within micro-
contact printed samples. 
 
4.4 Discussion 
In this work, we have shown that aggregate calcification initiates rapidly following aggregation as 
controlled by culture on collagen micro-contact printed circles. Controlling aggregates within micro-
contract printing allows for in vitro calcifications to form in a highly repeatable and reproducible 
manner. Using micro-contact patterning to control aggregate size, we have shown that calcification 
occurs within all aggregate sizes within one week. As the time in culture increases, so too does the 
intensity of Alizarin Red S staining, suggesting on-going mineralization processes. As an additional 
measure of calcification, we used SEM combined with X-ray microanalysis to analyze elemental 
composition within various regions of the aggregates and have discovered calcifications in several 
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forms including nanoparticles of calcium oxide and mineralization within rounded cells located in 
the center of the aggregate. It remains to be determined if the mineralized nanoparticles within cells 
and clustering of mineralized nanoparticles on the apical surface of the aggregates are two 
independent mechanisms of calcification or if these two types of calcification are different facets of 
the same mechanism. In addition, we have observed caspase 3/7 activity within our micro-contact 
printed aggregates in as early as 24 hours, in a highly repeatable and reproducible manner. By 
micro-contact printing on different stiffness polyacrylamide gels we have shown that this dystrophic 
calcification occurs regardless of aggregate size or substrate stiffness. TGF-β1 is not required in 
order to get dystrophic calcific nodules on polyacrylamide gels; although TGF-β1 does not increase 
caspase activity, it does appear to increase mineralization as evidenced by the darker Alizarin Red S 
staining. Mechanism of cell death appears to be apoptosis dependent as blocking with Z-VAD –FMK, 
a pan caspase inhibitor, decreased both apoptotic activity and the calcium staining within the micro-
contact printed aggregates. As this model can initiate apoptosis and calcification rapidly, and size of 
aggregates is highly controlled, we hope that this can be used in the future as a high-throughput 
platform for screening promising pharmaceuticals candidates for CAVD as well as elucidating the 
mechanisms behind apoptosis within the central region. As a proof-of-concept method for testing 
potential pharmaceuticals, Pravastatin was used as a pre-treatment for a subset of samples though 
no reduction in calcification was observed. This result is in agreement with clinical trials data, where 
patients did not experience any reversal of calcification with a Pravastatin regimen.  
4.4.1 Rapid Calcification Formation In Vitro 
Our unique approach to create aggregates utilizing micro-contact printing on polyacrylamide gels 
initiates apoptosis within 24 hours in smaller aggregate sizes (200 µm diameter and 50µm 
diameter). This is much faster than the earliest reported nodule formation currently in the 
literature, which is 48 hours by Merryman and colleagues. Merryman and colleagues report 
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dystrophic calcification which initiated only when VICs had been pre-treated with TGF-β1 for 24 
hours prior to application of cyclic stretch [17]. No calcific nodules were observed in control groups 
that been either treated with 5 ng/ml TGF-β1 or cells that had been cultured at confluence and 
underwent cyclic strain for 48 hours. This led the authors to hypothesize that it was the combination 
of TGF- β1 and cyclic strain which disrupted the monolayer culture leading to aggregate formation. 
Few apoptotic VICs are present within monolayers, indicating there are differences in mechanical 
and biochemical cues between monolayers and aggregates which initiate apoptosis.  
Our analysis of cell spread area within monolayers indicates that cells within micro-contact printed 
circles have smaller spread area than those which occur in monolayers. The exact reason for the 
area differences between monolayer and aggregate cells are not yet determined, but may be due to 
several factors. First, it is possible that that a high number of cells initially bind to the protein island 
following cell seeding. However, the cells in the center are unable to spread as large as the cells on 
the periphery and the physical effect of spread area restriction may initiate the apoptosis within the 
central region. Secondly, cells along the periphery could be proliferating and this creates a center of 
the aggregate that is of higher cell density. This increase in cell density cues VICs within the central 
region to undergo apoptosis. Restriction of geometry has been shown in single cells to induce 
apoptosis as cells on smaller protein islands underwent higher rates of apoptosis than cells on larger 
protein islands [103, 170]. Future work should focus on the mechanical environment which many 
initiate apoptosis within the central region of the aggregate. 
4.4.2 Calcifying Apoptotic Cells and Mineralized Particles 
Calcified nanoparticles were observed within cells, as determined by X-ray microanalysis. 
Additionally, what appeared to be accumulated calcified nanoparticles were found on the apical 
surface of several aggregates examined. Cells release micro-vesicles through exocytosis and these 
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vesicles are believed to be essential for many cell processes such as intercellular signaling. It remains 
to be determined if the mineralized particles found within the micro-contact printed aggregates are 
characterized as extracellular vesicles and if these particles contain enzymes or miRNA, as has been 
reported vesicles from other cell types. Release of spherical microparticles has been reported 
previously for VICs in response to strain [90], but to our knowledge, this is the first documentation 
of calcium nanoparticles within valvular interstitial cell aggregates.  
Excitingly, dense mineralized nanoparticles have been reported in diseased valve tissue [55]. These 
nanoparticles are approximately the same sizes as the ones we observed in the SEM images of our 
micro-contact printed aggregates. These calcified nanoparticles were present even in apparently 
“healthy” valves prior to appearance of visible nodules and sclerosis. Stevens and colleagues suggest 
that these calcified nanoparticles are involved in disease onset and initiation. There is ongoing 
debate if these vesicles are of cellular origin. Osteoblasts and chrondrocytes have been shown to 
release extracellular vesicles (termed matrix vesicles) from sites on the plasma membrane [171], 
and it is becoming increasingly recognized the role of matrix vesicles in bone formation [172]. The 
role of cellular derived vesicles in cardiovascular calcification remains contentious. Aikawa and 
colleagues report existence of an exosomal pathway in valvular interstitial cells and smooth muscle 
cells where extracellular vesicles are released and contributed to pathological calcification. Dr. 
Aikawa posits that extracellular vesicles may be involved in VIC cell signaling and differentiation to 
osteoblastic phenotypes as miRNAs 30, 125-b, 143, 145 and 155 all influence the expression of a 
specific set of osteogenic markers such as Smad1, RUNX-2, and alkaline phosphatase and have been 
found within the extracellular vesicles. 
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4.4.3 Geometric Control of Cell Behavior 
To our knowledge, this is the first use of micro-contact printing to replicate a disease model. 
However, geometric control over multicellular behavior has been reported in the literature for some 
time. Differences in proliferation behavior have been observed between cells along the periphery 
and centrally located cells on protein islands, indicating different mechanical environments [123]. 
Piccolo and colleagues examined YAP nuclear localization with multicellular aggregates and found 
that areas of high stress, such as along the micro-pattern perimeter, promoted YAP translocation to 
the nucleus[124] . Vunjak-Novakovic and colleagues examined mesenchymal stem cell  
differentiation on large (1000 μm)  protein rings (200μm inner diameter) and found osteoblastic 
lineage commitment varied with location within the ring. This differentiation was primarily localized 
to regions where cell area was small yet cells still remained elongated (such as the inner edge of a 
ring and the regions next to the short edges of rectangles) [125]. The differentiation and 
proliferation activity observed was abolished with use of cytoskeletal inhibitors, such as Blebbistatin 
and Y-27632, a Rho pathway inhibitor. Recently, studies investigating cellular alignment within 
annuli of increasing inner diameter and discs showed higher cellular alignment in areas of highest 
predicted mechanical stress [173]. Combined these studies show the power of mechanical stresses 
in regulating multi-cellular behavior, and that cellular behavior within aggregates can vary due to 
the differences in mechanical stresses through-out the geometry. 
4.4.4 Substrate Modulus and Calcification 
VICs have been known for many years to be sensitive to substrate modulus. Quinlan et al. showed 
increased cell spread area and increased α-SMA incorporation into stress fiber with increasing 
substrate modulus [81]. Benton et al. identified a “transitional stiffness” where VIC phenotype 
switched from fibroblastic to myofibroblastic to be at ~7 kPa [80]. Activation to the myofibroblast 
phenotype appeared not only to depend on substrate stiffness, but also biochemical properties, 
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such as adhesive peptide sequences incorporated into the thiol-Ene hydrogel [174]. The 
myofibroblastic phenotype is reversible with a decrease in substrate modulus [84].  
To our knowledge, this is the first study to use polyacrylamide gels to study dystrophic calcification. 
It was presumed that type of calcification was dictated by substrate stiffness as osteogenic 
calcification was reported by Yip et. al on soft collagen gels while dystrophic calcification was found 
on collagen coated tissue culture polystyrene. Merryman and colleagues use 22 kPa fibronectin 
coated polyacrylamide hydrogels for creating osteogenic nodule controls and has determined there 
to be no dystrophic activity as nodules do not uptake propidium iodine, a marker of cell death [95].  
4.4.5 Mechanical Characterization of VIC Aggregates 
To our knowledge, this is the first study to employ traction force microscopy to measure the traction 
force and average stress of valvular interstitial cell aggregates. Merryman and colleagues have 
mechanically characterized valvular interstitial cell aggregates using atomic force microscopy to 
elucidate differences in osteoblastic and dystrophic nodules once the aggregates had already 
formed calcifications [95]. Results showed that calcified dystrophic nodules have heterogeneous 
modulus and topography after calcifications have formed. Additionally, dystrophic nodules had a 
higher modulus than osteogenic nodules. One of the challenges of biophysical characterization of 
VIC nodules is that their formation is random, making mechanical measurements on aggregates 
difficult. In addition, for traction force microscopy, a clear region around the aggregate is needed so 
calculations are not influenced by nearby cells. In literature, images of calcific nodules usually 
appear near the edge of a monolayer, preventing traction force calculations. Micro-contact printing 
enables traction force microscopy of aggregates as the circular patterns direct cell attachment and 
cells cannot bind to the hydrogel without the protein. This allows for a clear boundary to be created 
around the aggregate, facilitating accurate traction force measurements. 
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4.4.6 TGF-β1 and the In Vitro Model of CAVD 
TGF- β1 has been frequently used with the in vitro model of CAVD to rapidly initiate the calcification 
response. The number of calcified nodules greatly increases in the presence of TGF- β1 [19]. It has 
been shown that TGF-β1 mediates the activation of VICs to highly contractile myofibroblasts  [12] 
and these activated cells aggregate followed by the formation of calcifications. Our micro-contact 
printing method allows the aggregation step to be separated from the subsequent calcification. 
These is beneficial for studying the pathology initiation downstream of aggregation. It is especially 
useful for elucidating the role of TGF- β1, and if the cytokine is required only for aggregation 
initiation, but also for disease progression through the calcification. As we did not see any significant 
differences between TGF-β1 and control groups with respect to caspase activity and calcium 
staining, our results suggest that TGF-β1 primarily affects the ability of VICs to aggregate, but once 
VICs have formed aggregates (as simulated with geometric restriction on micro-contact printed 
protein surfaces), the disease progressed through a largely TGF-β1 independent mechanism. 
TGF-β1 is involved with myofibroblast differentiation, and increasing cytoskeletal tension within 
individual cells. It has been proposed that high cytoskeletal tension is needed for aggregation to 
occur. Culture in the presence of TGF- β1 was not sufficient to induce aggregation and calcification 
within 48 hours on fibronectin flexcell plates [17], although other groups report aggregates under 
these conditions at one-week [9, 12]. It was only when TGF- β1 was combined with cyclic stretch 
that aggregates developed indicating that aggregate formation requires extraordinarily high 
intracellular tension which is found in the myofibroblastic phenotype. When cellular tension was 
decreased either by decreasing expression of α-SMA actin [19]   or with inhibiting Rho-pathway 
activity [18], nodule development was reduced or eliminated entirely.  
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Ex vivo, TGF-β1 has been implicated in CAVD as study of explanted valves reveals significantly more 
TGF-β1 localized within the extracellular matrix of diseased valve cusps when compared to healthy 
control valve leaflets. TGF- β1 positive areas are in close proximity to calcified nodules suggesting 
association between the cytokine and calcification [11].  
4.4.7 Statins for preventing CAVD 
Statins have been suggested as a potential pharmacological treatment which has shown great 
promise with inhibiting atherosclerotic calcification in the vascular system. However, the results 
from clinical trials investigating applications for CAVD have been mixed [8]. In vitro statins have been 
investigated by several research groups with respect to inhibiting or reversing VIC calcification. 
Benton et. al showed that although pravastatin is useful for decreasing nodules in culture; statins 
were unable to reverse the progression once  nodules had already formed  [19], and suggested that 
statins may be useful, but in a preventative role. We found that statins failed to decrease 
calcifications in this in vitro model system, likely as the geometric restriction simulated correctly 
nodule formation, adding additional support that our model is accurate at reproducing the 
pathological environment which occurs in the in vitro model for dystrophic calcification. Our pre-
treatment of VICs with pravastatin failed to inhibit calcifications, suggesting that either the five day 
pre-treatment was not long enough to prevent the disease phenotype from occurring, or that the 
geometric restriction and constraint itself is enough to initiate disease progression regardless of 
pharmacological pre-treatment. Additional research groups’ results with statins suggest potentially 
limited clinical use. Monzack and colleagues showed that success of statins with preventing 
calcification appeared to be substrate dependent [175] while work by Wu et al. showed that success 
of statins was dependent upon the specific VIC subtypes within cell population [176]. Statins may be 
useful for patients with a specific aortic valve protein composition or cell population, but in clinical 
practice it may be impossible to identify these individuals. 
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4.5 Conclusions 
In this work, we have shown that the in vitro model for calcific aortic valve disease is able to be 
replicated with micro-contact printing on polyacrylamide hydrogels. The utility of this method allows 
for tight control over aggregate shape, enabling investigation of aggregate size on time-course of 
pathological calcification. It was shown that apoptosis and dystrophic calcification is present in 
aggregates of all sizes. Mechanical characterization via traction force microscopy showed different 
mechanical environments between aggregates of different sizes, total traction force increased with 
size of aggregate. Further work is needed to elucidate the role of mechanical environment on 
apoptosis initiation within central regions of the aggregate. As polyacrylamide gels have easily 
tunable mechanical properties, investigation of the effect of substrate modulus on calcification was 
enabled. Dystrophic calcification was replicated on all moduli tested. Presence of TGF-β1 was not 
required to initiate apoptosis and calcification, although it slightly increased mineralization as 
determined by Alizarin Red intensity. Pravastatin did not reduce number of calcifications, indicating 
pravastatin may not be a suitable pharmacologic treatment for reversal of calcification once 
aggregation has occurred. 
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5.0 Abstract 
Calcific aortic valvular disease (CAVD) is the most prevalent valvular disorder in the developed 
world. Despite the high incidence, much is still unknown about mechanisms initiating the disease. 
An in vitro model has been developed which replicates the calcification seen in vivo. In the model, 
Valvular interstitial cells (VICs) first aggregate, then cells within the center undergo apoptosis and 
calcification ensues. Tension has been implicated in initiating the aggregation process; however, the 
distribution of tension has never been examined within the valvular interstitial cell aggregates. In 
this study, the different mechanical environments that exist within the center and periphery of the 
VIC aggregates and the role they may be playing in disease initiation are examined. Specifically, low 
tension environments have been known to initiate apoptosis in myofibroblasts. The hypothesis that 
a differing mechanical environment within the central portion of the aggregate may induce low cell 
tension and apoptosis is investigated. Several immunohistochemistry markers were used to 
qualitatively examine tension differences between the center and peripheral cells, and a finite 
element model of contraction was used to predict mechanical state. Modulation of the aggregate 
geometry shows that caspase 3/7 activity continues to occur within regions of low tension. 
Increasing aggregate tension with mechanical stimulation reduced caspase 3/7 activity. Combined, 
these results suggest that mechanical tension may be a key factor in VIC fate determination and 
could potentially be exploited for therapeutic purposes. 
5.1 Introduction 
Calcific aortic valvular disease (CAVD) is the most prevalent valvular disorder in the developed 
world. In the United States, it is believed that 81 million Americans are affected [2] with the 
prevalence expected to increase as the population ages. Calcifications, which form on the valve 
leaflets by currently unknown mechanisms, inhibit valve function and cause stenosis and 
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regurgitation. To date, there are no pharmaceuticals or alternative therapies to slow, halt, or 
reverse disease progression; the sole means of treatment is a complete valve replacement. 
Approximately 95,000 aortic valve replacement surgeries were performed in the United States in 
2010, the majority of which were necessitated by CAVD.  Development of additional treatments for 
CAVD has been hindered as currently there are no adequate animal models which can accurately 
recreate the calcification seen on explanted disease valves in humans [10]. Additionally, Ex vivo 
examination of disease valves only reveals the end-state of disease, giving no indication of pathology 
initiation or progression (Dr. Frederick Schoen, personal communication). 
An in vitro model has been developed which replicates the calcification seen in vivo. This model 
involves seeding valvular interstitial cells (VICs) at high density, often in the presence of TGF-β1, into 
tissue culture polystyrene dishes. After the VICs aggregate, cells within the center of the aggregate 
undergo apoptosis and calcifications develop within one to three weeks. Although simplistic, this 
model has revealed several factors which increase the frequency of aggregation and subsequent 
calcification. Notably, factors that increase intracellular tension and differentiation to 
myofibroblastic phenotype also increase aggregation. These include culture in the presence of TGF- 
β1 [12], culture on stiff surfaces [16], and culture on fibrin coated surfaces [9], as well as culture in 
conditions that combine TGF- β1 and cyclic mechanical stretch [17]. Although there has been a great 
deal of work done to understand the factors increasing aggregation, there remain few hypotheses as 
to why the cells at the center of the aggregate undergo apoptosis. To date, the current knowledge is 
that aggregation is required for the calcification, but the mechanisms initiating the apoptosis and 
calcification in the center of the aggregate remain elusive. 
Merryman and colleagues have proposed the hypothesis that aggregation occurs when VICs, which 
usually reside within a healthy monolayer in culture, become activated to the highly contractile 
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myofibroblastic phenotype. The monolayer essentially “rips apart” due to extraordinarily high 
tension. This tearing creates the cell death and initiates aggregate formation. Although an intriguing 
hypothesis, if the monolayer were to tear apart and create aggregates, the cell death would occur 
on the periphery of the aggregate, while experimentally, the cell death and calcification are found 
within the aggregate center. 
We hypothesize that cells at the center of the aggregate undergo apoptosis as a result of the low 
tension environment. Induction of apoptosis has been shown to occur in a variety of low tension 
mechanical environments. Physical cues that induce apoptosis include the following: release of 
contractile cell-populated collagen gels from rigid anchors [99], inhibiting adhesion to extracellular 
matrix proteins [100], low substrate modulus [33, 91, 101] and restricting cell spread area [103, 
104].  Although cell tension is not usually measured in tandem in these studies, separate studies 
demonstrate that cells free-floating in gels generate minimal tension [105], blocking integrin-
extracellular matrix binding leads to a decrease in traction force [106], and cells within a smaller 
spread area generate weaker traction forces [82, 107-109]. 
Non-uniform cell-generated tension within cell aggregates has been shown to regulate other aspects 
of cell behavior. Chen and colleagues used micro-contact printing to control cell growth. They 
observed higher proliferation around the periphery than in the center of the protein islands. The 
proliferation rates of these cells agreed well with thermo-cooling computational models that predict 
areas of highest stress along aggregate periphery [123]. Additionally, yes associated protein-1 (YAP-
1) undergoes differential nuclear localization depending upon center verses edge location of cells. In 
single cells, studies have shown that YAP-1 only translocate to the nucleus for cells under high 
tension [177].  YAP-1 was shown localize to the nucleus for cells along the periphery of protein 
islands, but not in the center [124]. Finally, stem cells whose differentiation has been shown to be 
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dependent upon cytoskeletal tension [32, 122] have been shown to differentiate to different 
lineages depending upon the location within micro-contact printed rings[125]. Collectively, these 
studies indicate that culture within micro-contact printed protein islands induces varying mechanical 
environments depending upon location within the aggregate.  
Although micro-contact printing has been used extensively to study geometric control of single cells 
and groups of cells, to date, has ever been employed as a disease model. The micro-contact printing 
method on polyacrylamide gels was introduced in Chapter 4 will be used to study mechanical 
tension differences between the center and the edge cells. Factors that have been shown to indicate 
cytoskeletal tension differences, including α-SMA intensity and incorporation into stress fibers, 
stress fiber alignment, and nuclear YAP localization will be examined. These results strongly indicate 
that the cells in the center are experiencing less tension than those along the periphery. Finally, the 
tension will be modulated by changing the aggregate geometry and applying external loads to alter 
the apoptotic time-course and calcification. 
5.2 Methods 
5.2.1 Microcontact printing stamp design for control of aggregate geometry 
The design of the polydimethylsiloxane stamps for micro-contact printing is described in Chapter 4. 
Because changes in geometry alter the distribution of tension, ovals were used in addition to circular 
shapes. 
5.2.2 Tunable substrate preparation 
Polyacrylamide gels of 38 kPa were created as described in Chapter 4. 
5.2.3 Microcontact printing 
The micro-contact printing process was replicated as described in Chapter 4. 
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5.2.4 Finite Element Modeling  
Abaques CAE was used to create a computational model of VIC aggregates. The VIC aggregate 
thickness was determined from confocal z-stacks of the aggregates (representative z-stack shown in 
supplemental data). The cell layer is assumed to behave as an elastic isotropic material with a 
Young’s modulus of 500 Pa, Poisson ratio of 0.49, and 10 µm thickness. A two-step computational 
model was used to simulate a contracting cell layer. In order to introduce contractility to the system 
computationally, two different modeling steps were performed. In the first step, a pre-strain of 10% 
is created with the aggregate. The circular cell layer was stretched in the radial direction to create a 
residual stress is in the system. This pre-strain magnitude has been used for similar modeling work 
previously reported [178] as well as having been found experimentally by studying pre-strain of cell 
stress fibers [179]. In the second step, the outer edge of the sample is fixed and the sample is 
released. This simulation results in a stress distribution in the cell layer. All simulations were three-
dimensional, with finite-element mesh density corresponding to a spacing of 5 μm per node.  Stress 
and strain tensors were calculated throughout the structure and the maximum principal stress at 
the bottom of the cell layer reported. We would like to thank Sina Askarinejad of Rahbar Lab at 
Worcester Polytechnic Institute for assistance in creating the model and the analysis.  
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Figure 5.1: Schematic of magnetic finite element model. a) the initial model defined as a linear 
elastic, isotropic material with a Young’s modulus of 500 Pa, Poisson ratio of 0.49, and cell aggregate 
height of 20 µm. b) Model was stretched 10% to induce a pre-strain in the system c) outer edge of 
the aggregate was fixed, and the material released. 
 
5.2.5 Cell culture 
Valvular interstitial cells (VICs) were isolated from porcine heart valve leaflets obtained from a local 
abattoir (Blood Farm, Groton, MA) within three hours of tissue harvest per published protocols 
[168]. Cells from passages 3-7 were used for all experiments. Cells were seeded at densities 
consistent with literature to encourage monolayer formation and complete cell coverage of the 
micro contact printed area (100,000 cells/cm
2
). Media was changed every 4 days. 
Transfected VICs which constitutively express nuclear YAP were generously donated by Dr. Dan 
McCollum of University of Massachusetts Medical School. 
5.2.6 Ligand coating magnetic beads 
Ferric oxide microbeads (Sigma-Aldrich) were obtained with an average of 5 micron diameter. A 
collagen solution was prepared by adding 1 mg/mL collagen solution (Advanced Biomatrix) with 10% 
0.1 M NaOH to bring the pH up to 7.4. The microbeads were mixed vigorously into the solution and 
sonicated for ten minutes to reduce clumping. The magnetic beads were allowed to incubate in the 
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collagen solution for one hour at room temperature. Beads were then rinsed by centrifugation, 
aspiration of waste solution, and resuspension of the beads in DPBS without calcium and 
magnesium (Cellgro). The microbeads were sonicated for an additional ten minutes to prevent 
clumping and then used immediately.  
5.2.7 Applying ligand coated magnetic beads to aggregates 
VICs were allowed to culture overnight on top of the polyacrylamide gels prior to application of 
ligand coated microbeads. The media was then changed and 10 μL of microbead mixture was added 
to the sample for each milliliter of media. The petri dishes were then gently shaken to disperse the 
microbeads evenly over the sample. Microbeads were allowed to incubate with the sample for 40 
minutes inside the incubator, with occasional shaking to minimize microbead clumping. After 
incubation, the sample was rinsed vigorously with DPBS (-) until excess beads were removed. Fresh 
media was then added to the cells. Microbeads preferentially located to the center of the 
aggregates, despite having been randomly applied to the sample, perhaps suggesting different 
integrin expression between center/edge cells. 
5.2.8 Magnetic pull 
Ceramic magnets of varying magnetic fields were purchased from Duramagnetics. Magnets were 
placed on top of samples prepared with magnetic microbeads. The magnetic field produced by the 
magnet then pulled on the microbeads, exerting an upward force on the cellular aggregates (see 
diagram in Figure 1).  Control cells without magnetic microbeads were also cultured within the 
magnetic field, an additional control of samples cultured solely with magnetic microbeads not under 
a magnetic field were used. Samples were allowed to incubate underneath a magnet for one week. 
An overview of the methods of 5.2.6-5.2.8 is shown in Figure 5.2. 
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Figure 5.2: Schematic of magnetic bead experiment. (left) VIC aggregates were formed using micro-
contact printing method as described in chapter 4. (middle) Collagen coated magnetic beads were 
placed into the dish so they attached to the aggregates. Method of application resultued in 
aggregates having magnetic beads primarily within central region. (inset 1) Enlarged schematic 
showing collagen coated ferromagnetic beads. (right). A magnet is placed ontop of petri dishes 
created an upward tensile force in the z-direction. (inset 2) Enlarged schematic of a single aggregate 
with ferromagnetic microparticles and upward force. 
 
5.2.9 Caspase Activity 
Caspase 3/7 activity was used as a measure of apoptosis detection. CellEvent® Caspase 3/7 Green 
ReadyProbes® Reagent (Thomas-Scientific) was used according to the manufacturer’s guidelines. As 
a positive control, cells were treated with 1 µM staurosporine (Apex Bio), a broad spectrum protein 
kinase inhibitor, for 48 hours. Caspase 3/7 activity was quantified manually by visually thresholding 
the amount of caspase-positive region within an aggregate using ImageJ. 
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5.2.10 Immunohistochemistry 
Cells were fixed with 4% Paraformaldehyde (USB Products) for fifteen minutes and permeabilized 
with 0.25% Triton-X (Calbiochem). Cells were blocked with 1.5% goat serum (Invitrogen) and stained 
for alpha smooth muscle actin (Sigma). Cells were counter-stained with Alexa-fluor 488 phalloidin 
(Thermo-Scientific) and Hoechst (Thermo-Scientific). Antibodies used: anti-αSMA (Sigma, A2547). 
To allow for imaging, coverslips were affixed to glass slides using SHUR/Mount™ Toluene-Based 
Liquid Mounting Medium (Ted Pella, Redding, CA). Prolong-gold (Life Technologies, Grand Island, 
NY) was then added to the polyacrylamide gel. Images for time-course imaging of caspase activity 
were acquired using a using a Zeiss inverted microscope and CCD camera. Z-stacks of micro-contact 
printed aggregates were also acquired at 63x magnification with a confocal microscope (Leica 
Microsystems). 
5.2.11 Regional cell spread area analysis 
To determine if cell spread area decreased within the central region of the aggregate, cell spread 
area was estimated. ImageJ was used to calculate total area of the aggregate. The aggregate center 
was manually identified from visual inspection of the actin staining and a circle was superimposed 
on the image whose diameter was equal to the radius of the aggregate. Nuclei within the 
superimposed circle were labeled “central cells”, while those outside the superimposed circle were 
labeled “edge cells”.  Cell area was estimated by dividing the areas of each region by the number of 
nuclei found within each area. A schematic of analysis is shown in Figure 5.4. 
5.2.12 Stress fiber analysis 
Custom MATLAB code was created to analyze regions of aggregate images for stress fiber alignment. 
Two dimensional fast Fourier transforms (FFTs) were used to assess stress fiber periodicity 
(indicating stress fiber alignment). One phalloidin image from a non-micro-contact-printed 
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aggregate and one phalloidin from a micro-contact-printed aggregate were used to compare stress 
fiber-alignment differences potentially created by restricting cells to protein islands.  
Further, sub-image FFT analysis was done to measure stress fiber alignment in the micro-contact 
printed aggregates. The f-actin image (1024 x 1024 pixels) was first converted to a 16 bit grayscale 
image. It was then broken up into (32 x 32 pixel) sub-images. The mean pixel value was subtracted 
from each subimage to remove the 0 Hz component of the FFT. The 2-D FFT was then computed. 
Using the matlab code fftshift (), the FFT was centered at the origin. The sub-image FFT was then 
binarized and fit to an ellipse. The threshold used to convert to a binary image was consistent across 
all sub-images with and image. The ellipse major and minor axis were calculated and the ratio was 
subtracted from 1. For a circular shaped 2D-FFT, created by a random array of stress fibers, the 
alignment index was 0. A highly aligned section of stress fibers will have an alignment index close to 
1. Heat maps were created to graphically show the regions of high and low alignment. 
5.3 Results 
VICs are a mechanosensitive cell type and alter their α-SMA actin expression and incorporation into 
stress fibers as a function of substrate stiffness [81]. Biophysical analysis of individual VICs on 
substrates of varying stifness shows their ability to alter tension as measured by traction force 
microscopy (Figure 2a), a form analysis conducted on similar cell types[78]. Atomic force microscopy 
of VICs cultured on substrates of varying stiffness revealed that cytoskeletal tension is positively 
correlated with cell stiffness. These findings show that cell stiffness could potentially be used as a 
surrogate measurement for analysis of tension distribution within multi-cellular aggregates. Initially, 
we examined the mechanical environments of aggregates that were formed without micro-contact 
printing. We found that cell stiffness was significantly lower (p<0.05) within the center of the 
aggregates, indicating a lower tension state. Cells within the center of the aggregate have a reduced 
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ability to spread due to proximity to neighboring cells. To confirm that cells with spread area 
restriction have a reduced ability to generate tension, micro-contact printing was used. 40 μm 
diameter circles were used to restrict cell spread area, and a low seeding density (2,000 cells per 
cm
2
) was used to ensure that only one cell attached to each circle. Cells that had grown within the 
protein circle generated ~ 80% lower traction force than unconstrained cells (Figure 3c). These 
results indicate that the tension state between cells within the center of the aggregate and those 
along the periphery are likely different. 
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Figure 5.3 Preliminary support for hypothesis a) Biophysical analysis of VICs cultured on 7.5 kPa and 
20 kPa polyacrylamide gels shows that VICs have positive correlation of traction force and cell 
stiffness as measured by AFM indentation, similar to relationship between cell pre-stress and 
stiffness as reported by Stamenovic and colleagues. This relationship shows that stiffness can be 
used as a surrogate measurement for cell tension when cell traction force measurements are not an 
option. Values reported are mean ± standard deviation. b) Cell stiffness varies with location in the 
aggregate. Inset showing triangular cantilever over a cellular aggregate in culture for five days. 
Values reported are the average stiffness of five 20 μm x 20 μm force maps using a 0.06 N/m 
cantilever with a 5μm diameter bead tip. c) Constraining individual VICs reduced ability to spread as 
evidenced by a decrease in area. Insets show representative unconstrained cell (left) and 
constrained cell (right). d) This spread area restriction, simulating center of aggregate, results in a 
marked decrease (~80%) in ability to generate tension, as measured by cell traction force.  
  Ch. 5: Distribution of tension within VIC aggregates  
130 
 
5.3.1 Regional cell area analysis 
Cells have been shown to have an increased ability to generate cell with increasing cell spread area 
[82]. As an indirect measure of tension, cell area was evaluated in both the central aggregate region, 
defined as the circle encompassed by ½ the radial length, and edge region of the aggregate. 
Aggregates of 50 µm, 200 µm, 300 µm, and 400 µm were examined. Cell area was relatively 
consistent between regions of aggregates of different diameter (Figure 5.4). On average, central 
cells had a cell spread area of 250 µm
2
, while those on the edge had a spread area of 500 µm
2
. The 
reduce spread area within the central regions of the aggregate was statistically significant for 
aggregates of every diameter (two-way ANOVA, p <0.05). 
 
 
 
Figure 5.4 Cells within central region of the aggregate have smaller area than those along the 
aggregate periphery. a) schematic of cell area analysis for center verses edge cells. Center was 
defined as a circle that was ½ the length of the radius b) representative image analysis. A circle was 
drawn on the aggregate using imageJ. The number of cell nuclei within the region of interest were 
counted. As the area of the circle is known, cell area was determined as an average of circular area 
divided by the number of nuclei. c) the cell area in aggregates of increasing diameter. Cell area was 
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fairly constant, regardless of aggregate size. d) ratio of edge cell area/center cell area. 
 
5.3.2 Stress fiber analysis as indication of tension environment 
As an estimate of differences in tension between the center and the edge of aggregates, stress 
fibers alignment was analyzed using two-dimensional FFTs on select regions of the aggregate. A two 
dimensional FFT (2D-FFT) analyzes the periodicity of an image. If the stress fibers are strongly 
aligned in one direction, there will be a repeating pattern that can be quantified with a 2D-FFT. If 
there are no repeating patterns (no stress fiber alignment), this will essentially be a random image. 
As stress fibers carry tension along their length, an estimation of tension state can be gleaned from 
alignment. Upon analyzing three regions per aggregate (as shown below in Figure 5.3), it was found 
that the center of the aggregates, for both non-micro-contact printed and micro-contact printed 
aggregates was highly random, and there was no preferred directionality for stress fiber alignment. 
In contrast, both aggregates saw more fiber alignment along the periphery. However, the micro-
contact printed aggregate did have more alignment, potentially contributing to the circumferential 
transfer of tension, as evidenced by the 2D-FFTs (Figure 5.5d,f and 5.5a,c, respectively). This 
alignment is similar conceptually to the “purse-string” hypothesis in wound healing, whereby the 
redirection of tensional forces contributes to a mechanical signal inducing apoptosis in the center of 
a closing wound. The high fidelity calcification of the micro-contact printed in vitro model, as 
highlighted in chapter 4, may be due to its ability to align stress fibers. 
To further evaluate the alignment within micro-contact printed aggregates, sub-image FFT analysis 
was done over the entire image. Each 1024 x 1024 pixel image was broken up into 32 x 32 pixel sub- 
images, creating 1024 different analysis areas over the image (subimage size was approximately 8 
µm x 8 µm ). Fitting the 2D-FFT to an ellipse gave an indication of alignment degree, as a very 
elongated ellipse would have a high degree of alignment and when the minor/major axis ratio was 
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subtracted from 1, would be close to one. On the contrary, poorly aligned stress fibers would have a 
circular 2D-FFT which when fit to an ellipse, the ratio of minor/major axis would be close to 1, and 
when that vale was subtracted from 1, the alignment index value would be close to zero. Sub-image 
FFT analysis of aggregates of increasing diameter showed that regardless of aggregate size, 
alignment of the stress fibers was highest along aggregate periphery (as shown by heat map 
columns in Figure 5.6).  
 
Figure 5.5: Stress fiber analysis indicates stronger directional tension transfer on edge of 
aggregate as compared to center in both non µprinted and µprint aggregates. Left) Non-micro-
contact printed aggregate. Three regions were analyzed using two dimensional FFTs to show fiber 
alignment. Notice strongest fiber alignment was seen in the peripheral regions of the aggregate (a,c) 
while no alignment was observed in the center of the aggregate. Right) Micro-contact-printed 
aggregate. (d,f) Peripheral alignment of stress fibers was observed, indicating tension transfer along 
fiber length. Like the non-micro-contact-printed aggregate, there was no fiber alignment in the 
center. Scale bar = 100 µm. 
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Figure 5.6: Stress fiber sub-image analysis indicates stronger directional tension transfer on 
edge of aggregate regardless of aggregate size. a) 200 µm diameter aggregate f-actin image, sub-
image 2D-FFT plot, and alignment index. b) 300 µm diameter aggregate f-actin image, sub-image 
2D-FFT plot, and alignment index c) 400 µm diameter aggregate f-actin image, sub-image 2D-FFT 
plot, and alignment index. Regardless of aggregate size, alignment (as indicated by red in 
alignment heat map) was greatest at periphery of aggregate. 
 
 
 
5.3.3 YAP localization suggests different mechanical environment between center and 
edge of aggregate. 
Piccolo and colleagues have shown that YAP is a mechanosensitive pathway, and YAP localization 
gives indication of the mechanical environment of the cells as cells of soft substrates or cultured in 
high density with restricted spread area did not have nuclear YAP localization, while cells in sparse 
culture or on stiff substrates had YAP translocate to the nucleus. As a qualitative measure of tension 
distribution within the micro-contact printed aggregates, location of YAP was assessed. As shown in 
Figure 5.7, the majority of peripheral cells had YAP localized to the nucleus, suggesting a higher 
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tension state, while cells within the center of the aggregate had cytosolic YAP, consistent with cells 
in a lower tension environment. 
 
 
Figure 5.7: YAP undergoes nuclear translocation for cells on the aggregate periphery. a) 200 μm 
diameter aggregate on 38. kPa PA gel stained with phalloidin  (green) showing f-actin stress fibers, 
Hoechst (blue) nuclear stain, and antibodies for YAP (red). scale bar = 100 μm b) Red channel 
showing YAP nuclear localization in peripheral cells c) overlay of red and blue channels to show YAP 
nuclear localization in peripheral cells. Nucleus appears purple where red and blue overlay, 
indicating YAP nuclear activity (white arrows). d) YAP heat map compiled from six different 
aggregates to show intensity distribution of YAP within the aggregates. Notice areas of highest 
intensity are along the periphery of the 200 μm diameter aggregate. 
 
5.3.4 Constitutive YAP expression 
To determine if YAP nuclear localization is sufficient to prevent apoptosis, cells were transfected to 
have continual YAP nuclear localization. Constitutive YAP expression appeared to affect VIC 
mechanosensing, as cells did not increase in area and had a more rounded morphology (Figure 5.8a 
and Figure 5.8b) on all substrates as evidenced by the high form factor, a measure of the number of 
cellular extensions (defined in Ch. 3). Although, YAP nuclear localization has been suggested in other 
types of fibroblasts to drive myofibroblastic differentiation, cells that had constitutive YAP 
expression had smaller spread area compared to control cells (myofibroblasts are known for being 
large spread cells, with large focal adhesions and α-SMA incorporation into stress fibers). YAP 
constitutively active cells had similar proliferation rates to control cells in sparse culture, but when 
plated in micro-contact printed aggregates, cells appeared to lack contact inhibition and continued 
proliferating (Figure 5.9). At 7 days, few aggregates remained in the printed pattern and instead 
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appeared as rounded cell clumps. Interestingly, although these cells were rounded, detached and 
appeared unhealthy, many still had plasma membrane integrity as shown by intracellular esterase 
activity (green). Few cells stained with ethidium homodimer-1 (red) (Figure 5.8). Additionally, no 
visible calcifications were detected. 
 
 
Figure 5.8: Constitutively active YAP interferes with mechanosensing. a) Control cells and VICs 
expressing constitutively active nuclear YAP were grown on PA gels of two moduli as well as TCPS. 
Control VICs increased spread area with increased substrate modulus; however, YAP constitutively 
active cells appeared unable to sense substrate compliance as area did not increase with substrate 
stiffness. b) Form factor, a measure of the number of cellular extensions, was larger for YAP stable 
cells, indicating a more rounded morphology. The smaller the form factor, the greater the number 
of cellular extensions. c) Although nuclear YAP allows for cellular proliferation, control cells and 
constitutively active YAP cells had similar rates of proliferation. 
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Figure 5.9: Constitutively active results in over-proliferation in micro-contact printed patterns. 
a) and b) Phase images for control cells at day 4 and day 7. c) Live (green)/dead (red) showing cell 
death primarily localized to central region of aggregate. White outline indicates edge of 
aggregate. d) and e) Phase images for YAP constitutively active cells days 4 and 7 in culture. f) 
Live/dead image of constitutively active YAP cells. Notice that even though cells are rounded, and 
many are apparently no longer bound to the surface, there is surprisingly little ethidium 
homodimer-1 staining, indicating that these cells still have an intact plasma membrane. No 
calcifications were observed in cultures with constitutively active YAP expression. 
 
 
 
5.3.5 α-SMA actin intensity correlates with high stress, as predicted by FEA model 
As a second qualitative measure of tension, α-SMA actin intensity distribution was assessed in 
aggregates of increasing diameters. Images of several aggregates (indicated in Figure 5.10) were 
“stacked” and the mean pixel intensity at each location was used to create the final α-SMA actin 
intensity heat map. In aggregates of all sizes, α-SMA was most strongly expressed in peripheral cells. 
The distribution of α-SMA intensity was then compared to predicted stress distributions by finite 
element model of contraction. As shown in Figure 5.10, α-SMA actin intensity correlated well with 
areas of high stress predicted by the models. 
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Figure 5.10: α-SMA intensity correlates well with Max Principal Stress predicted by pre-strain 
model. a) Von Mises stress on substrate for thermal cooling model of contractility predicted for 
aggregates of increasing diameter. Modeling courtesy of Sina Askarinejad, Rahbar Lab, Worcester 
Polytechnic Institute. b) Heat maps of α-SMA intensity within aggregates of increasing diameter. 
Mean intensity value for each pixel location displayed in heat map. N indicates the number of 
aggregates which were analyzed to create heat map shown. Notice that intensity correlates 
reasonably well with Von Mises stress, suggesting that although simplistic, the thermal cooling 
model is adequate at predicting mechanical environment within the aggregate.  
 
5.3.6 Finite element model predicts distribution of tension varies with geometry 
Next, after becoming fairly confident in the tension distribution of circular aggregates, we sought to 
modulate the distribution of tension, to determine if caspase and calcium staining correlated with 
areas of low tension. In Figure 5.11, the finite element predictions of maximum principal stress are 
shown. The tension distribution changes with geometry, although the areas of low tension remain in 
the center of the shape.  
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5.3.7 Caspase activity occurs in areas of low tension 
Caspase and calcification activity in aggregates whose shapes had been modulated to control the 
tension distribution was assessed. We predicted that areas of low tension would have higher 
caspase activity and is where calcification would occur. Aggregate area was held constant, but 
ellipses of increasing elongation were created. Using a caspase 3/7 detection reagent, apoptotic 
activity was monitored with time. Figure 5.11 shows representative phase/caspase overlay images 
from aggregates of each geometry. As seen in the figure, caspase activity occurs within the center of 
the shape. This activity also correlates nicely with areas of lowest tension within the geometry as 
predicted by finite element model of contraction.  
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Figure 5.11: Caspase activity occurs most frequently in areas of low tension, as predicted by finite 
element model of contraction, regardless of shape. (a-c) FE model of contraction for different 
geometries. Low area of tension within the VIC aggregate appears in the center. (d-f) Phase images 
of aggregates created in different geometries on 40 kPa PA gel. (a) represents control 200 µm 
diameter circular  aggregates used in other experimental studies in chapter 4. (g-i) Caspase activity 
in aggregates of increasing elongation. (j-l) Green pseudo-color shows areas of apoptotic activity in 
phase/caspase overlay in. Caspase activity occurs most prominently in areas of low tension in the 
center of the shape as predicted by the FE model. Scale bar = 50 µm. 
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5.3.8 Application of mechanical force reduced apoptosis and incorporation of α-SMA into 
stress fibers 
Lastly, the tension in the center of the aggregate was increased via application of force to determine 
if the mechanical stimulation was sufficient for a reduction in apoptosis. Collagen coated magnetic 
microbeads were placed on the center of the aggregates and a magnetic field was applied, creating 
an upward force (Figure 1) on the beads. Control aggregates were cultured in the presence of a 
magnetic field without microbeads. In addition, a separate sample of aggregates was cultured with 
microbeads, but not within the field to determine the effect of microbeads alone. 
Culture in the presence of microbeads was enough to reduce the apoptotic activity (Figure 5.13); 
however, the strongest effect of apoptotic reduction was seen when the aggregates were cultured 
within a magnetic field and the ligand coated beads were applying an upward force. The 
combination of microbeads and magnet had a profound effect on α-SMA expression within the 
aggregates. The contractile protein α-SMA gives a strong indication of phenotypic state in 
fibroblastic cells. When α-SMA is incorporated into stress fibers, as seen by the orange color in 
control aggregates (Figure 5.12), cells are considered myofibroblastic. However, the combination of 
microbeads and magnet resulted in mainly cystolic α-SMA expression in aggregates where forced 
was applied. The effect of microbeads alone on α-SMA was not as apparent with some aggregates 
maintaining filamentous actin, while others had mainly cystolic α-SMA actin. Interestingly, although 
the microbeads were placed mainly in the center of the aggregates, the cystolic α-SMA was found 
throughout the aggregates cultured with microbeads in the presence a magnet field. As both groups 
of aggregates cultured with microbeads saw a reduction in caspase activity, this would suggest that 
in addition to mechanical forces which may be influence apoptotic signals, ligand signaling may also 
play a role. 
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Finally, we sought to compare number of cells within each aggregate, to ensure that microbeads 
were not influencing attachment rates or proliferation. As shown in Figure 5.13b, number of cells 
attached within the three groups was not statistically different. Although, there was less apoptotic 
activity in groups with microbeads and microbeads and magnet, there appears to have not been an 
increase in proliferation. 
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Figure 5.12: Presence of magnetic microbeads affects α-SMA incorporation into stress fibers. α-
SMA (red), f-actin (green), nuclei (blue) scale bar= 100 μm (a) Representative images of 200 μm 
aggregates on 38.2 kPa PA gel without microbeads, cultured in the presence of a magnetic field for 
seven days. Notice orange hue where the α-SMA is incorporated into stress fibers. (b) Collagen-
coated magnetic microbeads (white arrows) on aggregates cultured in the presence of a magnetic 
field for seven days. α-SMA is entirely cytosolic throughout the aggregate, indicating reversal of the 
myofibroblastic phenotype. (c) Aggregates cultured with magnetic microbeads, but without magnet. 
Effect of microbeads alone was not as strong as within presence of magnet with respect to cytosolic 
α-SMA. Some aggregates still did have α-SMA in stress fibers. Insets of each channel shown below 
main figure. Scale bar = 100 µm  
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Figure 5.13: Presence of magnetic microbeads reduces caspase activity. a) Caspase 3/7 activity was reduced 
in the presence of μeads as measured by % of aggregate area positive for caspase. Reduction was most 
prominent when magnetic force was applied. Control aggregates increased in apoptotic activity with time in 
culture while magnetic data presented as mean ± sd. b) Cell number was not significantly between groups, 
suggesting that although magnetic force decreased apoptosis, it did not increase proliferation. Credit: Vivian 
Liang 
 
5.4 Discussion 
In this work, we proposed that differing mechanical environments between center and peripheral 
cells in VIC aggregates may be involved in disease initiation. For central cells, the decreased ability to 
maintain homeostatic tension would result in a mechanical cue to initiate programed cell death 
(apoptosis). Preliminary biophysical analysis of VIC aggregates that had not been micro-contact 
printed suggested that VICs in the center cells are under lower tension than cells on the edge.  This 
was further examined with the micro-contact printed aggregate model.  Cell spread area was 
estimated for the two regions of the aggregate (center and edge) by measuring the aggregate area, 
superimposing a circle in ImageJ on the image that whose diameter was equal to the radius of the 
aggregate and counting cell nuclei within each respective region. Cell spread area was over two 
times greater in the edge cells than in the center cells. Although this is an indirect measure of 
tension, cells of increasing spread area are able to generate large amounts of cytoskeletal tension, 
as measured by traction force microscopy [82]. YAP nuclear localization, an indication of a high 
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tension environment, was not found within the central region of the aggregate and only underwent 
nuclear localization in peripheral cells. This was further confirmed with heat maps of α-SMA 
intensity staining. The contractile protein α-SMA was most strongly expressed in peripheral cells 
than central cells for all aggregates, regardless of size. The α-SMA intensity heat maps correlated 
well with a finite element model of contraction, suggesting that, although this model makes a 
number of assumptions, it does predict the mechanical environment within the aggregate. This 
model was then used to predict stress distributions of aggregates of varying polarization, yet 
controlled area. By altering the aggregate geometry, the stress distribution has been changed, 
although areas of lowest stress were still in the center of the shape.  Next, we examined if location 
of apoptosis and calcification would follow the areas of low stress, as predicted by the model. 
Caspase activity was highest in the areas of low stress in agreement with the hypothesis. Lastly, 
tension distribution was modulated by applying magnetic microbeads to the aggregates and placing 
them within a magnetic field. The ligand-coated microbeads decreased apoptotic activity and this 
effect was most prominent within a magnetic field, although the beads themselves were moderately 
effective. 
5.4.1 Distribution of tension 
Tension has been shown to play a role in the aggregation process [16], as conditions of high tension, 
such as culture on stiff substrates, in the presence of TGF-β1 [12], and increased Rho-pathway 
signaling [18] all increase aggregation. However, how the distribution of tension affects cellular 
behavior within VIC aggregates is not currently known. To date, no studies have examined the 
tension state within VIC aggregates themselves, nor attempted to quantify the different mechanical 
environments that may be created within the VIC aggregates. To be complete, atomic force 
microscopy measurements have been done on calcified nodules [95], as well as on individual VICs 
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and nuclei [76], but the hypothesis that there may be a distribution of tension which initiates 
disease onset is a novel concept. 
The distribution of tension has been recognized for a decade as potentially instrumental in 
regulating cell behaviors in the developing embryo. Human beings and all organisms in the kingdom 
Animalia evolve from a single fertilized egg, called a zygote. The single-cell zygote then divides until 
it becomes approximately 32 cells large; this is termed the blastocyst. At the blastocyst stage, the 
tri-layer structure of the organism evolves (ie the endoderm, the mesoderm, and the ectoderm) 
with formation of the blastocyst cavity. Although embryology and organ development is still a very 
active area of research, it is believed that the endoderm becomes the endothelial lining of the 
digestive tract and associated glands, respiratory system, and bladder and urinary system while the 
mesoderm evolves into tissues which form the mesenchyme, mesothelium, and non-epithelial blood 
cells. It has become increasingly accepted that cells with widely different behaviors and lineage 
commitments must be controlled not only by cytokines but from the mechanical environment, as 
cytokines would not have the precision necessary to discern cells just microns apart [180].  
Drosophila Melanogaster (common fruit fly) wing development is one of the more frequently used 
models for the study of morphogenesis, and many findings about the importance of mechanical 
state to organogenesis and development have been uncovered with this model. Using the principals 
of photoelasticity, Nienhaus et. al determined that there was different mechanical stress in various 
regions of the developing wing discs by measuring stress birefringence [181]. The differing 
mechanical environments have been shown to be essential for activating tissue patterning genes in 
Drosophila Melanogaster larva.  
Distribution of tension has shown to affect a range of cellular behaviors in multicellular aggregates 
in two-dimension culture. Areas of high tension were shown to increase proliferation [123] and YAP 
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localization [124, 177]. Position within a multicellular aggregate has also been shown to affect stem 
cell lineage commitment. Vunjak-Novakovic and colleagues examined MSC differentiation on large 
(1000 μm) rings (200 μm inner diameter) and found that osteoblastic lineage commitment varied 
with location within the ring. This differentiation was primarily localized to regions where cell area 
was small yet cells still remained elongated (such as the inner edge of a ring and the regions next to 
the short edges of rectangles) [125]. The differentiation and proliferation activity observed was 
abolished with the use of cytoskeletal inhibitors, such as Blebbistatin and Y-27632. Together, these 
studies show the power of mechanical stresses in regulating multi-cellular behavior, and that cellular 
behavior within aggregates can vary due to the differences in mechanical stresses throughout the 
geometry. 
Although this work focused on low-tension environments and induction of apoptosis, cell tension 
and apoptosis regulation, or dysregulation, can be seen in virtually all other disease states. For 
example, cancer is caused by the absence of cell death and Alzheimer’s disease is the result of 
increased cell death. Although this statement is a great simplification, a recent study in Italy did 
show that these were somewhat related. In the elderly population, Alzheimer’s patients had a much 
lower incidence of certain types of cancer, while cancer patients had a lower incidence of dementia 
[182]. The broad reaching goal of this work is to provide support for the concept that diseases 
should not be considered as simply a dysregulation of apoptosis, but that cell death or absence of it, 
is the result of something which happens earlier, and that is the result altered cell tension. We 
propose that development of future pharmaceuticals, be they small molecules, anti-bodies, etc., 
should focus on the modulation of cell tension in the appropriate “direction”. 
In addition to CAVD, altered cell tension state has been implicated in the progression of cancer. 
Atomic force microscopy has also shown cancer cells with decreased stiffness (decreased cell 
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tension) to have increased metastatic potential [183, 184]. In addition, decreasing the cell tension 
with myosin-II inhibitor resulted in an increase in invasion capabilities [183].  Cancer cells appear 
unable to sense substrate rigidity as they do not alter cell area like healthy cells [33]. 3-D growth of 
cancer cells in tumor spheroids within collagen gels shows high compressive stress experienced 
within the center of the spheroid inducing apoptosis and necrosis [185]. This growth is similar to 
what we observed in this 2-D micro-contact printed model, although our data should not be directly 
compared to 3-D data due to increased complexity of such data. Finally, compressive stress is 
interpreted differently between center and peripheral cells of the tumor spheroid suggesting that 
mechanical stress may effect signal transduction within multicellular systems. 
Measurement of the tension states within multicellular systems is challenging. The most common 
forms of measuring cell tension, traction force microscopy, are unusable in these systems as it is 
impossible to assign bead/post displacement from which force values are calculated to a specific cell 
within the multicellular system.  However, new computational methods, such as monolayer stress 
microscopy (MSM) have been used to study epithelial cell migration [186, 187]. Prior to MSM, cell 
stiffness measurements were used as cytoskeletal tension has been shown to be linearly correlated 
with cell traction force [78]. Additional surrogate measures by immunohistochemistry have also 
been used in the literature, such as YAP nuclear localization [124] and vinculin size [128]. In this 
chapter, we qualitatively examined differences in tension between the center and the peripheral 
cells by evaluating f-actin alignment, YAP localization, and α-SMA intensity. All 
immunohistochemistry analysis strongly indicates a lower tension environment within the center of 
the aggregate than is experienced by the cells along the periphery. 
In this chapter, “tension” was used to mean the amount a cell is able to contract against the 
substrate. We postulated that cells in the center of the aggregate are not able to contract as much 
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as the cells on the periphery. All experimental evidence agrees with this hypothesis, but there are 
other aspects of the mechanical environment that may be causing the apoptosis in the center of the 
cell. These include loss of cell polarity (elongation) and exposure to an isotropic mechanical state. 
Cells in the center of the aggregate are denser than the cells on the periphery, resulting in both 
smaller spread area, and less elongated, cuboidal shaped cells. Cell polarity has been shown to be 
necessary for f-actin polymerization and stress fiber formation [188]. In 2D culture, VICs are highly 
polarized and elongated cells. As elongation correlates with increased traction force [107, 136], 
reducing polarity also decreases tension. Few studies have examined the role of anisotropic cell 
morphology and directionality of mechanical forces on apoptosis, future experiments could be 
designed to tease apart the overlap between cell tension and the lack of anisoptropic cell 
morphology in central aggregate cells. Secondly, as shown with the Von Mises stress plots in Figures 
5.7 and 5.8, cells within the center of the aggregate experience an isotropic stress state, while cells 
along the periphery of the aggregate have anisotropic stress states due to differences in radial and 
circumferential stress.  
Myofibroblasts, identified by α-SMA positive stress fibers, are implicated in many pathologies 
affecting mankind such as asthma [189], idiopathic pulmonary fibrosis, hepatic cirrhosis, 
myelofibrosis, systemic sclerosis, Dupuytren's contracture, hypertrophic scars, aortic valve sclerosis 
and keloids [190]. It is important to understand that myofibroblasts are essential for many bodily 
functions required for organism survival such as proper wound closure, tissue maintenance and 
repair. Persistence of the myofibroblast phenotype is believed to be a critical for the onset and 
propagation of these fibroproliferative disorders; therefore, understanding factors which encourage 
fibroblast de-differentiation may prove beneficial to the aforementioned disease states. This 
mechanosensitive cell type has shown to revert to the fibroblast phenotype when substrate stiffness 
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was reduced [84], though reducing tension state, such as boundary release of a collagen gel have 
been shown to initiate apoptosis [99].  
5.4.2 YAP in myofibroblastic differentiation 
YAP is the downstream target of the Hippo pathway and is considered to be a mechanosensitive 
pathway. YAP localization has been shown to be indicative of tension state for cells on different 
substrates and in different density cultures [124]. YAP has been implicated in several cell types to 
drive myofibroblast activation [128, 191, 192]. Additionally, when YAP was excluded from the 
nucleus, cells had decreased tension levels [128], consistent with a fibroblast phenotype. We used 
recombinant cells which had YAP constitutively expressed to test the hypothesis that nuclear YAP 
would prevent apoptosis and calcification within the center of our micro-contact printed aggregates. 
Surprisingly, VICs that had constitutively active YAP were smaller than control cells. VICs in the 
myofibroblastic state have large spread areas (Chapter 3). Constitutively active YAP appeared to 
make the cells lack contact-inhibition. The micro-patterns “over-proliferated” and the cell clumps 
detached. Constitutively active YAP expression has been shown in mammary epithelial cells to 
confer tumorigenic phenotypes and partial resistance to the chemotherapy drug Paclitaxel [193]. 
Nuclear YAP is involved with MSC differentiation. Piccolo and colleagues were able to rescue MSC 
differentiation from adiopoengic lineages(which predominates on soft substrates) to osteogenic 
lineage (which occur on stiff substrates) [194]. YAP localization was sufficient to “trick” cells in 
thinking they were on a mechanically stiff substrate. However, our constitutively active cell line 
appeared to be insensitive to substrate stiffness, and only slightly increased area when cultured on 
stiff substrates and did not have any changes in form factor as has been previously reported for 
control VICs [28]. 
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5.4.3 Altering myofibroblast behavior with mechanical force 
Collagen type I coated magnetic beads when placed near the center of the aggregates decreased 
apoptosis. This effect was significant when aggregates were in the presence of a magnetic field and 
beads provided an upward force, presumably increasing the tension on the central cells. The way in 
which a vertical (z-direction) force translates to a measurable increase in cell generated tension (in 
the x-y plane) can be visualized by considering a simple truss system. In a simple truss, if there is a 
load placed upon the structure, in the vertical direction, this will translate into an x and y 
component in reaction forces (depending upon the configuration of pins/rollers when considering 
statically determinant trusses). As a cell has a fibrous network (which can be analogous to truss 
members) and is connected to the substrate at discrete locations (analogous to pins), it is logical 
that a z-direction force, would cause in-plane reaction forces. Future work with this system could 
experimentally measure this increase in cell generated tension. 
This technique was developed by McCulloch and colleagues and has been used to study α-SMA 
regulation in cardiac fibroblasts [195]. They found that static force application through collagen 
receptors reduces constitutive α-SMA mRNA and protein that is mediated by p38 [195]. Our findings 
of diffuse, cytoplasmic α-SMA when aggregates were cultured with microbeads under a magnetic 
field is in agreement with these results. Another very similar study using identical methods saw 
increased α-SMA expression in neo-natal cardiac fibroblasts that had been cultured on TCPS < 24 
hours with applied load, but for cells that had been cultured for three days α-SMA was decreased by 
32% [88]. This apparently paradoxical effect was dependent upon baseline α-SMA expression 
(fibroblasts take ~72 hours to incorporate α-SMA into their stress fibers) and appears to be 
mediated by the MAPK pathways. These findings suggest integrin signaling may play a role in disease 
progression and appears to be a promising avenue for future discovery. It also raises the possibility 
of a prospective treatment option for early stages of CAVD as micro-particles are in the 
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development stage for treatment of numerous diseases [196-198]. Future experiments to isolate the 
contributions of ligands to the prominent effect seen in α-SMA could involve using Concanavalin A 
(conA) which instead of binding to a ligand receptor, would bind to the glycosugars located on the 
cell membrane. This would separate the effect of the ligand from the local stiffness created by the 5 
µm diameter microsphere. An additional interesting experiment would be if coating the beads with 
n-cadherin elicited the same effect. Research has shown that cells are capable of generating 
measurable forces, comparable to integrins, through n-cadherins [199]. Coating non-ferromagnetic 
microparticles, such as glass microbeads, would ensure that the α-SMA response is not material 
specific. Finally, evaluation of α-SMA when using anti-n-cadherin molecules in combination with 
integrin coated microbeads would determine the contribution of n-cadherin molecules to the 
cytosolic protein response. 
5.4.4 Comparison of computational model and experimental data 
The computational finite element model of a VIC aggregate is based on a number of assumptions, 
including that the cells behave as isotropic, linear elastic, homogenous material with consistent 
modulus throughout. We know that this is a great simplification as magnetic bead twisting 
rheometry measurements have shown viscoelastic behavior of the cytoskeleton [79]; the 
cytoskeleton is not a homogenous material but a filamentous network. Additionally, atomic force 
microscopy force mapping measurements of cells in culture have shown a wide variety of different 
moduli in sub-regions of the cell depending upon if the atomic force microscopy probe was 
indenting over a stress fiber, the cell nucleus , or other organelles [200]. Our computational model 
predicted that for a circular aggregate, the central region would have a very low stress level of 0-40 
Pa, the middle region would have upwards of 80 Pa, and the very edge of the aggregate would see 
the highest stress level of 160 Pa. Substrate stress beneath aggregates was measured in chapter 4. 
For aggregates cultured on the 40 kPa PA gel and of 200 µm diameter, the minimum stress values in 
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the center were comparable to what was predicted by the model of 0-40 kPa. However, higher 
stress regions along the aggregate periphery were one fold higher than what was predicted by the 
computational model, suggesting that VICs are capable of contracting (and therefore having a 
greater pre-strain value), then the stress fibers measured experimentally [179]. Myofibroblastic VICs 
have been shown to have minimal increase in contraction when potassium chloride was added to 
the media, suggesting these cells are generating maximum force [201]. Future iterations of the 
model could increase the pre-strain value computationally to get closer to the measured substrate 
stresses. However, the purpose of including the model in this work was not to measure VIC 
aggregate contraction but to simulate the distribution of tension within the aggregate. To determine 
the tension distribution, the exact magnitude of the parameters does not matter. As can be seen 
from our results, the model predicts increased tension (shown by an increase in maximum substrate 
stress in the bottom of the cell layer) which is in agreement of our experimental findings of high 
stress fiber alignment, incorporation of α-SMA into stress fibers along the aggregate periphery, and 
YAP localization to the nucleus in peripheral cells. 
5.5 Conclusion 
Differences in mechanical environments have been shown to affect proliferation and mesenchymal 
fate in micro-patterned systems. In this chapter, I provide evidence that there is a difference in the 
mechanical environment between the center of and edge of valvular interstitial cell aggregates. 
Atomic force microscopy measurements of cell stiffness shows that low tension exists in the center 
of non-micro-contact printed aggregates. Spread area restriction, which is present in aggregate 
center, reduces the ability for VICs to generate tension. Examination of stress fiber alignment using 
2-D FFTs shows that there is little to no alignment in center of the aggregates, for both non-micro-
contact printed and micro-contact printed aggregates. Immunohistochemistry analysis of nuclear 
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YAP, an indication of high tension state shows the greatest localization in the aggregate periphery. 
α-SMA, which incorporates into stress fibers in high tension state, had highest expression along 
aggregate periphery. α-SMA expression correlated with areas of highest maximum principal stress 
as predicted by a finite element model. The finite element model was then used to examine stress 
distributions in aggregates of constant area, but changing geometry. Micro-contact printing of 
aggregates with constant area and increased elongation showed that apoptosis occurred most 
frequently in the areas of low tension, regardless of geometry. Finally, collagen coated magnetic 
microbeads were added to the aggregates to apply upward force when aggregates were placed in a 
magnetic field. This resulted in a visible reduction in α-SMA expression in stress fibers. 
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Chapter 6: Discussion, Limitations, and Future Work 
 
The work presented herein examines two different aspects of mechanical regulation of valvular 
interstitial biology. The first aim focused on single valvular interstitial cell traction force response to 
cyclic stretch, and the second validated a novel in vitro disease model for calcific aortic valvular 
disease and the effects of the distribution of tension within the aggregate on disease initiation and 
progression. Both aspects of VIC biology, how single cells regulate their tension and phenotype in 
dynamic environments and the different mechanical environments within cell aggregates and 
respective VIC behavior provide valued information which is useful to understanding calcific aortic 
valvular disease initiation and progression.  
6.1.1 Study objectives Aim 1 
Aim 1 consisted of validating a method for long-term stretch of VICs on hydrogels of tunable 
modulus and evaluating the traction force response to stretch as it varied with cell pre-stress. 
Prior to this work, valvular interstitial cell traction force response to cyclic stretch was only inferred 
from measurement of cell area [28]. A number of technical challenges made completion of these 
experiments difficult. The first is that polyacrylamide does not bind well to silicone materials. The 
protocol that was developed by Quinlan et al. is enormously finicky and is extraordinarily 
challenging for attaching soft polyacrylamide gel formulations. The second was that Flexcell™ plates, 
the commercially available system for stretching cells, were completely unsuitable for traction force 
measurements. Lubrication applied to bottom of Flexcell™ plates to allow for the membrane to slide 
easily across the vacuum posts (necessary for stretching the membrane) is not easily removed, 
making obtaining clear images necessary for traction force microscopy impossible. In addition, the 
Flexcell™ plate membrane is quite thick; for inverted scopes, such as the Zeiss, the working distance 
of objectives represents a limitation to data acquisition. To circumvent these challenges, a custom 
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cell culture well (with <150 µm thick bottom membrane), custom cell stretch device, and graphical 
user interface were created. The strain field of the well was validated to ensure homogenous strain 
in the area where traction force images would be taken (center of the well). The creation of these 
custom wells also was unique and innovative as the bottom membrane is cast at the same time as 
the rest of the well, ensuring the bottom membrane is perfectly taunt, enabling correct strain 
transfer as well as clear imaging. 
VICs have been shown to be sensitive to substrate stiffness, altering their shape, area, and α-SMA 
incorporation into stress fibers depending on the substrate modulus [28, 80, 81, 84].  I have shown 
that VIC response to stretch is dependent upon initial prestress condition. Under conditions of high 
prestress, VICs decrease their cell area, traction force, contractile moment and maximum substrate 
stress in response to long-term cyclic stretch. Increasing cell tension with differentiation to the 
myofibroblast phenotype by culture in the presence of TGF-β1 did not prevent this response.  
Although it did increase cell traction force for statically cultured cells compared to static VICs 
untreated with TGF- β1, the same decrease in traction force, cell area, contractile moment and 
maximum substrate stress was observed. This has strong implications for regulation of the 
myofibroblast phenotype. VICs readily activate in culture from quiescent fibroblast-like cells to the 
highly contractile, synthetic myofibroblast phenotype. This phenotype is advantageous for 
remodeling during injury, but too high a population of valve myofibroblasts have been implicated in 
calcific aortic valvular disease; in addition, presence of too high a population of myofibroblasts has 
hampered the creation of successful tissue engineered heart valves (TEHV) as high residual stress in 
novo tissues causes retraction during implantation and renders the valve unsuitable due to the 
backflow of blood from the aorta to the left ventricle. Reversal of the myofibroblast phenotype with 
stretch has been reported for lung myofibroblasts [26]. Although α-SMA incorporation into stress 
fibers has been correlated with increased traction force [66], we did not directly evaluate α-SMA 
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expression in these experiments. Our results from traction force data indicate that myofibroblast 
phenotype in VICs may be reversible if cultured in the presence of dynamic stretch, but further 
experimentation needs to be conducted to confirm this finding.  
The second major finding from our first aim is that cells with low cell prestress increase their 
traction force in response to mechanical stretch. A low prestress state was accomplished to ways, 
via chemically inhibiting myosin-II motors as well as mechanically by culturing on a low-modulus 
substrate. Myosin motor inhibition has been shown to decrease traction force in stem cells [127], as 
well as rapidly decrease VIC traction force within 20 minutes (data not published). Blebbistatin 
treated cells trended to increase cell traction force, contractile moment, and cell area with stretch, 
although this was not significant. VICs cultured on soft (0.6 kPa) gels had a rounded morphology, in 
agreement with earlier studies [28], but when stretched, elongated, increased in cell spread area, 
traction force, maximum substrate stress, and contractile moment. Although the traction force for 
cells cyclically stretched on soft substrates was three-fold lower than the traction force for stiff 
controls, these cells were still able to reorient.  
In addition to looking at overall cell traction force, we also calculated traction moment as defined in 
[202], which is the combination of traction forces weighted by their corresponding x and y 
coordinates. As defined, a cell contractile moment will be negative if the cell is contracting inward 
(pulling towards itself) and positive if the cell is pushing outward (away from the cell body). Cell 
traction moment, unlike cell traction force, is not an absolute value magnitude. This is advantageous 
because the signage provides valuable information about the cell contraction state that is lost with 
only a cell traction force calculation. Although most studies to date report inward pulling forces as 
well as negative contractile moment, Sheetz and colleagues reported negative forces on micro-posts 
(micro-posts that are being pushed away from the cell) for cells that were stretched on very soft 
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substrates [29] possibly indicating growth of the cell outward as increased cell area has been 
observed for cells on very soft substrates [28, 29]. Interestingly, we observed positive contractile 
moments for half of the control cells that had been treated with Blebbistatin, all of the stretched 
cells that had been treated with Blebbistatin and stretched cells on soft, indicating outward 
displacements of the cell. To our knowledge, this is the first time cell traction force has been 
measured for cells treated with Blebbistatin and that a positive contractile moment and outward 
displacements have been observed. A possible explanation for the outward displacement with 
Blebbistatin treatment is that the myosin II motors become inhibited with Blebbistatin and cannot 
contract against the actin filaments which continue to polymerize outward. 
 As the reorientation response observed on very low modulus materials conflicts with current 
findings of reorientation on soft collagen gels with short-term stretch [30], the experiment was 
repeated with an additional cell type, U2OS, a human osteosarcoma cell line. At 12 hours, 
osteosarcoma cells were reoriented in the direction perpendicular to stretch, consistent with our 
findings in VICs. Combined, our studies of soft and stiff substrates support the theory of “homestatic 
tension set-point” for cells and that this tension set-point varies with the mechanical environment. 
To date, there are no models which can accurately predict all of the observed cellular behaviors 
from our experiments and we hope our data can aide in the creation of more complete 
mathematical and phenomenological models of cell tension with dynamic stimulation as well as cell 
reorientation. 
6.1.2 Study objectives Aim 2 
Study objectives of this aim were two-fold:  first, we validated a reliable and repeatable method for 
creating high-content in vitro assay for the study of dystrophic mechanisms in calcific aortic valve 
disease, and the second, to use this model to test the hypothesis that low tension within the 
  Ch. 6: Discussion, Limitations, and Future Work  
159 
 
aggregate center initiates apoptosis. Dystrophic calcification is characterized by presence of the 
myofibroblastic phenotype, cell death, and calcification. α-SMA positive stress fibers were used to 
determine presence of the myofibroblastic phenotype. α-SMA, when incorporated into stress fibers, 
is indicative of a highly contractile, high tension cell-type.  
To ensure that cell death was present, we stained aggregates with ethidium homodimer-1 to 
evaluate plasma membrane integrity. Cells that are considered “dead” uptake the dye and appear 
red under a fluorescent microscope. To evaluate type of cell death, we added caspase3/7 live 
detection reagent. This reagent was advantageous because it was relatively non-toxic to cells and 
allowed evaluation of caspase signal over multiple time-points and also allowed us to record 
location within the aggregate that positive staining occurred. In addition, to confirm the mechanism 
of cell death was indeed apoptosis, we cultured a subset of samples with Z-VAD-FMK. This reagent is 
a pan-caspase inhibitor and would interfere with caspase 3/7 effector signaling and prevent 
apoptosis. Culture with Z-VAD-FMK resulted in a profound decrease in calcification, suggesting the 
mechanism of cell death was indeed apoptosis. 
Finally, to confirm that the micro-contact printing model was indeed an accurate representation of 
dystrophic calcification, mineralization was evaluated. Micro-contact printed aggregates were seen 
several times to have apparent calcifications within two days of culture, but as Alizarin Red S is a 
terminal stain, it was assessed at day seven for all model validation trials. At one week, aggregates 
were assessed for calcification via positive red staining due to Alazarin Red S binding to free calcium 
ions. The micro-contact printing model worked with high fidelity, on average 67% of aggregates 
stained positive for Alizarin Red at one week. To further investigate the type of calcification seen in 
the aggregates, SEM and X-ray microanalysis was used. Calcium was found in the center of 
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aggregates, mainly in the form of calcium oxide. The calcium was found in two forms: within 
mineralized nanoparticles and what appears to be apoptosising cells, as discussed in 6.2.4. 
After validation of the model, we were able to form the aggregates with high fidelity to allow for 
analysis of stress distribution within cell aggregates and the role low tension environments play on 
apoptosis. We hypothesized that VICs were undergoing apoptosis within the center of the aggregate 
as the central region of the aggregate is a low tension environment and cells are no longer able to 
maintain homeostatic tension. VICs are considered a fibroblastic- like cell, and are capable of 
differentiating into myofibroblasts in conditions of high tension. The first work to show that 
mechanical environments are capable of affecting myofibroblastic fate was done in 3D collagen gels 
by Grinnell and colleagues [99]. The release of boundaries around the 3D collagen gel model trigged 
apoptosis in these cells. Chen and colleagues have shown that when cells are not able to maintain 
tension via spread area restriction, incidence of apoptosis increases [136]. We first confirmed that 
tension distribution may vary within valvular interstitial aggregates that were not micro-contact 
printed. This was done first by biophysical analysis of VICs. VICs on cultured on stiff substrates (a 
higher tension environment) had increasing stiffness and increasing traction force. The relationship 
between traction force and stiffness appeared to be linearly dependent. The same relationship 
between stiffness and cell traction force was found by Stamenovic and colleagues between tension, 
termed cell prestress in the study, and stiffness as measured by magnetic bead twisting rheometry 
[78]. These findings suggest that cell stiffness is a reasonable estimation of the tension state of the 
cell. AFM analysis on five aggregates revealed there is a distribution of tension within the 
aggregates; the center of the aggregate was less stiff than the peripheral cells, implying a state of 
lower tension. To confirm cells that were restricted from spreading, such as those within the center 
of the aggregate, micro-contact printing was used to restrict spread area to a 40φ μm collagen 
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island and traction force was measured. Spread area restriction greatly decreased the ability of cells 
to generate tension. 
As currently quantitate measures of tension within cell aggregates are challenging and rely on a 
number of assumptions, we sought to qualitatively evaluate the differing mechanical environments 
using immunohistochemistry. Three parameters were considered: Stress fiber alignment, YAP 
nuclear localization and α-SMA intensity. As an estimate of differences in tension between the 
center and the edge of aggregates, stress fibers alignment was analyzed using two-dimensional fast-
fourier transform on select regions of the aggregate. It was found that the center of the aggregates, 
for both non-µcontact printed and µcontact printed aggregates was highly random, and there was 
no preferred directionality for stress fiber alignment. In contrast, both aggregates saw more fiber 
alignment along the periphery.  As stress fibers carry tension along their length, an estimation of 
tension state can be gleaned from alignment. YAP nuclear localization was found to occur when cells 
were under high tension environments, such as in sparse culture and on stiff hydrogels while cystolic 
YAP was found in low tension environments, such as on soft substrates or in dense monolayers 
[124]. In our aggregates, YAP nuclear localization was mainly confined to cells along the aggregate 
periphery, indicating a higher tension environment between the center and the edge. We further 
probed this finding with the average α-SMA intensity for aggregates of increasing size and compared 
these heat maps with maximum principal stresses predicted by the finite element model of 
contraction. The average α-SMA intensity was greatest along the periphery of the aggregate. This 
distinction in α-SMA intensities was more noticeable as the average size of the aggregate increased. 
The correlation between α-SMA intensity and maximum principal stress suggested that although a 
number of assumptions had been made, such as assuming the cells behave as a linear, elastic, 
isotropic material, the finite element model of contraction did adequately predict the stress state 
within the aggregates.  
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The finite element model was then used to predict maximum principal stresses for aggregates of 
increasingly elongated geometries but constant area. The model predicted that areas of low tension 
would remain in the center of the shape, but that the distribution of tension changes with the 
geometry. Micro-contact printed stamps were then designed to allow for aggregates to be created 
with constant area, but with ellipses of increasing linearity to determine if caspase and calcification 
activity would follow areas of low tension within the aggregate. Caspase activity was found to occur 
with highest frequency in areas of low tension (visual observation), supporting our hypothesis that 
the pathology initiates as cells undergo apoptosis as they are no longer able to hold their 
homeostatic tension. 
As a final method for testing our hypothesis, we mechanically modulated the tension distribution by 
applying ligand-coated ferromagnetic beads to the center of the aggregates and applying an upward 
force by placing the aggregates within the magnetic field. The application of magnetic beads 
markedly reduced caspase activity, suggesting that apoptosis was prevented with this mechanical 
stimulation. Not only did this upward force reduce caspase activity; there was a profound effect on 
α-SMA expression. α-SMA became noticeably cystolic with the combination of microbeads and the 
magnetic field. Microbeads alone were able to decrease the caspase activity as well; however, the 
effect was not as noticeable. Although apoptosis was reduced, proliferation was not increased as 
the number of cells counted within aggregates of each category was not noticeably different. 
Although not a main focus of aim two, VICs were genetically engineered to constitutively express 
nuclear YAP to determine if nuclear YAP was sufficient to prevent apoptosis. Culture of these 
constitutively active YAP cells on differing substrates of polyacrylamide gels, showed little area 
change, suggesting that constitutively active YAP in VICs interferes with mechanosensing, as spread 
area remained unchanged. Proliferation rates were not affected between constitutively active YAP 
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and controls. However, nuclear YAP did not reduce apoptosis in our in vitro model. Cells instead 
appeared to lack contact inhibition, creating over populated “cell clumps” which had poor adhesion 
to the substrate.  
In summary, the objectives of aim two were met by 1) validating a reproducible, high-fidelity model 
for dystrophic calcification and 2) using this model to provide evidence in support of the hypothesis 
that a low tension environment induces apoptosis within the VIC aggregates. 
6.2.1 Study limitations and future work: Aim 1 
The major limitation of aim 1 was that individual cells were not tracked over time with stretch and 
the reported values are of a population average and not of a single cell before/after stretch. To my 
knowledge this has not been done and the work of aim 1 is the first study to date to have measured 
traction force after long-term cyclic stretch. However, as individual cells were not tracked, 
conclusions cannot be made about changes the pre- and post- stretch traction levels, magnitudes of 
maximum substrate stress, and cell area, etc. The way the stretch system was designed currently 
makes it impossible to track an individual cell over time and future work should focus on redesigning 
the system to allow for stretch about a central point which can remain in view of a microscope for 
the duration of the stretch cycle. The device as is, has four motors which stretch the custom well 
from one fixed corner either uniaxially or biaxially, the cells within the field of view of the 
microscope when the well is in the relaxed state, slide out of view when the well is stretched. This 
makes tracking the same few cells overtime with stretch extremely difficult.  
For designing future experiments, smaller time increments would yield a great deal of information 
about how cells undergo reorientation, especially on soft substrates where the cells must first 
elongate from a rounded morphology and to undergo reorientation. It seems logical that a cell that 
is rounded an unable to generate enough cytoskeletal tension to spread would first elongate in the 
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direction of stretch as it is capable of generating tension against the stretch, as was found by Kaunas 
and colleagues [30]. However, if these cells are capable of orientation, and do reorient towards the 
angle of zero strain as others have reported [156], how is it possible that these cells on soft 
substrates are able to maintain their cell spread area, and elongation if the membrane is essentially 
static in this direction? This remains an open research question and whose answer will provide a 
unique view of cell mechanosensing. 
To further understand the regulation of the VIC myofibroblast phenotype future experiments should 
asses α-SMA incorporation into the f-actin stress fibers and extracellular matrix protein synthesis in 
conjunction with traction force activity of the cells. As mentioned previously, stretch has shown to 
reverse the myofibroblast phenotype for lung myofibroblastic cells [26]. However, how stretch 
impacts the VIC myofibroblast phenotype is still not well understood. Several studies have 
suggested that mechanical stimulation with stretch induce a disease phenotype in this cell type. 
Merryman and colleagues use stretch, in conjunction with TGF-β1, to induce aggregation for 
studying dystrophic calcification. Others have reported increased collagen production, an indication 
of the myofibroblastic phenotype, that is dependent on strain and production of calcium micro-
particles with stretch. However, as VICs are naturally in a highly dynamic environment in the heart 
valve, it seems somewhat skeptical that stretch of just a few hours can cause disease and is an 
adequate representation of a physiologically relevant phenotype. 
Finally, this study was done on a two dimensional surface while the cells in the native heart valve are 
in a three-dimensional environment. Cells behave much differently in three dimensions than in two 
dimensions. For example, cell spreading in three dimensions in not merely the result of substrate 
stiffness, but density of extracellular matrix. In poly(ethylene glycol) (PEG), hyaluronic acid, and 
methacrylated gelatin hydrogels, cell spreading and αSMA staining are more intense in the most 
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compliant gels which have the lowest monomer concentration [203, 204]. In addition to space 
availability in the ECM, increasing integrin binding sites by adding exogenous RGD peptides 
increases VICs ability to spread and form stress fibers [205]. However, traction force microscopy in 
three-dimensional matrices is more complex. Mainly, the protein gels frequently used in three-
dimensional culture such as fibrin and collagen, unlike polyacrylamide gels, are non-linear and allow 
for force-transmission at much greater distances   [206]. In addition, solving finite element 
equations with nonlinear materials is much more complex as the material modulus (hence the 
calculated traction force values) varies with the loading conditions. Despite these challenges, 
understanding how valvular interstitial cells regulate tension in three-dimensional protein gels is the 
most clinically relevant and would have valuable applications for creating de novo tissue engineered 
heart valves.  
6.2.2 Study limitations and future work: Aim 2 
6.2.2.1 Cell type 
Porcine aortic VICs were used instead of human VICs. Healthy human valves are extraordinarily 
difficult to obtain, and the only tissue samples that are available are valves that had been removed 
because of pathology. Often studies that utilize human VICs do so from healthy portions of a 
diseased valve. Due to the difficulties in obtaining human tissues, and the likely variability of using 
diseased cells from different patients, we sought to identify a cell type from a comparable species 
which would  give us similar yet consistent results. Porcine cells have been used in a multitude of 
studies with the in vitro CAVD model [12, 17, 18, 97, 175]. In contrast to the difficulties in obtaining 
human tissue, porcine hearts are readily available from control animals for other experiments or can 
be obtained through a slaughterhouse. The similarities of pig and human hearts have been explored 
with respect to pigs becoming transgenic donors to humans [207, 208]. However, there are 
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important differences between the species with respect to how the heart sits in the body cavity. Pigs 
have a classical valentine heart shape while the human heart has a trapezoidal frontal projection.  
Human are bipedal while pigs are quadrupedal; with gravity playing an important role in the 
evolution of each species cardiovascular system.  
Both human and porcine aortic valves values have a trilaminar structure, consisting of the 
ventricularis, spongisosa, and fibrosa. However there are small differences between aortic valve 
anatomy of humans and pigs. The length of the free edge of the aortic valve leaflets are shorter in 
pigs than in humans [209]. The percent of circumference contribution by each leaflet is also 
different between species. For humans, it is the non-coronary cusp which contributes the most to 
valvular circumference, while for pigs it is the right coronary cusp [209]. Finally, humans have less 
myocardial support of the aortic valve. For humans 43% of the valve has muscle attachment while in 
pigs it is larger at 56% [209]. The differences in geometry, as well as differences in the overall heart 
orientation within the body cavity, and the differences in human and pig stance, means that the 
blood flow through the aorta’s of the different species’ hearts is not identical and the mechanical 
environment that each valvular interstitial cell population experiences will likely be different. 
Certainly, prior to proceeding with using this model as an in vitro drug screen for development of 
targeted therapies to treat CAVD, experiments with human valves to ensure they have the same 
calcification response on micro-contact printed geometries is absolutely warranted. Porcine VICs do; 
however, have a number of similarities with human VICs which makes them a suitable experimental 
cell type. The blood pressures of pigs is similar to humans, but slightly higher (145/105 
systolic/diastolic and 120/80 respectively). They have a similar heart rate (100 bpm, average healthy 
human has 60 bpm) and a comparable cardiac output to humans. 
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6.2.2.2 Measurement of protein transfer 
Integrin density has been shown to affect VIC aggregation potential on rigid materials [9], as well as 
cell spreading response on compliant hydrogels [210].  However, in these studies we did not 
measure the protein density which adhered to the hydrogel and assumed 100% transfer from the 
stamp to the polyacrylamide. As protein has been shown to adhere differently to polyacrylamide 
gels depending upon composition (and therefore stiffness) [210], it’s possible that different stiffness 
gels tested in these experiments had different amounts of protein coatings and ligand density. The 
effect of ligand density might be more crucial to determine  in non-microcontact printed cells 
aggregation will occur rather than if apoptosis and calcification will occur once the cells have 
aggregated. In contrast to the current model of just seeding cells on TCPS, in our system aggregation 
has already occurred and is simulated by the restriction of cells on micro-contact printed protein 
islands. Apoptosis and calcification were observed on all stiffness tested; although, the rate of 
calcification was slightly less on 9.6 kPa gels. This difference could potentially be from different 
attachment propensities on softer materials or perhaps a different ligand density. 
6.2.2.3 Role of integrin signaling  
VIC aggregation response as well as response to statins has been shown to be dependent upon 
protein coatings in experiment on TCPS, highlighting the importance of integrin signaling in disease 
initiation [9, 175, 211]. Collagen and fibronectin coated polystyrene were shown to be preventative 
against aggregation while fibrin appears to enhance the aggregation process [9]. In these studies, I 
only used collagen type I for both aim one and two to coat the polyacrylamide gel in addition to 
micro-contact printing purposes. Collagen type I is found in the native valve [212, 213], and as such 
was a logical choice for these experiments.  Integrins α1β1 and α2β1 bind to monomeric collagen. It 
remains an open research question if fibrin or another protein could create a faster and more robust 
calcification response.  
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An additional finding of note was that collagen type I coated magnetic beads when placed near the 
center of the aggregates actually decreased apoptosis. This effect was significant when aggregates 
were in the presence of a magnetic field and beads provided an upward force, presumably 
increasing the tension on the central cells. This technique was developed by McCulloch and 
colleagues and has been used to study α-SMA regulation in cardiac fibroblasts [195]. They found 
that static force application through collagen receptors reduces constitutive α-SMA mRNA and 
protein that is mediated by p38 [195].  Our findings of diffuse, cytoplasmic α-SMA when aggregates 
were cultured with microbeads under a magnetic field is in agreement with these results. Another 
very similar study using identical methods saw increased α-SMA expression in neo-natal cardiac 
fibroblasts that had been cultured on TCPS < 24 hours with applied load, but for cells that had been 
cultured for three days α-SMA  was decreased by 32%[88]. This apparently paradoxical effect was 
dependent upon baseline α-SMA expression (fibroblasts take ~72 hours to incorporate α-SMA into 
their stress fibers )and appears to be mediated by the MAPK pathways. These findings suggest 
integrin signaling may play a role in disease progression and appears to be a promising avenue for 
future discovery. It also raises the possibility of a prospective treatment option for early stages of 
CAVD as micro-particles are in the development stage for treatment of numerous diseases [196-
198]. 
6.2.2.4 Protein coating 
As mentioned above, the protein coating is critical to VIC aggregation and calcification response with 
culture on TCPS [9]. Additionally, efficacy of statins in preventing aggregation and calcification was 
dependent upon the type of coating [20]. Combined, these results suggest the importance of the 
extracellular matrix and integrin signaling in the disease pathology. In this study, we used collagen 
type I for all of the micro-contact printing as it is one of the major component proteins of the native 
heart valve. Although collagen was reported in earlier literature to be “protective” against 
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calcification [9], VIC aggregates that formed on our micro-patterned geometries exhibited apoptotic 
activity and calcification. This suggests that protein coating may be more important to cue the 
“aggregation” step, but once the cells have aggregated, apoptosis and calcification proceed 
regardless of integrin signaling. To test the hypothesis that apoptosis and calcification will occur 
regardless of type of ligand signalling, future work should involve micro-contact printing of other 
protein types, including fibronectin and fibrin. 
6.2.2.5 Importance of cell-cell contacts 
Cadherins are a type of cell-to-cell contact. Cadherin expression is cell type specific, and it is possible 
that cadherin profiles are different between fibroblasts and myofibroblasts [63]. Cadherin-11 has 
been shown to be necessary for aggregation to occur and has been observed in diseased valves [97]. 
Within groups of cells, there appears to be an inter-play between cadherin and integrin expression. 
Cells within the center of the aggregate of cells have increased cell-cell force transfer compared to 
cell-integrin force transfer [214]. The blocking of cadherins “encourages” cells to bind to the 
substrate via integrins [214]. In our hypothesis, we postulate that the decrease in integrin binding 
within the central cells decreases cell tension, inducing apoptosis. Cells undergo apoptosis and the 
lipid membrane serves as a nucleation site for intracellular calcium. As these cells are bound to their 
neighbors via cadherins, they do not float away or are able to be cleared by the immune system and 
instead serve as nucleation sites for calcium. 
6.2.2.6 Mechanisms initiating apoptosis: Role of YAP/TAZ 
Increasingly, the physical and mechanical properties of the cellular microenvironment are being 
recognized as potent modulators of cell phenotype and fate. However, how these mechanical 
signals are sensed and converted into changes in gene expression has remained elusive and is the 
one of the “holy grails” of the field of mechanotransduction [177]. A potentially promising nuclear 
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transcription factor which cytoskeletal tension appears to control is YAP/TAZ. These nuclear 
transcription factors are the down- stream effectors of the Hippo pathway, and have received much 
attention in the field on embryology as they are involved in organ development. YAP/TAZ nuclear 
localization results in different outcomes depending on cell type, and has been shown to be involved 
with proliferation and osteogenesis. Excitingly, it appears that cytoskeletal tension via actomyosin 
contractility can control YAP/TAZ localization, independent of the Hippo pathway [194]. Cytoskeletal 
regulation of YAP/TAZ appears independent of integrin signaling, the logical upstream molecule of a 
mechanically activated pathway. When spreading was artificially induced using poly-Lys-coated 
substrates (non-integrin binding), nuclear YAP/TAZ localization occurred [215] suggesting that the 
cytoskeletal tension itself is capably of YAP/TAZ regulation. In addition, cell spreading on micro-
pilliars supported YAP/TAZ nuclear localization, even though the ECM ligand contact area was 
reduced by about 90% [194]. Furthermore, it has been shown in mesenchymal stem cells that 
cytoskeletal to nuclear strain regulates YAP/TAZ translocation to the nucleus [127] and that a 
physical nuclear connection to the cytoskeleton via linker of nucleus and cytoskeleton (LINC) 
complexes, such as Nesprin-1, is required for YAP/TAZ translocation to occur [127]. Finally, TGF-β1 
has been shown to activate YAP which promotes nuclear localization and activity of Smad1 and 
Smad3 [216, 217]. In the nucleus YAP associates with transcription expression of genes such as 
connective tissue growth factor and the β2 integrin [218]. 
The role of YAP/TAZ in our model is an interesting area for further research. Like others, we found 
that the central cells of the micro-contact printed aggregates exclude YAP from the nucleus [194], 
indicating that they are under lower tension. However, whether YAP exclusion itself is necessary and 
sufficient to induce apoptosis is not currently known, but would provide a mechanistic answer to 
how the apoptosis within the central cells initiates. To determine if YAP nuclear localization was 
sufficient to prevent apoptosis a cell line was created that had constitutively active YAP nuclear 
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expression. While these cells did not have proliferation rates significantly fasters than the controls, 
these cells apparently lacked contact inhibition and continued to proliferate when constrained to 
protein circles. Cells appeared to float away, presumably undergoing apoptosis; however, these cells 
did not stain positive for makers of cell death. Piccolo and colleagues were able to rescue MSC 
differentiation from adiopoengic lineages  (which predominates on soft substrates) to osteogenic 
lineage (which occur on stiff substrates) [194]. YAP localization was sufficient to “trick” cells in 
thinking they were on a mechanically stiff substrate. However, our constitutively active cell line 
appeared to be insensitive to substrate stiffness, and only slightly increased area when cultured on 
stiff substrates and did not have any changes in form factor as has been previously reported for 
control VICs [28]. As VICs are mechano-sensative cells, YAP may be involved in regulation of the 
myofibroblast phenotype, as discussed in section 6.2.3. 
6.2.3 Regulation of the myofibroblastic phenotype 
Several environmental factors inducing activation and differentiation into the myofibroblast 
phenotype have been identified [9, 12, 81, 211] including substrate stiffness and TGF-β1, but the 
exact molecular pathways which initiate this differentiation remain unknown. One potential nuclear 
transcription factor of interest is YAP/TAZ. As mentioned above, YAP/TAZ has been shown to cross-
talk with TGF-β1 signaling [216, 217]. Additionally, one of the genes YAP/TAZ has been shown to 
regulate is the β2 integrin [218], enabling increased contractile activity. Large spread area has been 
shown to be necessary for nuclear localization of YAP [124, 177]. In parallel, force has been shown 
to be necessary for myofibroblast differentiation due to α-SMA incorporation into stress fibers [88, 
157], and larger cells are able to generate more contractile force  [82]. YAP has also been shown to 
drive myofibroblast differentiation in lung fibroblasts [128] as well as skin fibroblasts [191]. 
Regulation of YAP to control myofibroblast differentiation of VICs could be a potential target of 
pharmaceuticals and is an interesting area for future research. 
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Although there is no treatment currently for fibro-calcific diseases, a conceptual idea, “mechano-
medicines” [8], has been proposed to regulate the tension of myofibroblasts in hopes of reversing 
disease progression. For CAVD, potential pharmaceuticals that have been tried in several recent 
clinical trials are statins [4]. Statins did not improve outcomes for patients with CAVD [219-221]. In 
vitro, statins have been shown to reduce presence of myofibroblasts by reducing α-SMA expression 
[19]. However, statins were not effective in treating calcific nodules once they had formed, 
suggesting a time-dependence of drug administration [19]. Pravastatin was used in chapter 4 with 
the micro-contact printing model as an example to show utility as a potential drug assay for 
promising pharmaceutical candidates. We, like Benton, found that Pravastatin was incapable of 
reversing mineralization activity once the aggregates had formed (aggregates form immediately 
with the microc-contact printed model). This supports the hypothesis by Benton et. al that 
Pravastatin may be useful for treatment before disease onset to discourage progression, but it is 
incapable of reversing calcification once it has occurred. 
6.2.4 Similarities to CAVD  
Future work should be done to show the similarity of this micro-contact printed model to 
calcification observed in native disease valves. Several studies have examined explanted disease 
valves [7, 11, 41, 55]. Our micro-contact printed model replicates some of the hallmarks of CAVD 
reported, including presence of the myofibroblast phenotype [7, 41] and apoptosis [11]. Scanning 
electron microscopy of the in vitro model on tissue culture polystyrene has shown that dicalcium 
phosphate dihydrate (DCPD) is the predominate form of calcium in calcium positive aggregates. 
Approximately ~60% of aggregates that stain positive for calcium have DCPD compared to a much 
lower percentage (~10%) that has hydroxyapatite [9]. Other forms of calcification observed in the in 
vitro model include octacalcium phosphate (~20%) and tricalcium phosphate (~15%)[9]. 
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Hydroxyapatite is one of the main components in bone, and it is contentious whether bone forming 
mechanisms are involved in the formation of the calcified nodules (“osteogenic calcification”). 
Mohler observed what appeared to be bone marrow in the center of calcified regions of diseased 
valves in a small subset of the pathological specimens examined [7].  Stevens and colleagues 
examined VIC nodules and compared them calcium nodules formed by bone cells via Raman 
spectroscopy; these calcium nodules formed by each cell type had distinctly different peak shifts, 
suggesting different calcium deposition and mineralization [164].  Notably, VIC nodules in vitro 
lacked the 960 cm
-1
 apatite peak which has been reported in disease explanted valves [164, 222]. 
However, the representative phase images shown in the manuscript appear to be more of a 
monolayer of VICs rather than an aggregate; the poor reliability of the model may have resulted in 
analysis of not “true aggregates”, and potentially incorrectly analyzing highly confluent monolayers 
instead. 
Nano-analytical methods of calcified valves have revealed that mineralized calcium nanoparticles 
appear prior to disease calcification, and even in apparently “healthy -to-the-eye” tissue these 
nanoparticles can be found [55]. Elena Aikawa (Harvard University and Brigham and Women’s 
Hospital) has also shown micro-particle mineralization in excised valves (NAVBO presentation). 
Stevens and colleagues have shown that these nano-particles are present in atherosclerotic lesions 
in other areas of the cardiovascular system. Currently, it is not known if the mineralized particles 
initiate the disease phenotype, or if it is a by-product of the disease. Selected area electron 
diffraction analysis of disease valves has revealed that the calcium present in explanted valves is 
highly crystalline, even more so than the hydroxyapatite found in bone [55]. Excitingly, SEM and X-
Ray microanalyisis studies of our micro-contact printed model appeared to reveal two mechanisms 
of calcification. The first is that mineralized nanoparticles which apparently release from cells as 
they have been found below the plasma membrane in SEM images become trapped in the 
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extracellular matrix fibers of the aggregate. These particles were approximately the same size as 
those reported in disease valve tissue. These particles can aggregate together, forming large 
clusters. The second form of calcification appears to occur within rounded cells located in the center 
of the aggregate. Several aggregates that were examined contained these rounded cells with 
mineralized nanoparticles in locations where we have observed apoptosis. If these mechanisms 
(mineralizing rounded central cells and mineralized nanoparticles found on the surface of the 
aggregate) are inter-related remains an open research question. 
Although the micro-contact printed model improves upon the current in vitro model for CAVD 
becoming vastly more reproducible and efficient, it is still a two dimensional, static model which is 
greatly simplified from the complex, dynamic, three-dimensional environment of the native heart 
valve. In moving towards a more realistic representation of the heart valve, there are several next 
steps one could take with the model. The first is using this model in a dynamic environment. Chapter 
3 of this dissertation measured traction force with stretch and found that traction forces change 
with dynamic culture, decreasing tension. It would be interesting to see, if the tension distribution 
within the aggregate changes with stretch. Inflation of micro-contact printed protein islands of cells 
was shown to induce YAP nuclear localization in central cells, an indication of increasing tension 
[124]. Perhaps this mechanical means of increasing tension is sufficient to reduce apoptosis in the 
central region of the aggregate.  
In addition to dynamic stimulation, creating a three dimensional model would also be more realistic 
than a flat, planar environment. I envision two ways of transitioning to a three-dimensional model of 
CAVD. The first, is growing valvular interstitial cells within PDMS wells and allowing them to self-
aggregate, forming three dimensional spheres, similar to tumor spheroids. This method has been 
used previously to create and mechanically test tumor spheroids [223]. However, one issue 
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complicating potentially going forward in this manner is that apoptosis could be cued from limited 
diffusion of nutrients and oxygen while in two-dimensions, diffusion is not a problem. It would be 
difficult to separate the effects of mechanical environment from diffusion related cell death. A 
second method for creating a three-dimensional environment reminiscent of the valve structure is 
to embed the valvular interstitial cells within a hydrogel.  Anseth and colleagues developed a matrix 
metalloproteinase (MMP) degradable poly(ethylene glycol) (PEG) hydrogel system as a tool for 
characterizing VIC function in 3D. The system showed that VICs were responsive to TGFβ-1 in three 
dimensions by incorporation of α-SMA and production of collagen I indicating a transition to the 
myofibroblastic phenotype, but VICs did not form aggregates within the system. Aikawa and 
colleagues recently cultured VICs in a three-dimensional hydrogel of hyaluronic acid and gelatin 
crosslinked with methacrylic anhydride. Osteogenic calcification was induced by culturing in 
osteogenic media [40]. Control VICs that were not cultured osteogenic media did not form 
calcifications. Combined these results suggest that VICs behave differently in three dimensions than 
in two dimensions, and studying dystrophic calcification in three dimensions still remains 
challenging. 
6.2.5 Fibro-calcific diseases: impact of the model 
We do not believe the results to be VIC specific, and do believe that this model can be used with 
other types of fibroblasts. There are many different types of fibro-calcific diseases including, 
Dupuytren disease and calcinosis cutis (Cushing’s disease), as well as genetic conditions such as 
Pseudoxanthoma elasticum (PXE); although, calcific aortic valve disease is potential the most well-
known as it has large prevalence and a considerable effect on mortality. The mechanism behind 
fibro-calcific diseases may be similar (with apoptosis playing an initial role prior to the onset of 
calcification). Specifically with our model, human dermal fibroblasts (courtesy of the Pins lab at WPI) 
were seeded onto a ~10 kPa PA gel.  These fibroblasts had been pre-treated with 5 ng/mL TGF-β1 
  Ch. 6: Discussion, Limitations, and Future Work  
176 
 
for five days prior to seeding to trigger differentiation to the myofibroblast phenotype. Caspase 3/7 
activity was evaluated using the live cell event marker for apoptosis. Apoptotic activity was apparent 
in the dermal fibroblast aggregates by day 4, see Figure 6.1. The ability to use the model with 
numerous fibroblast types provides an avenue for finding potential medicinal treatments that are 
applicable to multiple disease states.  
 
Figure 6.1. Human dermal fibroblasts also exhibited apoptotic activity when cultured in micro-
patterned substrates on polyacrylamide. a) phase image of 200 µm aggregate on ~10 kPa PA gel. b) 
caspase 3/7 activity within aggregate indicating apoptosing cells in central regions of the aggregate. 
 
 
An additional interesting avenue for future research would be to use this system to create and study 
atherosclerotic lesions. Smooth muscle cells might have similar behavior when cultured in this 
system. Micro-contact printed geometries could be created on a compliant surface, such as silicone 
sheeting, and then “rolled” to create a tube, mimicking an artery. This adaptation to the model may 
be useful for studying the effect of cytokines and pharmacologics which increase collagen deposition 
to stabilize the calcification, making it less likely to rupture and cause secondary incidents of stroke, 
heart attack or pulmonary embolism [8]. 
6.2.6 Cell movement and proliferation in aggregates 
The hypothesis that cells within the center undergo apoptosis due to low cell tension is somewhat 
simplistic as center and edge cells do not stay in one constant location over time. Cells are capable 
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of migration, even in dense monolayers where there is “no apparent room” to navigate around 
other cells. This raises the question, if cells can migrate between the center and edge regions, and 
experience different mechanical environments, at what point does the apoptosis occur? Could the 
central cells navigate to the edge region and “save” themselves from entering apoptosis? Once a cell 
dies, does it restrict the movement of other cells and limit how many cells can be in the central 
region, or can other cells push the dead cell “out of the way”?  Furthermore, the cells also are 
capable of proliferation within these dense aggregates as well. Confluence, we have learned, is a 
somewhat relative term, and just because the protein patterned area is covered with cells does not 
mean that proliferation will not occur. Shown in figure 6.2 are two aggregates of different sizes that 
were tracked with Hoechst over one day. The 200 µm aggregate showed no change in cells over the 
24 hour period, while the 400 µm aggregate saw an increase in cells from 97 to 107. Future work 
should focus on tracking aggregates over time to understand the impact of migration and 
proliferation on apoptotic activity. 
 
Figure 6.2. 24 time course shows migration and proliferation within aggregates. a) day 1 200 µm 
diameter aggregate on 40 kPa PA gel. scale bar = 50 µm b) 24 hours later, same 200 µm aggregate. 
Cell number did not change between time points. scale bar = 50 µm c) 400 µm diameter aggregate 
on 40 kPa PA gel on day 1 and d) day 2. Cell number within aggregate increased from 97 to 107. 
scale bar = 100 µm 
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6.2.7 Caspase and cell death, the importance of aggregate tracking 
The apoptosis analysis done in the dissertation was based on a population of aggregates. Caspase 
analysis presented was not the result of tracking individual aggregates over time. Future work 
should develop methods of accurate time-lapse microscopy in order to evaluate how long the 
caspase signal stays active in valvular interstitial cell aggregates. In addition to tracking caspase 
activity with time, ethidium homodimer-1 uptake (a maker for cell death which localizes to the 
nucleus) could be measured over-time to evaluate how aggregate cell death changes over time. 
 
6.3 Clinical Significance 
The clinical impact of the presented model is two-fold. The first is it allows clinical researchers to 
have a more reliable, repeatable model system for generating valvular interstitial cell aggregates to 
better understand the mechanisms behind the apoptosis and calcification which appear to initiate 
the pathology. The second is that the micro-contact printing system is translatable to an in vitro 
platform to test potential pharmaceutical candidates. This product could help pharmaceutical 
companies identify molecular targets of calcification, as well as test antibodies, small molecules, and 
pharmacologic agents that could slow, halt or reverse the calcification process. These biomimetic 
aggregates created with micro-contact printing have the advantage over the current system in that 
they are highly controllable, resulting in consistent, repeatable time-course of apoptotic and 
calcification activity. 
Studying CAVD in vivo remains challenging as currently there are no widely accepted animal models 
for this disease. The valve response which initiates calcification does not naturally occur in rodent 
models (the most “low-cost” animal model). Calcification can be induced in small animals by feeding 
a high fat diet; however, the relevance of this model to humans is debatable as valve calcification 
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has not been correlated with high lipid levels in the blood stream. Additionally, examination of 
explanted disease valves reveals only one time-point of the pathology, often at late-stages where 
little mechanistic insight into disease initiation can be gleaned.  
We hope that wide acceptance and usage of this model system will enable studies into the 
apoptotic signaling cascades, allowing for the identification of promising molecular targets, as well 
as providing further understanding of the mechanisms of calcification. Further, we believe this 
technology is translatable in two forms. The first would be a license agreement (as this in vitro 
system for generating valvular interstitial cell aggregates is patented), where companies could adapt 
this technology for use “in-house”, the second would be a small “start-up”/contract research 
organization to evaluate and report on the effectiveness of the medicinal agents at the request of 
the company. 
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Chapter 7: Thesis Conclusions 
 
Aim 1:  
A novel stretch device, custom well, and software program was created and validated to allow for 
uniaxial and biaxial cyclic stretch to be applied to custom cultured cells. As the custom wells are 
made out of polydimethylsiloxane, polyacrylamide gels were able to be covalently attached using a 
method developed previously in our lab, enabling traction force measurements. Using a spacer, the 
bottom of the well was cast at the same time as the sides, allowing for the bottom membrane to be 
perfectly taunt which facilitated clear imaging. In addition, the well mold was designed so that the 
bottom membrane was sufficiently thin (~150 µm) so even with attachment of 70 µm thick 
hydrogel, clear images could be obtained for traction force analysis. VICs were cyclically stretched 
for 24 hours after being allowed to attach to the polyacrylamide gel overnight. It was found for 
conditions of high cell tension, “high prestress”, cells decreased spread area, traction force, and 
maximum substrate stress with stretch. These results were repeated and confirmed with U2OS as an 
additional cell type. Prestress was decreased in a subset of experiments by using both chemical 
(Blebbistatin) and mechanical (low substrate modulus) means. For cells under low prestress, spread 
area, traction force, and maximum substrate stress increased with 24 hours cyclic stretch. 
Contractile moment, the combination of traction forces weighted by their corresponding x and y 
coordinates, was also computed. As defined, a cell contractile moment will be negative if the cell is 
contracting inward (pulling towards itself) and positive if the cell is pushing outward (away from the 
cell body). For VICs that had an intact cytoskeleton (not inhibited with Blebbistatin), contractile 
moment was negative, in agreement with most of the reported literature values. However, for 
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Blebbistatin treated VICs, contractile moment was positive for half of the control VICs and all of the 
stretched VICs, a unique and novel finding.  
Finally, reorientation response was examined for VICs under both high and low prestress conditions. 
VICs reoriented perpendicular to stretch in all experimental conditions, the exception being the sub-
set that had been treated with Blebbistatin, which oriented parallel to stretch. As VICs reorientation 
perpendicular to stretch on low modulus gels conflicted results found in literature, the experiment 
was repeated with U2OS cells on a low modulus substrate with identical findings. 
Aim 2:  
In aim two, a novel method for creation of aggregates for the study of dystrophic calcification in 
vitro is developed and validated. The in vitro model for calcific aortic valve disease is able to be 
replicated with micro-contact printing on polyacrylamide hydrogels. Aggregates formed 
calcifications in a highly repeatable manner, as determined by Alazarin Red S staining. Scanning 
electron microscopy and X-ray micro-analysis revealed that calcium predominates in the form of 
calcium oxide within the aggregates. Calcification was found both in mineralized nanoparticles both 
as well as in what appears to be apoptosing cells. Whether these mechanisms of mineralization are 
distinct or inter-related remains an open research question 
The utility of micro-contact printing allows for tight control over aggregate shape, enabling 
investigation of aggregate size on time-course of pathological calcification. Alazarin Red S was used 
to confirm calcification in our control aggregates, which we defined as 200 µm diameter on 38 kPa 
PA gel. SEM and X-ray micro-analysis was used as a second measure of calcification and identify the 
chemical form of calcium within the aggregates. Interestingly, two types of mineralization was found 
within the aggregates: mineralized spheroid micro-particles which accumulated on the aggregate 
surface as well as mineralization within what appeared to be apoptosing cells due to their rounded 
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morphology. It was shown that apoptosis and dystrophic calcification is present in aggregates of all 
sizes. Micro-contact printing also enables aggregate formation on all stiffness of polyacrylamide; 
dystrophic calcification was found to occur regardless of substrate stiffness. Traction force of the 
aggregates showed that overall traction force increases both with aggregate size and substrate 
stiffness. Additionally, the center of the aggregates had low substrate stress in all conditions. TGF-
β1, although frequently used in literature to increase aggregation in the in vitro model, did not 
increase apoptotic activity, but did slightly affect mineralization as Alazarin Red S staining was more 
intense. Pravastatin, a potential pharmaceutical for treatment of CAVD had no effect on 
mineralization within aggregates or caspase activity. This suggests that pravastatin is not suitable for 
disease prevention or reversal once the CAVD has progressed to the point where cell aggregates are 
present. 
The model was then used to answer the hypothesis: do cells undergo apoptosis within the center of 
the aggregate because they are experiencing a low tension environment. Atomic force microscopy 
measurements of cell stiffness show that low cell stiffness, an indication of cell tension, exists in the 
center of non-micro-contact printed aggregates. Spread area restriction, which is present in 
aggregate center, reduces the ability for VICs to generate tension. Examination of stress fiber 
alignment using 2-D FFTs shows that there is little to no f-actin alignment in center of the 
aggregates, for both non-micro-contact printed and micro-contact printed aggregates. 
Immunohistochemistry analysis of nuclear YAP, an indication of high tension state shows the 
greatest localization in the aggregate periphery. α-SMA, which incorporates into stress fibers in high 
tension state, had highest expression along aggregate periphery. α-SMA expression correlated with 
areas of maximum principal stress as predicted by a finite element model of contraction. The finite 
element model was then used to examine stress distributions in aggregates of constant area, but 
changing geometry. Micro-contact printing of aggregates with constant area and increased 
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elongation showed that apoptosis occurred most frequently in the areas of low tension, regardless 
of geometry. Finally, collagen coated magnetic microbeads were added to the aggregates to apply 
upward force when aggregates were placed in a magnetic field. This resulted in a visible reduction in 
α-SMA expression in stress fibers. 
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Appendix A 
A.1 Valvular Interstitial Cell Isolation Protocol 
 
Protocol modified from: 
Gould R.A., Butcher J.T. (2010). Isolation of Valvular Endothelial Cells. JoVE. 46. 
http://www.jove.com/details.php?id=2158, doi: 10.3791/2158 
Preparation (do day before tissue harvest) 
1. Autoclave: 
a. Serrated tissue forceps 
b. Tissue scissors 
c. Cotton swaps 
2. Make Sterile Collagenase media 
a. Use normal media 10% FBS +1% Anti-Anti in DMEM 
b. Measure 600 U/ml collagenase II 
c. Add collagenase type II to media 
d. Filter sterile 
e. Keep on rocker to ensure homogenized solution 
Steps to isolate valve leaflets 
1. Excise the aortic root 
2. Thoroughly rinse the aortic root with cold sterile, DPBS 
3. Isolate valve leaflets (3 per valve) from the root and place directly in sterile 15 ml conical 
tube filled with 12 mL cold DPBS 
4. Shake several times to remove debris 
5. Keep on ice 
6. Place tissues in sterile hood 
 
Steps to isolate valvular interstitial cells 
1. Fill a sterile 15 mL centrifuge tube with 10 mL collagenase solution per valve 
2. Immediately place them in the appropriate 15 mL conical tube with collagenase solution 
3. Make sure to check the samples after 6 hours. If sufficient digestion has occurred at 6 hours, 
immediately proceed to step 4. 
4. Mix the degraded tissue gently with a stereological pipette until the cell suspension becomes 
homogenized 
5. Centrifuge the digest for 5 min at 1000 rpm and aspirate the supernatant 
6. Add 5mL of media to the tube and centrifuge a second time, and aspirate the suspernatent 
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7. Re-suspend the centrifuged endothelial cells in 5 mL of porcine media and plate in a T-75 
flask 
8. Let the cells grow 1-2 days before changing the media. Tissue debris is normal. 
A.2 PDMS Well Mold Design 
The PDMS well mold design was built off of a design made by an MQP team. For details of their 
design as well as finite element modeling of strain fields with applied  stretch please refer to their 
capstone report available at the WPI library. Advanced Cell Culture Well for Mechanobiology by: 
Jeffery Pruden, Jennifer Mann, Jeffery Kelly, and Daniela Garcia. 
A.3 Creation of PDMS wells, releasing wells from mold, and cleaning mold  
Protocol developed by Heather Cirka, modified from Jennifer Mann (WPI MQP team 2012) 
 
The purpose of this experiment is to create PDMS wells which can be used with the cell stretch 
device. PDMS wells are able to be treated so they can attach to polyacrylamide gels (see appendix D) 
to allow for traction force studies. It has been noted that 1:10 PDMS was too rigid and ripped when 
stretched 10%, therefore, 1:15 PDMS (crosslinker:base mass ratio) was used for uniaxial experiments 
and 1:20 PDMS was used for equibiaxial experiments 
Materials: 
· Well Mold (3 pieces of polycarbonate) 
· Metal Spacer 
· 5 x ¼ inch No. 8 screws 
· 4 x 1 inch No. 6 screws 
· Polydimethlysiloxane base and crosslinker –Sylgard 184 
· Balance 
· Weigh boat 
· Transfer pippet 
· Vacuum dessicator 
· House vacuum 
· ½ inch long metal pins 
Methods: 
Creating PDMS wells 
Place weigh boat on balance and tare machine 
Measure enough PDMS base to fill the four well mold. (About 60 g) into weigh boat 
Add desired amount of cross-liner. For 60g and wells for uniaxial experiments, add 4 g of crosslinker 
Mix vigorously and thoroughly with transfer pippet 
Place weighboat in dessicator under house vacuum for 1 hour 
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While under vacuum, prepare the mold: 
Ensure that the mold is clean, take care not to scratch the bottom surface of the mold as it will 
effect stretch of the wells. It is better to use your fingers to rub off PDMS from previous runs 
than kim wipes or paper towels  
Using ¼ inch No. 8 screws, screw together bottom piece, metal spacer and middle piece 
When PDMS has been under vaccum for one hour, carefully pour PDMS into mold. Take care as to 
not form any bubbles 
If bubbles do form, use N2 gas air gun or scapel blade to pop them. Additionally, mold can be placed 
in dessicator (Pins lab) for one hour to remove any bubbles 
Carefully top of mold ontop of PDMS, again take care as to not form any bubbles as bubbles formed 
with the cover are even more difficult to remove. 
Secure top of mold with 4 x 1 inch No. 6 screws.  Do not over tighen screws!! Over tightening the 
screws “arcs” the top plate and you well will have an un even thickenss 
Place mold onto two test tube holders so that the sides are supported and the mold is level. If the mold 
is tilted, wells will not be a uniform thickness 
Heat oven to 65 degrees. Allow PDMS to polymerize for five hours. Best results were found for 
molds polymerized at 5 hours, do not leave molds overnight. 
Remove from oven and place on bench top to cool to room temperature 
Removing polymerized wells from mold 
Extreme care must be taken when removing well from the molds as the molds are very delicate and 
the bottom membrane is easily torn. If difficult is found with removing the wells, the mold can be 
coated with a silence (details below). One coating of the silane is good for many runs of making 
molds. 
Ensure that the mold has cooled to room temperature. Do not attempt to remove the wells if the mold 
is warm. 
Fill a glass pyrex dish with 70% ethanol and completely submerge the well. 
Using pliers remove metal pins, wipe pins with kim wipe to remove ethanol and prevent rusting 
Remove screws holding top mold and bottom mold in place 
Let mold sit undisturbed in ethanol for 5-15 minutes. 
Gently pull up on bottom layer mold, alternate sides to be even, bottom layer of mold should easily 
release. 
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Using scalpel blade, liberate the metal spacer carefully from the PDMS. Take care not to tear the 
membranes. 
Push corners of wells through the middle layer of the mold to the top of the mold side. Carefully pull 
up on mold to pull wells “through” the middle layer and separate the middle layer from the top. 
Sometimes wells attach to the inserts of the top layer of the mold, but should peel away easily 
Schematic of custom PDMS mold creation: 
 
Notes: If wells are difficult to release, mold may be put into -20 for one hour and then brought up to 
room temperature for one hour prior to removal of wells. Working with the mold when its not at room 
temperature can lead to breaking of the mold. 
Additionally, if mold is still difficult to separate, mold can be silanized with a silane  
Very Improtant! There is an established vacuum dessicator for this! MUST BE DONE IN THE 
HOOD. Silane is a carcinogen and very dangerous to your lungs. 
 
Cleaning Mold 
Care must be taken to clean the mold in between “runs”. If any PDMS is left on the mold, particularly 
the metal spacer, the wells will have an altered thickness, and potentially un-uniform thickness 
It is recommended that you do not use kim wipes, paper towels, or any  
A.4 Attachment of polyacrylamide gels onto the PDMS wells 
Materials: 
· 4 custom PDMS culture wells (see Appendix C for instructions) 
· 22mm circular glass coverslips (with evaporated bead solution if doing traction force) 
· 30 mm diameter o-rings (diameter dimension not critical) 
· Glass syringe with gradations (200ul) 
· Glass pipettes with gradations (10ml) 
· Pipet-Aid 
· Plasma Prep, plasma oxidizer (chem. dept) 
· 3-(Trichlorosilyl)propyl methacrylate (TPM, Sigma 64205, store in fridge under desiccate 
and N2) 
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· Heptane 
· Carbon tetrachloride 
· Hexane 
· Vacuum 
· Vacuum desiccator 
· 40% Acrylamide (Biorad) - refrigerator 
· 2% Bis-acrylamide (Biorad) - refrigerator 
· 1x PBS  
· TEMED (Biorad) – Chemical shelf 
· 10% aqueous solution of APS in DI (aliquots store in -20 ) 
· Nitrogen tank 
· 50 mM HEPES pH to 8.2 
· Molecular Sieves (Fluka 69839) 
· 1.7 ml eppendorf tube 
· 0.65 eppendorf tube 
· Test tube rack 
· Glass peri dish  
· Timer 
· Vortex machine 
 
Chemical Hood Prep: 
Place the following items in or near the chemical hood: 
· Vacuum dessicator 
· Glass pippets 
· Glass syringes 
· Manual pippetor 
· TPM 
· Glass syringe 
· Carbon Tetrachloride 
· Hexane 
· Heptane 
· Waste container (all chemicals can be combined into a single waste container) 
1b. label the glass pippets with tape. ‘Hexane’, ‘Heptane’ ‘Carbon Tetrachloride’ and ‘Waste’ 
2. Mass 1g molecular sieves and place in eppendorf tube. 
3. Using the glass pipettes and manual pippettor, measure 16 ml heptane and add 4 ml carbon 
tetrachloride into 50 ml beaker 
4. dump 1g molecular sieves into beaker 
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5. cover solution with larger beaker, so that it does not evaporate. 
Plasma treatment of the flexcell plate is time sensitive, after this operation, everything must be done 
quickly. 
Making Polyacrylamide gel solution 
Method was adapted from Wen lab 
Materials:  
· 40% acrylamide solution 
· 2% acrylamide solution 
· TEMED 
· HEPES pH 8.2 
· 10% APS aliquot from freezer and kept on ice 
· Vortex machine 
· 0.65 mL test tube 
· 1.7 mL test tube 
Methods: 
Make ‘stock solution’ in 1.7 ml Eppendorf tube 
Depending on the stiffness, add correct amount of  acrylamide, bis-acrylamide, and HEPES (pH to 
8.2) totaling 1 ml of solution 1.7 ml Eppendorf tube 
Vortex polyacrylamide stock solution 
Add 250 μL of stock solution to 0.65 mL Eppendorf tube 
Add 0.9 μL of TEMED to 0.65 mL tube 
Do not add APS until you are ready to have the gel polymerize 
Vortex the 10% APS solution, then add 2.5 μL of 10% APS to the PA gel solution in the 0.65 mL 
tube 
Solution should polymerize within 7 minutes 
 
Plasma treatment of PDMS wells 
Materials: 
· Plasma machine (Chemistry department) 
· PDMS wells 
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Directions: 
Take note of the plasma prep machine. The vacuum and ‘on’ switches are down and the ‘meter’ 
switch is up. The level knob should be turned completely to the left. 
1.  Open gas regulator 
2. turn on plasma prep machine by pressing large square  red button 
3. allow the machine to run for three minutes (to warm up). The longer you are able to run it, the 
better the results may be. 
4. carefully remove sample container from device. Place slits  facing downward.  
5. put uncovered PDMS wells (they should not be in a petri) glass sample container, make sure the 
sample is level for equal plasma treatment on all surfaces 
6. replace sample container CAREFULLY as to not damage the glass rod 
7.to turn on vacuum pump, flip vacuum switch up 
8. Press gently on the sample container to ensure there is a tight seal 
9. Close mesh door 
10. Wait for the vacuum pressure to stabilize.  
11. Flip the on switch up 
12. Turn the level knob to 40 
13. Adjust the tuning knob until there is a magenta glow around the sample. 
14. turn level knob to maximum  
15. Adjust with tuning knob until there is no noise and the plasma is bright purple (it will soon switch 
to bright blue once all the air in the container has been removed) 
16. Set timer for 2 minutes, start timer at this point 
17. after two minutes has past, turn level knob all the way to the left. 
18. Flip ‘on’ and ‘vacuum’ switches off in that order 
19. turn off vacuum pump 
20. wait for the vacuum to release. DO NOT TURN OFF PLASMA PREP UNTIL VACUUM HAS 
RELESED. The machine must be on in order for the vacuum to release. 
21. when the vacuum is released the sample container will slightly pop out. 
22. carefully remove sample container, it might be warm/hot. Do so with caution 
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23. immediately cover treated PDMS wells. The surface is activated and will react with components 
in the air. 
24. turn off plasma machine 
25. close regulator 
It is important to work quickly from this point forward. It has been noticed that the process of PA gels 
attaching to PDMS membranes works better when the building is not humid and not warm. To get 
desired results you may have to work after-hours when building is colder (in the winter). Difficulty 
was had attaching PA gels during the month of August 2014 when the weather was especially humid, 
no problems one month prior. 
Chemical activation of custom PDMS wells 
1. Using glass syringe (do not open container, puncture septum) remove 20 microliters of TPM.  
2. Holding the syringe vertical just of the surface of the heptane/carbon tetrachloride mixture, expel 
the TPM and watch the drops fall into the beaker to confirm that there was indeed chemical in your 
syringe 
3. Using glass pipette and pippettor mix the solution 
4. place solution (use as much as possible without sucking the molecular sieves into your pipet tip) 
onto flexcell membranes . Solution should be divided evenly between the six wells. Cover the flexcell 
plate 
5. The solution should be kept on the membrane for 5 minutes. While the solution is reacting with the 
membrane, take this time to clean the glass syringe (details on syringe cleaning at the end of this 
document) 
6. The membranes will distort due to the chemical treatment and a white residue may deposit on the 
cover due to the reaction taking place.  
7. Remove solution from wells via pipet tip and place in waste beaker/container 
8. Rinse membrane with hexanes 
9. Place the custom PDMS cell culture wells uncovered into the vacuum desiccator. Ensure that the 
valve is open. WARNING: custom wells should be placed on an o-ring. Vacuum restores to 
original shape and they stick to shelf in desiccator as well as petri dishes. From this point forward, 
keep custom PDMS wells on o-rings for all work. 
10. Turn on vacuum pump 
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11. Within a few minutes you should not be able to lift the top of the lid of the desiccator due to the 
vacuum created 
12.  Allow vacuum to pull for 5 minutes for flexcell to return to its normal geometry. 
13. During this time, return to the glass coverslips. Coat thoroughly with Rainx and dry with a kim 
wipe. Handle the coverslips as little as possible with your hands. Lay coverslips on a clean surface, 
such as a paper towel. 
14. After the 5 minutes, close valve and CAREFULLY remove vacuum hose (care is needed during 
this processes because the valve could pull out and expose your chamber to the Atmosphere. The 
vacuum will immediately be filled with air, causing much turbulence in the chamber and possible 
destroying your sample). 
15.  Allow vacuum to run unattached to the chamber for several seconds before switching off 
16. Bring chamber to bench top. Attach to N2 and let nitrogen flow through the sample 
17. Allow plate to sit under flow for 5 minutes 
18. Prepare your PA gels by adding 100 microliters APS and 1.5 microliters TEMED. 
19. Agitate eppendorf to ensure mixing of components. Do a couple of quick taps on the agitator, so 
as not over disturb the gel 
20. Place 50 microliters in the center of the well of the custom PDMS wells. (It is best to do all 6 
wells at once) 
21. Using curved tweezers, pick up the coverslip. Hold coverslip in front of the flowing nitrogen to 
“rinse it” Gently lay the coverslip over the gel. Capillary action will wick the gel underneath the 
coverslip so you will have a circular gel. 
22. Once the coverslip is sitting on the gel, DO NOT MOVE IT to try and center the cell or adjust the 
gel for any reason 
23. Allow the gels to polymerize under nitrogen flow for 30 minutes. Leave undisturbed 
24. Turn off nitrogen and let gels sit undisturbed for another 15 minutes. 
The appropriate time to remove coverslips is when a ‘ring’ or space has formed underneath the 
coverslip. This means the gel has fully polymerized.  
25. Removing the coverslip from the gel is an extremely delicate process. If the gel has not fully 
polymerized it will stick to the coverslip as it is removed. Release the gel from the coverslip by 
pressing GENTLY around the perimeter of the gel. For the custom cell culture wells, I found it easiest 
to remove the coverslip when the well was placed on the machine. It sometimes is helpful to add PBS 
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(or HEPES) prior to removing the coverslip). When applying pressure near the gel, you should see it 
visibly release from the coverslip. To remove the coverslip, push gently into the membrane until a 
tiny corner of the gel has released and the coverslip is free. Take a second pair of tweezers and grab 
the coverslip. Lift the coverslip off in one motion. Make sure that your cover slip does not fall onto 
the gel if you lose hold of it.  
Special note: Gel that has not polymerized around the edges will look like a ruffle. This gel can be 
removed via tweezers. 
26. Gels should be submerged in 1x PBS, covered, and stored in the refrigerator. 
 
References: 
Quinlan, A. M. T., Sierad, L. N., Capulli, A. K., Firstenberg, L. E., & Billiar, K. L. (2011). 
Combining dynamic stretch and tunable stiffness to probe cell mechanobiology in vitro. PloS 
one, 6(8), e23272. 
 
A.5: Activation of coverslips and glass slides of polyacrylamide gel attachment 
Protocol from Wen lab 
Materials: 
· Glass coverslips (square 22mm and square 25mm is what was used most frequently in this 
dissertation)  
· Aminopropyltrimethoxysilane (Sigma, product number) 
· diH2O 
· Two 500 ml beakers 
· 0.5% gluteraldehyde 
· Ceramic coverslip rack 
· Tweezers 
· Plastic slide containers Tiny stir bar (should be able to spin freely without hitting any 
coverslips loaded in the ceramic rack) 
· Timer 
· Stir plate 
Methods: 
Fill one of the 500 ml beakers with 150 mL of diH2O 
Add 1.5 mL of Aminopropyltrimethoxysilane 
Add tiny stir bar 
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Place beaker on stir plate, set the turn rate to XX rpm 
Add coverslips of desired size to ceramic rack. Using tweezers carefully place into 1.5% 
aminopropyltrimethoxysilane solution for 30 minutes 
Fill second beaker with diH2O 
When treatment time has completed, carefully lift up ceramic coverslip rack and dunk it several times 
into diH2O. Excessive rinsing will remove the silane treatment; however two little rinsing will cause 
an undesirable reaction with gluteraldehyde 
Transfer the coverslips to 0.5% gluteraldehyde coverslips storage containers. Keep in fridge until 
ready to use. Treatment is good for several months 
Dispose of 1.5% aminopropyltrimethoxysilane solution in appropriate hazardous waste container 
A.6: Creating PDMS Stamps 
Materials: 
· PDMS base and cross-linker 
· Wafer of desired pattern 
· Petri dish 
· Vacuum desiccator 
· Weigh boat  
· Scapula for mixing 
· Oven set to 55? 
Methods: 
1. Weigh out 10:1 PDMS (base to cross-linker ratio) 
2. Mix throughly with a spatula 
3. Place in vacuum dessicator, pull a vacuum for 15-20 minutes. Release the vacuum 
several times to remove bubbles 
4. Pour over silicone wafer; ensure there are no bubbles. If bubble remain, place back in 
the vacuum for another 15 minutes releasing vacuum several times 
5. Bake at 55 degrees for 3 hours 
6. cool overnight prior to removing stamps 
A.7: Preparing bead glass 
The purpose of this protocol is to evaporate micro-beads onto glass coverslips. The coverslips can 
then be placed upon un-polymerized polyacrylamide gel droplets so that a uniform layer of beads 
becomes attached to the gel. 
Materials: 
· 100% ethanol 
· Plasma cleaner (chemistry lab) 
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· Fluorescent microbeads, size, company product number 
· 22 mm square coverslips. Note: 22 mm circular coverslips and 25 mm square coverslips have 
also been used 
· 1.7 mL Eppendorf tube 
· Vacuum Oven (Wen lab) 
· Ceramic coverslip rack 
· Sonicator 
· 500 mL beaker 
· Coverslip tweezers (electron microscopy science) 
· Brass test tube rack, Wen lab (not critical, just to ensure that the coverslips have a level 
surface to rest on in the oven. 
 
Methods: 
Heat Oven to 140C- 150 C. The temperature is critical, too hot and bead solution evaporates causing 
bead clumping, too colder and beads clump together forming a cobble stone appearance 
Create a 0.5% bead solution in an Eppendorf tube with 1 mL of 100% ethanol and 5 uL of bead 
solution. 
Place coverslips in coverslip rack 
Add to 500 mL with ethanol. 
Place both the beaker with the coverslips and the Eppendorf tube in a sonicator for 5 minutes 
After sonication, remove coverslips and place in oven to dry. When dry, using coverslip tweezers 
remove from the coverslip rack and place in a petri dish to carry to the UV plasma cleaner. 
Place coverslips in plasma cleaner (for instructions on using the plasma cleaner see Appendix D) 
Clean for 30s- 1 minute at full power. Note: use coverslips within 10 minutes after cleaning. Wait 
until oven is sufficiently hot prior to starting this step 
Place 6 coverslips (no more than six at one time, if doing more see note below) on flat surface (brass 
test-tube rack) that is compatible with high temperature 
Add 35 μL of bead solution to 22 mm coverslip (if using different size coverslips, adjust volume 
accordingly) 
Wait 10 seconds as the ethanol solution spreads out along the coverslip prior to placing in the oven 
After placing in the oven, pull a vacuum until the gauge reads -20 
Release vacuum, coverslips are ready to use.  
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Note: If doing more than six coverslips, the brass test tube rack must be cooled prior to re-use. I 
accomplished this by dumping it in the ice chest. 
A.8 Preparing petri dishes for traction force measurement 
Materials: 
· Tissue culture polystyrene 60mm dishes or six well plate 
· Metal Tissue biopsy punch  (~20mm in diameter) 
· Bunsen Burner (located in Lambert lab in Chemistry department) 
· Oven mit or other protection from the heat 
· Lighter 
· Razor Blade 
 
Directions: 
Take cover off of petri dish/6- well plate and over turn on bench top 
Turn on gas and light Bunsen burner 
Heat  metal tissue biopsy punch (angle the punch so the tip is up, placing it tip down will direct the 
flame up towards your hand 
After sufficient heating time, approximately 15 seconds for first punch, apply gently pressure, 
constant pressure  to underside of petri dish 
The punch should glide through the material 
One through, remove the punched material (inside the biopsy) immediately as if the punch is not hot 
it will be impossible to do so. 
“Sand” rough edges around the punch with a razor blade, be careful not to create cracks in the hole as 
that will cause the dish to leak later on. 
A.9 Micro-contact printing protocol 
The protocol for microcontact printing has been broken up into two parts a) activation of 
polyacrylamide gels with hydrazine hydrate and b) micro-contact printing. 
Protocol modified from Vesna Damljanovic 
Part I: activation of polyacrylamide gels 
 
Materials: 
· Hydrazine hydrate (reagent grade, Sigma-Aldrich) 
· Glacial acetic acid (Fluka/Sigma-Aldrich) 
· Tweezers 
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· Ceramic rack 
· Three 500 mL beakers 
· Glassware for hydrazine hydrate 
· Note 1: it is best that all glass ware used for activation with hydrazine hydrate be used only 
for this activation protocol and kept separate from other laboratory equipment. Hydrazine 
hydrate is extremely carcinogenic and should only be used in a fume hood. 
· Note 2: Hydrazine hydrate comes at 78-82% solution. 55% Hydrazine hydrate was used for 
activation for all gels in this thesis. 
 
Methods: 
 
1. In the hood, place 3 500 mL beakers. Fill one with 55% hydrazine hydrate, one with 0.05 N 
acetic acid, and one with di H2O 
2. Fill the ceramic rack with coverslips with gels attached 
3. Using tweezers, carefully lower ceramic rack into hydrazine hydrate 
4. Allow gels to sit in hydrazine hydrate undisturbed for 2-4 hours 
5. After incubation in the hydrazine hydrate, move ceramic rack to 0.05 N acetic acid. Carefully 
dispose of hydrazine hydrate in the appropriate waste container 
6. Incubate gels in acetic acid for 1 hour. At the end of incubation time, transfer gels to diH2O 
and allow to rinse for one hour. 
7. Store gels in PBS wrapped in parafilm until ready for micro-contact printing. Gels will 
remain activated for several months. 
 
Part 2: Micro-contact printing 
 
Materials 
· 0.1 N Glacial acetic acid 
· Type I collagen (bovine, biomatrix) 
· Sodium acetate 
· Sodium n-peridontate 
· Alexa 488 collagen conjugate (if labeling) 
· PDMS stamps for micro-contact printing 
· Compressed Nitrogen with air gun 
 
1. Prepare and filter sodium acetate buffer 
2. Dilute protein stock to 100 μg/ mL 
3. Add 3.0-3.6 mg/ml Sodium n-periodate crystals, swirl the tube a few times gently 
4. Incubate for one hour at room temperature 
5. Place collagen solution on patterned side of PDMS stamps (or place solution in 100 mm petri 
dish and add PDMS stamps pattered side down) 
6. Incubate stamps in collagen solution for 45 minutes – 1 hour 
7. While stamps are incubating, remove PA gels from PBS storage. Place in a vacuum 
desiccator and pull a vacuum using a vacuum pump for 2-20 minutes until gel surface appears 
dry 
8. When stamps have completed incubation, blow off excise protein with a filtered air gun 
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9. Gently place the stamp onto PA gel. DO NOT touch stamp after it has been placed on the PA 
gel.  
10. Leave stamps on gel undisturbed for 2 minutes. If desired, better protein transfer has been 
found if the gels are placed in the oven for two minutes. 
11. After stamping, allow gels to sit at room temperature for 10 minutes, then store in 35mm petri 
dish, full submerged in PBS. Treat with antibiotics/antimycotics before seeding cells. 
 
A.10 Gluing coverslips to Petri dishes for TFM 
Norland Optical Glue was used to affix coverslips to the bottom of petri dishes for the purpose of 
traction force experiments. Norland Optical Glue formulation 63 was purchased in a 30 cc hydrolic 
syringe (not with plunger). A 20 gauge needle was then placed in the glue syringe to allow for tight 
control of the application of the glue.  
Materials: 
· Norland Optical Glue 
· Coverslip with gel 
· Petri dish with hole 
Methods: 
1. Aspirate the back of the coverslip and dry with kim wipe 
2. Place a drop of norland optical glue at each corner of the coverslip and then place into petri 
dish 
3. Irradiate the gel for 1 minute 
4. After glue has polymerized, over turn sample 
5. Glue around the hole in the petri dish, ensuring a complete seal with the coverslip 
6. Irradiate the sample for 7 more minutes 
7. Check to ensure good seal by filling the petri dish with PBS. 
 
 
A.11 Antibiotic solution for gel sterilization 
Antibiotic/antimyocytic Solution for gel sterilization 
The following solution is placed upon polyacrylamide gels both micro-contact printed or collagen 
coated that are going to be used for culture for multiple days. As the activation of glass coverslips, 
polyacrylamide gel fabrication, and micro-contact printing all take place outside of the hood, it is 
impossible to keep sterile. 
The antibiotic/antimyocytic cocktail containing 100 μg/mL penicillin–streptomycin (MediaTech), 2.5 
μg/mL amphotericin B (Corning), 10 μg/mL ciprofloxacin (Alfa Aesar), and 100 μg/mL gentamycin 
(Alfa Aesar) described by Clement, et al.  
Example Calculations: 
Desired amount of antibiotic/antimycotic solution: 500 mL 
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Total need for each ingredient 
Penicillin-streptomycin= ???? ????? ???? ? ????????? of Pennicillin-streptomycin 
amphotericin B=???? ????? ???? ? ??????? 
ciprofloxacin=???? ???? ???? ? ??????? 
gentamycin=???? ????? ???? ? ????????? 
Product concentrations (as determined by reading the bottle) 
Paper reference: Clement AL, Moutinho TJ, Pins GD. Micropatterned dermal-epidermal 
regeneration matrices create functional niches that enhance epidermal morphogenesis. Acta 
Biomaterialia 2013;9:9474–84. doi:10.1016/j.actbio.2013.08.017. 
A.12 Image Acquisition for Traction force 
Materials 
· Traction force sample 
· 0.25% EDTA Trypsin 
· Three fine tipped transfer pipettes  
· PBS 
· Zeiss microscope 
Methods: 
1. Label fine tipped transfer pipettes “media”, “ PBS”, and “trypsin”. 
2. Place sample on microscope, and remove lid. It is of critical importance that the petri dish not 
be bumped or moved once it has been placed on the microscope and cell positions have been 
acquired. 
3. Open up axiovision software 
4. Create a folder, and allow for image capture to go directly into that folder 
5. Open up mark/find window. 
6. Find desired cells and mark positions with software. It is suggested that the number of cells 
be between 10-15 cells per sample.  
7. Acquire a phase and fluorescent image for each cell 
8. Carefully, using fine tipped transfer pipette remove media 
9. Add PBS to sample, carefully, so as not to bump the dish 
10. Remove the PBS slowly with a fine tipped transfer pippet 
11. Add trypsin 
12. Check to ensure all cells have detached from the substrate before taking final fluorescent 
image of the beads. 
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A.13 Collagen  attachment to PDMS and polyacrylamide gels 
Materials: 
· Type I bovine collagen (biomatrix) 
· Sulpho-SANPAH 
· Test tube 
· HEPES 
· 0.02 N glacial acetic acid 
· UV light 
Methods: 
1. Thaw sulpho-SANPAH aliquots 
2. Add solution to HEPES to ensure concentration of 0.5 mg/mL (each 20 μL aliquot makes 2 
mL of solution) 
3. Place 100-200μL of solution on to each PA gel 
4. Irradiate the gel with UV light for 5 minutes 
5. Rinse with HEPES, for best results repeat once more. 
6. Add collagen solution to 0.02 N acetic acid to create 200 μg/mL concentration. 
7. Apply collagen to PA gel, ensure the gel is uniformly covered 
8. Incubate at room temperature for 2 hours or overnight. 
A.14 Cell Culture Media 
The following media was used for culture of VICs, U2OS cells, and HDFs during the course of this 
thesis. 
Final concentrations: 10% FBS, 1% antibiotic/antiomycotic 
Materials: 
· 500 mL bottle of 1x DMEM, Gibco product #: 
· Fetal Bovine Serum (FBS), aliquoted into 25 mLs stored in -20 
· Antibiotic-Antimycotic product # , aliquoted into 5 mL tubes in -20 
· Two extra 50 mL conical tubes 
 
Methods: 
1.) Place FBS and anti-anti aliquots into warm water bath 
2.) Remove 55 mL of DMEM from 500 mL bottle using stereological pippet and empty into 
conical tubes. Aspirate into vacuum container 
3.) Once thawed, add 50 mL FBS and 5 mL of anti-anti to media container 
4.) Label with initials, and final concentration 10% FBS and 1% anti-anti 
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Store in 4C refridgerator 
A.15 Traction Force Calculation and Codes 
%% The first part of the traction force code is the pre-processing step in which the drift is removed 
and the cell boundaries outlined. File name is Preprocess2.m 
clear all; 
 Dishn='dish1' 
 posn='pos02' 
 a1=imread([Dishn,'_fluor_',posn,'.tif']); 
 a2=imread([Dishn,'_tryp_',posn,'.tif']); 
 a3=imread([Dishn,'_phase_',posn,'.tif']); 
  
 cimg(:,:,3)=zeros(size(a2)); 
 cimg(:,:,1)=double(a2)/(max(double(a2(:)))); 
 cimg(:,:,2)=double(a1)/(max(double(a1(:)))); 
 imshow(cimg,[]); 
  
 for i=1:4; 
 [xd(i) yd(i)]=im_shift(a1,a2); 
 xd=mean(xd(i)); 
 yd=mean(yd(i)); 
 end 
  
 imshow(a3,[]); 
 rg2=round(getrect); 
 rg2=round((16*rg2)/16); 
 rg2(3)=[round(rg2(3)/16)]*16; 
 rg2(4)=[round(rg2(4)/16)]*16; 
%change rg2 (3) and rg2(4) 
 imgf_a1=imcrop(a1,rg2); 
 imshow(imgf_a1); 
 figname=[Dishn,posn,'_wMedium.tif']; 
 imwrite(imgf_a1,figname); 
  
  figure(2),imgf_a2=imcrop(a2,[rg2(1)+xd rg2(2)+yd rg2(3) rg2(4)]); 
  imshow(imgf_a2); 
  figname=[Dishn,posn,'_wtrypsin.tif']; 
  imwrite(imgf_a2,figname); 
   
  imgf_a3=imcrop(a3,rg2); 
  imshow(imgf_a3); 
  figname=[Dishn,posn,'_phase.tif']; 
  imwrite(imgf_a3,figname); 
  close all; 
   
  cimg2(:,:,3)=zeros(size(imgf_a2)); 
  tempr=double(imgf_a2)/(max(double(imgf_a2(:)))/4)-0.4; 
  tempg=double(imgf_a1)/(max(double(imgf_a1(:)))/4)-0.4; 
  cimg2(:,:,1)=tempr-tempg; 
  cimg2(:,:,2)=tempg-tempr; 
  figure,imshow(cimg2,[]); 
   
  [xi,yi,iu,iv,D]=mpiv(imgf_a2,imgf_a1,32,32,0.5,0.5,25,25,1,'mqd',2,0); 
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  [iu_f,iv_f,iu_i, iv_i] = mpiv_filter(iu,iv, 2, 2.0, 3, 0); 
  [iu_s, iv_s] = mpiv_smooth(iu_i, iv_i, 1); 
  [xm,ym]=meshgrid([min(xi):xi(2)-
xi(1):max(xi)],[min(yi):mean(diff(yi)):max(yi)]); 
  figure(4),imshow(cimg2,[]); 
  hold on, quiver(xm',ym',iu_s,iv_s,'b'); 
  figname=[Dishn,posn,'.tif']; 
  imwrite(cimg2,figname); 
  scal=1e-6/2; 
  xs1=xm'*scal; 
  ys1=ym'*scal; 
  dx2=iu_s*scal; 
  dy2=iv_s*scal; 
    
   % Draw cell edge 
  
  figure(5),imshow(imgf_a3,[]) 
  [bw,xc,yc]=roipoly; 
  reg=bwlabel(bw); 
  [s,l]=bwboundaries(bw); 
  g=regionprops(l,'PixelList'); 
  hold on,plot(s{1}(:,2),s{1}(:,1),'b.') 
  hold off 
  
  %imshow(cimg2,[]); 
   
  figure(6),hold on, quiver(xm',ym',iu_s,iv_s,'b'); 
  plot(s{1}(:,2),s{1}(:,1),'b.') 
  hold off 
   
  
  % Saving files for Ansys 
   
  fid=fopen([Dishn,posn,'_cell.txt'],'w'); 
  fprintf(fid,'%10.4e \t %10.4e\n',[s{1}(:,2)*scal s{1}(:,1)*scal]'); 
  fclose(fid); 
  save([Dishn,posn,'_disp.mat'],'xs1','ys1','dx2','dy2','rg2'); 
   
%%The traction force code then requires a combination of matlab/ansys to model the cell applying 
the displacement field to the substrate. The main function was created to batch process several cells 
at one time. The main folder runs the files getnlist2.m, getprnsol2.m, and getTFM.m 
%%: 
%%main2.m 
Dishn = '40kPa100um';        % Dish number 
img_num=  [01 02 03 04 05 06 07 08 09 10];                % image numbers 
ansyspos= [01 02 03 04 05 06 07 08 09 10]; 
  
  
% %Generate NLIST files 
for i = 1:length(img_num) 
 Appendix  
217 
 
        getNLIST2(Dishn, ansyspos(i), img_num(i)); 
end 
  
pause; 
  
% % Generate PRNSOL files 
for i= 1:length(img_num) 
    getPRNSOL2(Dishn, ansyspos(i), img_num(i)); 
end 
  
pause; 
  
%Calculate Traction Force 
  
for f=1:length(img_num) 
    getTFM(Dishn, ansyspos(f), img_num(f)); 
end 
 
Reproduced here are the functions:  
 
function getNLIST2(Dishn,ansyspos,img_num) 
  
load([Dishn,'pos', num2str(img_num,'%2.2d'), '_disp.mat']); 
scal=1e-6/2;length=rg2(:,3)*scal; width=rg2(:,4)*scal;height=600*scal; 
meshsize=16*scal; 
  
% Making ansys text file to define the model 
  
filn=[Dishn,'pos', num2str(img_num,'%2.2d'), '.txt']; 
fid=fopen(filn,'w') 
line1=['/TITLE,newgel\n','/PREP7\n']; 
fprintf(fid,line1); 
line2=['ET,1,SOLID185\n']; 
fprintf(fid,line2); 
line3=['KEYOPT,1,2,0\n','KEYOPT,1,3,0\n','KEYOPT,1,6,0\n']; 
fprintf(fid,line3); 
line4=['MPTEMP,,,,,,,, \n','MPTEMP,1,0 
\n','MPDATA,EX,1,,40000\n','MPDATA,PRXY,1,,0.4\n','!*  \n']; 
fprintf(fid,line4); 
line5=['BLC4,0,0,',num2str(length),',',num2str(width),',',num2str(height),
'\n']; 
fprintf(fid,line5); 
line6=['AESIZE,ALL,',num2str(meshsize),'\n','MSHKEY,0\n','MSHAPE,1,3d 
\n','CM,_Y,VOLU \n','VSEL, , , 
,\n','CM,_Y1,VOLU\n','CHKMSH,''VOLU''\n','CMSEL,S,_Y\n']; 
fprintf(fid,line6); 
line7=['MSHAPE,0,3d \n','MSHKEY,1\n','VMESH,_Y1\n','MSHKEY,0\n']; 
fprintf(fid,line7); 
line8=['nsel, s, loc, z, 0 \n']; 
fprintf(fid, line8); 
line9=['/OUTPUT, nlist_',Dishn,'pos', num2str(img_num,'%2.2d'), ', txt 
\n']; 
fprintf(fid,line9); 
line10=['nlist \n']; 
fprintf(fid, line10); 
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line11=['/OUTPUT \nFINISH \n']; 
fprintf(fid,line11); 
fclose(fid); 
  
infile=[Dishn,'pos',num2str(img_num, '%2.2d'), '.txt']; 
outfile = ['nlist_', Dishn, 'pos', num2str(img_num, '%2.2d'), '_2.txt']; 
system(['"C:\Program Files\ANSYS Inc\v140\ansys\bin\winx64\ANSYS140.exe" -
b -i ' infile ' -o ' outfile]);  
 
function getPRNSOL2(Dishn, ansyspos,img_num) 
  
load([Dishn,'pos', num2str(img_num,'%2.2d'), '_disp.mat']); 
scal=1e-6/2;length=rg2(:,3)*scal; width=rg2(:,4)*scal;height=600*scal; 
meshsize=16*scal; 
  
m=readnode(['nlist_',Dishn,'pos',num2str(img_num, 
'%2.2d'),'.txt'],2,10,50,7); 
nlist=m.nodes; 
xn=nlist(:,2); yn=nlist(:,3);  
dxn=interp2(xs1',ys1',dx2',xn,yn); 
dyn=interp2(xs1',ys1',dy2',xn,yn); 
  
celllist=dlmread([Dishn,'pos',num2str(img_num, '%2.2d'),'_cell.txt']); 
  
xcell=celllist(:,1); 
ycell=celllist(:,2); 
Incell=inpolygon(xn, yn,xcell, ycell); 
index_cell=find(Incell==1); 
xpos=xn(index_cell); ypos=yn(index_cell); 
xdisp=dxn(index_cell);ydisp=dyn(index_cell); 
  
% Making table for ansys  
B=[[1:size(index_cell,1)]' (nlist(index_cell,1)) xpos ypos xdisp ydisp]; 
B(2:size(xpos,1)+1,:)=B(1:size(xpos,1),:); 
B(1,:)=[0:5]; 
format shortG; 
dlmwrite([Dishn,'pos',num2str(img_num, 
'%2.2d'),'_table_firstl.txt'],B,'\t'); 
  
index_outcell=find(Incell==0); 
xout=xn(index_outcell); yout=yn(index_outcell); 
dxout=dxn(index_outcell); dyout=dyn(index_outcell); 
C=[(1:size(index_outcell,1))' (nlist(index_outcell,1)) xout yout dxout 
dyout]; 
C(2:size(xout,1)+1,:)=C(1:size(xout,1),:); 
C(1,:)=[0:5]; 
format shortG; 
dlmwrite([Dishn,'pos',num2str(img_num, 
'%2.2d'),'_nulfnodes_firstl.txt'],C,'\t');  
  
% Making ansys input text file for ansy - to apply the load on top 
filn=['ansys_',Dishn,'pos',num2str(img_num, '%2.2d'),'On1.txt']; 
fid=fopen(filn,'w'); 
line1=['/TITLE,newgel\n','/PREP7\n']; 
fprintf(fid,line1); 
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line2=['ET,1,SOLID185\n']; 
fprintf(fid,line2); 
line3=['KEYOPT,1,2,0\n','KEYOPT,1,3,0\n','KEYOPT,1,6,0\n']; 
fprintf(fid,line3); 
line4=['MPTEMP,,,,,,,, \n','MPTEMP,1,0 
\n','MPDATA,EX,1,,40000\n','MPDATA,PRXY,1,,0.4\n','!*  \n']; 
fprintf(fid,line4); 
line5=['BLC4,0,0,',num2str(length),',',num2str(width),',',num2str(height),
'\n']; 
fprintf(fid,line5); 
line6=['AESIZE,ALL,',num2str(meshsize),'\n','MSHKEY,0\n','MSHAPE,1,3d 
\n','CM,_Y,VOLU \n','VSEL, , , 
,\n','CM,_Y1,VOLU\n','CHKMSH,''VOLU''\n','CMSEL,S,_Y\n']; 
fprintf(fid,line6); 
line7=['MSHAPE,0,3d \n','MSHKEY,1\n','VMESH,_Y1\n','MSHKEY,0\n']; 
fprintf(fid,line7); 
line8=['*dim,Txy,table,',num2str(size(index_cell,1)),',5,1\n']; 
fprintf(fid,line8); 
line9=['*tread,Txy,''',Dishn,'pos',num2str(img_num, 
'%2.2d'),'_table_firstl.txt''\n']; 
fprintf(fid,line9); 
line10=['*do,i,1,',num2str(size(index_cell,1)),',1\n']; 
fprintf(fid,line10); 
line11=['d,Txy(i,1),ux,Txy(i,4)\n']; 
fprintf(fid,line11); 
line12=['d,Txy(i,1),uy,Txy(i,5)\n']; 
fprintf(fid,line12); 
line13=['*enddo\n']; 
fprintf(fid,line13); 
line14=['*dim,loadf,table,',num2str(size(index_outcell,1)),',5,1\n']; 
fprintf(fid,line14); 
line15=['*tread,loadf,''',Dishn,'pos',num2str(img_num, 
'%2.2d'),'_nulfnodes_firstl.txt''\n']; 
fprintf(fid,line15); 
line16=['*do,j,1,',num2str(size(index_outcell,1)),',1\n']; 
fprintf(fid,line16); 
line17=['f,loadf(j,1),fx,0\n','f,loadf(j,1),fy,0\n','f,loadf(j,1),fz,0\n',
'*enddo\n','da,2,ux,0\n','da,2,uy,0\n','da,2,uz,0\n']; 
fprintf(fid,line17); 
line18=['FINISH\n']; 
fprintf(fid, line18); 
line19=['/SOLU\n']; 
fprintf(fid,line19); 
line20=['SOLVE\n']; 
fprintf(fid, line20); 
line21=['FINISH\n']; 
fprintf(fid, line21); 
line22=['/POST1\n']; 
fprintf(fid, line22); 
line23=['nsel, s, loc,z,0\n']; 
fprintf(fid, line23); 
line24=['/OUTPUT, PRNSOL_' Dishn,'pos',num2str(img_num, 
'%2.2d'),',txt\n']; 
fprintf(fid, line24); 
line25=['PRNSOL, s, comp\n']; 
fprintf(fid, line25); 
line26=['/OUTPUT\n']; 
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fprintf(fid, line26); 
line27=['FINISH\n']; 
fprintf(fid, line27); 
fclose(fid); 
  
%send files to anysy and get back the PRNsol file 
infile=['ansys_',Dishn,'pos',num2str(img_num, '%2.2d'),'On1.txt']; 
outfile = ['PRNSOL_' Dishn,'pos',num2str(img_num, '%2.2d'), '_2.txt']; 
system(['"C:\Program Files\ANSYS Inc\v140\ansys\bin\winx64\ANSYS140.exe" -
b -i ' infile ' -o ' outfile]);  
 
function getTFM(Dishn, ansyspos, img_num) 
  
m=readnode(['nlist_',Dishn,'pos',num2str(img_num, 
'%2.2d'),'.txt'],2,10,50,7); 
nlist=m.nodes; 
xn=nlist(:,2); yn=nlist(:,3);  
% dxn=interp2(xs1',ys1',dx2',xn,yn); 
% dyn=interp2(xs1',ys1',dy2',xn,yn); 
  
celllist=dlmread([Dishn,'pos',num2str(img_num, '%2.2d'),'_cell.txt']); 
  
xcell=celllist(:,1); 
ycell=celllist(:,2); 
Incell=inpolygon(xn, yn,xcell, ycell); 
index_cell=find(Incell==1); 
xpos=xn(index_cell); ypos=yn(index_cell); 
% xdisp=dxn(index_cell);ydisp=dyn(index_cell); 
  
% index_outcell=find(Incell==0); 
% xout=xn(index_outcell); yout=yn(index_outcell); 
% dxout=dxn(index_outcell); dyout=dyn(index_outcell); 
% C=[(1:size(index_outcell,1))' (nlist(index_outcell,1)) xout yout dxout 
dyout]; 
% C(2:size(xout,1)+1,:)=C(1:size(xout,1),:); 
% C(1,:)=[0:5]; 
  
ress1=readnode(['PRNSOL_',Dishn,'pos',num2str(img_num, 
'%2.2d'),'.txt'],2,17,37,7); 
list_1=ress1.nodes;syz_1=list_1(:,6);sxz_1=list_1(:,7); 
S1=sqrt((syz_1(:)).^2+(sxz_1(:)).^2); 
S1_cell=S1(nlist(index_cell,1)); 
  
% Force Calculation 
scal=1e-6/2; 
meshsize=16*scal; 
Area=meshsize*meshsize; 
  
 % Layer 1 
 Force=Area*S1; totForce=sum(Force); 
 Cell_force=Area*(S1_cell); totForce_cell=sum(Cell_force); 
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 save([Dishn,'pos',num2str(img_num, '%2.2d'), 
'_data.mat'],'xn','yn','S1','S1_cell','Force','totForce','Cell_force','tot
Force_cell'); 
  
 %Contour Plot and stress distribution 
  
m=round(xn/meshsize)+1; 
n=round(yn/meshsize)+1; 
  
% for i=1:max(m); 
%     for j=1:max(n); 
%         Xn(i,j)=xn(j+(i-1)*max(n)); 
%         Yn(i,j)=yn(j+(i-1)*max(n)); 
%         Zn(i,j)=S1(j+(i-1)*max(n)); 
%     end 
% end 
% figure,contour(Xn,-Yn,Zn) 
% colormap(jet); colorbar; 
% xlabel('m'); ylabel('m'); 
% hold on,  plot(celllist(:,1),-celllist(:,2),'r.') 
% hold off; 
  
mx=max(xn)/scal; 
my=max(yn)/scal; 
[xssm,yssm]=meshgrid([0:1:mx],[0:1:my]); 
zmsh=griddata(xn/scal,yn/scal,S1,xssm,yssm); 
figure, imshow(zmsh,[]);colormap(jet);colorbar; 
hold on, plot(xcell/scal,ycell/scal,'r','LineWidth',2); 
cbar=colorbar; 
set(get(cbar,'ylabel'),'String','Stress [Pa]'); 
caxis([0 2500]); 
 
A.16 Caspase live cell detection reagent 
 
This reagent was purchased and used according to the manufacturer’s instructions. Please see: 
https://www.thermofisher.com/order/catalog/product/C10423 
 for more information about this product. It was used at working concentration of 1 μM. 1 μL of 
reagent was added for every 2 mL of culture media. Reagent was incubated with cells for 1 hour prior 
to imaging. The cell culture media and live cell detection reagent was replenished every 48 hours for 
the duration of the experiment. 
 
A.17 Fixing Cells 
To be done in the fume hood. Dispose of paraformaldehyde in hazardous waste. Use proper PPE 
(personal protective equipment) such as gloves and labcoat 
Materials: 
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· 4% Paraformaldehyde 
· Hazardous waste container 
· 2 Transfer pipets 
· 1x PBS 
· Timer 
Methods: 
1. Place haz waste container, transfer pippets and paraformaldehyde 
2. Remove cells from incubator. 
3. Bring to lab bench 
4. Aspirate media and replace with 1x PBS 
5. Bring cells and 1x PBS to chemical hood 
6. Remove 1x PBS by draining it into haz waste container using the transfer pippet 
7. Apply enough 4% paraformaldehyde to coat the surface you are fixing, you do not need that 
much volume. 
8. Allow the paraformaldehyde to stay on sample for 15 minutes 
9. Dispose into haz container 
10. Rinse 2x with 1x PBS, disposing each time into haz container. 
11. Apply PBS to sample to store 
 
A.18 Staining for α-SMA, Phalloidin, and Hoesct with cover slipping details 
 
 (TAG 09/24/08, Edited AZR 02/11/15, Edited VL with HC 05/11/15) 
 
Samples: Cultured cells on glass coverslips or polyacrylamide gels 
Primary Antibody: Monoclonal anti-actin αSMA produced in mouse [Sigma, cat#A2547] 
Secondary Antibody: Goat anti-mouse immunoglobulin (H+L); conjugated to AlexaFluor 546 
[Invitrogen, cat#A11003] 
Materials: 
· Four Eppendorf tubes or 15 mL conical tubes depending on the number of samples 
· PBS or DPBS 
· Goat Serum 
· Alexafluor-488 Phalloidin 
· Hoescht 
 
Methods: 
1) Gently rinse cells twice in PBS.   
2) Fix cells in 4% paraformaldehyde (4% PFA) and incubate 20 minutes at room temperature 
(RT). 
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3) Collect 4% PFA into specified waste container. 
4) Rinse cells twice in PBS for 5 minutes each.*  
5) Permeabilize the cells with 0.25% Triton-X 100 in dH2O for 10 minutes at RT. 
6) Rinse cells twice in PBS for 5 minutes each.  
7) Block with 1.5% goat serum (GS) in PBS for 30 minutes at RT. 
8) Add primary antibody diluted in 1.5% GS in PBS (dilution 1:100); incubate for 1 hour at 
RT.* 
9) Wash three times in PBS for 5 minutes each.  
1. Add secondary antibody diluted in 1.5% GS in PBS (dilution 1:400); incubate for 45 minutes 
at RT – SAMPLES SHOULD BE PREOTECTED FROM LIGHT FROM THIS POINT ON! 
Can also be incubated overnight. As it is important to keep the sample hydrated, I place 35 
mm petri dishes (with coverslips inside) within a 100 ml petri dish along with a PBS soaked 
kim wipe) 
10) Rinse three times with PBS for 5 minutes each. 
11)  Stain with Alexa fluor-488 phalloidin for 40 minutes (dilute stock 1:100 in PBS) 
12) Counter stain with Hoechst dye (1:6000; 1.67 μg/ml in dH2O) for 2 minutes. 
13) Rinse twice with PBS.  
14) Coverslip using aqueous (non-organic) mounting medium (Prolong Gold), especially on 
plastic plates and chamber slides. PROTECT FROM LIGHT! 
 
* STOPPING POINTS: 
Step 4 – Fixed cells can be stored in PBS at 4°C if they cannot be stained right away 
Step 6 – Primary antibody incubation can be carried out overnight at 4°C if plates/wells/slides are 
humidified (wet paper towels, etc.) to prevent drying. Overnight incubation at 4°C may work 
BETTER for some primary antibodies 
Step 11 – Stained slides can be photographed later, but it’s best not to wait too long. SAMPLES 
MUST BE PROTECTED FROM LIGHT (wrap in aluminum foil) to prevent loss of fluorescent 
signal.  
Cover slipping protocol 
Materials: 
· Stained sample 
· Tweezers 
· Prolong Gold, Life Technologies 
· Shur-Mount, Tedpella, 
· Disposable transfer pippet 
· 25 mm glass coverslips (assuming 22 mm square samples) 
· Glass slide 
· Clear nail polish 
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Methods: 
Label your slides appropriately. 
Carefully take coverslip from staining dish. If wet, gently blot the back with a kim wipe to dry. 
Using transfer pippet, place a large droplet of shur-mount on to glass slide. Be careful as to not get 
any bubbles in the shur-mont. 
Carefully place the sample (with the surface that is not of interest to you, ie. the side of the samples 
that do not have any cells on it) onto the droplet of Shur-mount. 
Allow to harden for 1-2 minutes before proceeding to the next step. 
For a 22 mm coverslip, use 30 μL of Prolong gold. Gently tilt the slide so the prolong gold droplet 
goes all over the sample surface. If there are bubbles, carefully pop them using a scalpel. Take care 
not to hit your sample. 
Using a 25mm glass coverslip (so its slightly larger than your sample) and tweezers (or if you are 
more comfortable without using tweezers), gently place the coverslip on top of the prolong gold 
droplet. Be very careful to not get bubbles in the prolong gold as this will make your imaging 
difficult. 
Seal the edges of coverslip with clear nail polish 
Image within 5 days for best results. 
 
Notes: Toluene mounting media (Shur-mount) will harden when exposed to air. Take care with 
storage, close the bottle well, so that it does not harded. Prolong gold as well as Shur-mount can be 
stored at room temperature. 
A.19 Staining for α-SMA, Phalloidin, and alkaline phosphatase  
Alkaline Phosphatase Staining Protocol_v1 
HC with VL 10/14/2015 
 
Samples: Cultured cells on glass coverslips or polyacrylamide gels 
Primary Antibody: Monoclonal anti-alkaline phosphatase produced in goat 
Secondary Antibody: anti-goat IgG-Alexa 568 produced in donkey; conjugated to AlexaFluor 546 
[Invitrogen, cat# A-11057] 
Materials: 
· Four Eppendorf tubes or 15 mL conical tubes depending on the number of samples 
· PBS or DPBS 
· Goat Serum 
· Alexafluor488 Phalloidin 
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· Hoescht 
For slides- first: Deparaffinize 
1. Heat slides to 60C for 10 mins (oven) 
2. Xylene 1 for 10 mins 
3. Xylene 2 for 10 mins 
4. 100% ethanol for 2 mins (dehydration) 
5. 95% ethanol for 2 mins (rehydration) 
6. 70% ethanol for 2 mins (rehydration) 
7. DI water for 5 mins (change DI 5 times; 1x/min) 
 
Methods: 
15) Gently rinse cells twice in PBS.   
16) Fix cells in 4% paraformaldehyde (4% PFA) and incubate 20 minutes at room temperature 
(RT). 
17) Collect 4% PFA into specified waste container. 
18) Rinse cells twice in PBS for 5 minutes each.*  
19) Permeabilize the cells with 0.25% Triton-X 100 in dH2O for 10 minutes at RT. 
20) Rinse cells twice in PBS for 5 minutes each.  
21) Block with 1.5% goat serum (GS) in PBS for 30 minutes at RT. 
22) Add primary antibody diluted in 1.5% GS in PBS (dilution 1:50); incubate for 1 hour at RT.* 
23) Wash three times in PBS for 5 minutes each.  
2. Add secondary antibody diluted in 1.5% GS in PBS (dilution 1:400); incubate for 45 minutes 
at RT – SAMPLES SHOULD BE PREOTECTED FROM LIGHT FROM THIS POINT ON! 
Can also be incubated overnight. As it is important to keep the sample hydrated, I place 35 
mm petri dishes (with coverslips inside) within a 100 ml petri dish along with a PBS soaked 
kim wipe) 
24) Rinse three times with PBS for 5 minutes each. 
25)  Stain with Alexa fluor-488 phalloidin for 40 minutes (dilute stock 1:100 in PBS) 
26) Counter stain with Hoechst dye (1:6000; 1.67 μg/ml in dH2O) for 2 minutes. 
27) Rinse twice with PBS.  
28) Coverslip using aqueous (non-organic) mounting medium (Prolong Gold), especially on 
plastic plates and chamber slides. PROTECT FROM LIGHT! 
A.20 Staining for vinculin, Phalloidin and Hoescht 
Adapted from Jain lab 
Materials: 
· Cytoskeletal buffer solution (see below) 
· 4% paraformaldehyde 
· Eppendorf tubes 
· Goat serum 
· Vinculin antibody: 
· Alexafluor-488 phalloidin 
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· Hoescht 
· 15 ml conical tube 
Cytoskeleton Buffer Preparation (courtesy of Dr. Anita Shukla) 
1. To prepare 250 mL of Cytoskeleton Buffer  
a. Measure 250 mL milliQ H2O 
b. Add 1.25 mL of triton X-100 
c. Add 25.67 grams sucrose 
d. 730.50 mg sodium chloride 
e. 598.78 mg HEPES 
f. 152.48 mg magnesium chloride-hydrate 
2. Bring pH of the solution to 6.8 using 0.1 N NaOH 
Methods: 
3. Remove growth media from cells 
4. Rinse cells with cytoskeleton buffer to remove soluble proteins.   
5. Rinse with 250 uL PBS 3 times 
6. Add 200 uL of 4% paraformaldehyde to cover the cell monolayer 
7. Incubate at room temperature for approximately 10-15 minutes to complete fixation.  
8. Permeabalize membrane with 0.25% Triton-X-100 for 10 minutes 
9. Block with 4% goat serum in PBS for 30 minutes  
10. Incubate in primary antibody overnight at 4C (Vinculin: 1:800 in 4% goat serum in PBS). As 
it is important to keep the sample hydrated, I place 35 mm petri dishes (with coverslips 
inside) within a 100 ml petri dish along with a PBS soaked kim wipe) 
11. Wash 3x in PBS for 5 minutes 
12. Incubate in secondary antibody for 2 hours at room temperature (1:220 in 2% goat serum in 
PBS) 
13. Wash 3x in PBS for 5 minutes 
14. Rinse three times with PBS for 5 minutes each. 
15.  Stain with Alexa fluor-488 phalloidin for 40 minutes (dilute stock 1:100 in PBS) 
16. Counter stain with Hoechst dye (1:6000; 1.67 μg/ml in dH2O) for 2 minutes. 
17. Rinse twice with PBS.  
18. Coverslip using methods detailed in appendix S with Shurmount and Prolong Gold 
A.21 Staining for YAP, Phalloidin and Hoescht 
Adapted from Jain lab 
Materials: 
· 4% paraformaldehyde 
· Eppendorf tubes 
· Goat serum 
· YAP antibody: 
· Alexafluor-488 phalloidin 
· Hoescht 
· 15 ml conical tube 
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Methods: 
19. Remove growth media from cells 
20. Rinse cells with cytoskeleton buffer to remove soluble proteins.   
21. Rinse with 250 uL PBS 3 times 
22. Add 200 uL of 4% paraformaldehyde to cover the cell monolayer 
23. Incubate at room temperature for approximately 10-15 minutes to complete fixation.  
24. Permeabalize membrane with 0.25% Triton-X-100 for 10 minutes 
25. Block with 4% goat serum in PBS for 30 minutes  
26. Incubate in primary antibody overnight at 4C (YAP: 1:800 in 4% goat serum in PBS). As it is 
important to keep the sample hydrated, I place 35 mm petri dishes (with coverslips inside) 
within a 100 ml petri dish along with a PBS soaked kim wipe) 
27. Wash 3x in PBS for 5 minutes 
28. Incubate in secondary antibody for 2 hours at room temperature (1:220 in 2% goat serum in 
PBS) 
29. Wash 3x in PBS for 5 minutes 
30. Rinse three times with PBS for 5 minutes each. 
31.  Stain with Alexa fluor-488 phalloidin for 40 minutes (dilute stock 1:100 in PBS) 
32. Counter stain with Hoechst dye (1:6000; 1.67 μg/ml in dH2O) for 2 minutes. 
33. Rinse twice with PBS.  
34. Coverslip using methods detailed in appendix S with Shurmount and Prolong Gold 
A.22 Ligand Coating Magnetic Beads 
Materials: 
· Fe3O4 beads ~5μm in diameter [Sigma No. 310069-25G] 
· DPBS (-) 
· 0.1 M NaOH 
· Sonicator 
· 3 mg/mL collagen type I 
· 1 mL centrifuge tube 
· Centrifuge 
· Aspirator 
Procedure: 
1. In centrifuge tube, dilute stock collagen to 1 mg/mL collagen in DPBS by adding 333μL 
of stock collagen to 666μL of DPBS (-).  
2. Measure 0.4g of Fe3O4 beads. Add to collagen solution. 
3. Add 100 μL of 0.1 M NaOH to increase pH to ~7.4 
4. Mix solution vigorously and sonicate for 5 minutes. 
5. Incubate beads in solution for 1 hour in room temperature, occasionally inverting the tube 
for better bead dispersion. 
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6. Rinse beads three times by centrifuging, aspirating solution, and re-suspending in DPBS 
(-). 
7. Sonicate for 5 minutes and place in 4°C fridge or use immediately for best results. 
Sonicate prior to usage.  
A.23 Adding Magnetic Beads to Cell Aggregates 
Materials: 
· Collagen coated Fe3O4 μbeads in DPBS (-) 
· DPBS (-) 
· Cells growing on PA gel coverslip in 35 mm petri dish 
· Culture hood 
· DMEM 
· Incubator 
· Aspirator 
Procedure: 
8. In a cell culture hood, remove old media from petri dish with cells and add 2 mL of fresh 
media.  
9. For a high density of μbeads, add 10 μL of Fe3O4 μbead solution for each 1 mL media.  
10. Gently shake petri dish to disperse μbeads evenly.  
11. Place petri dish in 37°C incubator for 40 minutes. Gently shake petri dish every 10 
minutes to re-disperse μbeads to minimize clumping.  
12. Remove dish from incubator, and aspirate media in hood.  
13. Rinse vigorously with DPBS (-) until excess μbeads are removed. 
14. Add fresh media to cells and check for μbead attachment under a microscope.  
15. Replace petri dish in 37°C  incubator.  
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Appendix B: Supplemental Data 
Appendix B.1 Supporting Information for Chapter 3 
 
 
Design of stretch device 
The custom cell stretch device designed for this project contains four stepper motors with encoders, 
with two in a stacked configuration to apply forces to three of the four corners of the well one 
corner of the well remains stationary during stretch. Schematic of the device is shown in 
Supplementary Figure 1a. The motors are attached using motor mounts to an aluminum sub-plate 
and baseplate which can be placed on-top of a microscope stage for simultaneous stretching and 
imaging, although the stretching was done in a standard incubator for this study. A microchip 
controlled by multi-platform integrated development environment (MPIDE) was used to control the 
motors. Processing® software was used in conjunction with MPIDE to create a graphical user 
interface which allows the operator to select the waveform, stretch magnitude in both x and y 
directions, and frequency. A picture of the graphical user interface is shown in Supplemental Figure 
1b. 
 
Supplementary Figure S1 (a) Schematic of stretch device showing the four stepper motors with 
encoders strategically placed atop a baseplate. The motors are secured to the base plate using 
motor mounts. (b) Graphical user interface for control of the stretch regimen. User can select 
frequency, magnitude of stretch in the x and y directions, as well as the percent of time in extension, 
and percent of cycle time held in extension. Representative waveform of stretch regimen changes in 
real time as user changes the aforementioned settings. 
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Design of custom well 
To preform traction force measurements, a polyacrylamide hydrogel of approximately ~70 um thick 
was covalently attached to our custom well using previously established protocol in our lab 
{Quinlan, 2011 #29}. In order to be able to obtain clear images, the bottom membrane of the culture 
wells had to be < 150 um thick. We decided to manufacture the wells out of polydimethylsiloxane 
(PDMS) as it is relatively inexpensive, optically clear, and non-cytotoxic when fully cured. The molds 
of the PDMS wells were created out of polycarbonate sheets (TAP plastics, Seattle, Washington). A 
metal spacer was used to create the thickness of the membrane so that the entire well and well 
bottom surface could be cast at the same time, ensuring the bottom membrane was perfectly taunt 
allowing better strain transfer. See Supplementary Figure 2 for well dimensions. 
Supplementary Figure S2 : Dimensioned drawing created in Solidworks of a polydimethylsiloxane 
well with attached polyacrylamide gel. The design was optimized to allow for maximal region of 
homogenous strain in the well’s center. Using this design, we are able to get a larger central 
homogenous region when compared to current commercially available wells. All units are in mm. 
Strain field verification- finite element analysis 
Finite element models were created of our wells to allow for analysis to determine design 
parameters which enable a maximally uniform strain field.  A model of our custom well was created 
in Solidworks (Dassault Systems, Waltham, MA). The CAD models were then imported into ANSYS 
Workbench (ANSYS, Canonsburg, PA). All analyses were conducted in the same manner with 
identical settings. Meshes were created with 0.00075 m element size, medium relevance center, 
medium smoothing and medium span angle center, with all other settings set to default. Thermal 
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strain effects were turned off and large deformations were turned on. The analysis was done with 
the program-controlled stepping turned off and the number of sub-steps set to 6, allowing for the 
same time spacing between displacement results for each well. Once the wells were analyzed, 
ImageJ was used to measure the useable area of the well defined as the central region of uniform 
strain. When the wall and membrane thickness were optimized, the uniform area measured 70 mm
2
. 
Strain field verification- high density mapping 
 To measure the strain fields in the wells, a 50:50 mixture of silicon carbide microparticles 
(Silicon carbide 400 grinding compound, Alfa Aesar, Ward Hill, MA) and reflective paint (Scotchlite 
Reflective Ink 8017, 3M, St. Paul, MN) was applied to the cell culture surface in three of 
representative wells to produce a unique light intensity distribution across the well. Videos of the 
wells were recorded across multiple stretch cycles at 5% and 10%  uniaxial nominal strain and 1Hz 
stretch rate and captured using a Fastec Hispec4 camera at 1696x1730 pixels and 60 frames per 
second. Videos were collected such that data spanned at least five cycles. Regional displacement 
fields of the center of the well were computed using our previously published High Density Mapping 
(HDM) technique{Tao, 2013 #927}. Strain fields were computed from displacement fields by 
computing local displacement gradients followed by Green’s strain in MATLAB. Assuming steady 
state, strain fields were averaged across several stretch cycles. 
Validation experiments with additional cell type 
Traction force with long term cyclic stretch 
To confirm our results of a decrease in cell traction force with uniaxial stretch, U2OS cells 
(generously provided by Dr. Roland Kaunas) were cultured and tested under identical conditions. 
U2OS cells were seeded onto stiff (7.5 kPa) polyacrylamide gel which had been attached to custom 
PDMS well. Cells were seeded at low density (3,000 cells/cm
2
) and allowed to attach to gel 
overnight. Cells were stretched for 24 hours, uniaxially at 1 Hertz in 10% CO2. Results are shown in 
Supplemental Figure 3. 
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Supplemental Figure S3: U2OS traction force and area decrease with uniaxial stretch. Cells were 
stretched uniaxially at 1 Hz for 24 hours on 7.5 kPa PA gels attached to PDMS substrates. 
Representative substrate stress plots are shown for (a) static cultured cell and (b) stretched cell. 
Insert of stretch cell scaled to show maximum and minimum stresses. (c) Maximum substrate stress 
was greater for static cells than for stretched cells, p <0.05. (d) Static cells had random orientation 
U2OS that were stretched showed statistically significant alignment perpendicular to stretch, p< 
0.05. (stretch direction was 0-180). (e) Representative fluorescent images of static U2OS cells and (f) 
stretch U2OS. Green is actin cytoskeleton and blue is nuclei. (g) Cell area was trended towards being 
larger for static controls than stretched cells although it was not significant.  h) Shape factor was 
unaffected by stretch. (i) Elongation was unaffected by stretch (j). Cell traction force was 
significantly lower in stretched cells verses controls.  
Reorientation on soft substrates with uniaxial stretch 
To determine if soft substrates alter cell reorientation, GFP labelled U2OS cells cultured on 0.6 kPa 
substrates were subjected to 10% uniaxial stretch. PDMS substrates without polyacrylamide gels 
attached were used as the stiff substrate comparison group and cells on 0.6 kPa static gels were 
used as a control. After 12 hours of stretch, cells were fixed with 4% paraformaldehyde and stained 
for actin (Alexafluor 488 Phalloidin) and nuclei (Hoescht). ImageJ was used to obtain cell area and 
orientation measurements. In agreement with our studies on VICs, U2OS reoriented perpendicular 
to stretch. The average angle of reorientation after stretch was not statically different between stiff 
and soft stretched substrates (p<0.05). See Supplemental Figure 4.
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Supplemental Figure S4: U2OS are capable of reorientation on soft substrates with dynamic stretch.  
(a) % of cell population verses angle of orientation plot for U2OS cells cultured statically on a 0.6 kPa 
substrate, U2OS cells that had undergone 12 hrs cyclic 10% uniaxial stretch on a 0.6 kPa substrate 
and U2OS cells that had undergone 12 hrs cyclic 10% uniaxial stretch on a 1 MPa PDMS cell culture 
well (b) Cell area comparisons between groups. Statistical significance was found in cell area 
between 0.6 kPa PA gel static culture and 0.6 kPa PA gel culture with stretch, as well as 0.6 kPa PA 
static culture and 1 MPa PDMS culture with stretch, p<0.05. No statistical difference in cell area was 
found between 0.6 kPa PA gels culture with stretch and 1 MPa PDMS culture with stretch (ANOVA 
on ranks). (c)Representative image of U2OS cells on a 0.6 kPa PA, static culture. (d) Representative 
image of cells on a 0.6 kPa PA, stretch (e) representative image of cells on a 1 Mpa PDMS well. 
Green=actin, blue= nuclei, sb= 50 μm.  
Alternating stretch effects reorientation 
To ascertain how cells integrate stretch signals over time, GFP labelled U2OS cells were subjected to 
one of three patterns of stretch: 10% uniaxial stretch, 10% equibiaxial stretch, or alternating uniaxial 
stretch (10% uniaxial x-direction stretch, followed by 10% uniaxial y-direction of stretch). Statically 
cultured U2OS cells were used as a control. After 12 hours of stretch, cells were fixed with 4% 
paraformaldehyde and stained for actin (Alexafluor 488 Phalloidin) and nuclei (Hoescht). ImageJ was 
used to obtain cell area and orientation measurements.  In agreement with our studies of VICs, 
statically cultured cells had a random orientation. Uniaxially stretched U2OS reoriented 
perpendicular to stretch, with more than 90% of cells falling within 10 degrees of vertical. No 
reorientation was observed in cells that were stretched equibiaxially or alternating uniaxially, 
although distinct morphological differences were observed. The actin cytoskeleton of equibiaxially 
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stretched groups appeared less robust than other groups, possibly indicating a depolymerization of 
stress fibers as they were stretched above their maximum tension (see Supplemental Figure 5).  The 
cytoskeleton of alternatingly uniaxial stretched groups appeared diamond in shape with peaks at 
approximately 45 degrees from the directions of stretch.  This finding may indicate that the stress 
fibers in the direction of either of the stretch directions depolymerized and those at angles of lower 
stretch were reinforced. To our knowledge this is the first time that the effects of alternating axis 
stretch have been investigated.  
 Supplemental Figure S5: Supplemental Figure S5: U2OS cells reorient most strongly in response to 
uniaxial stretch.  U2OS cells were stretched for 12 hours at either 10% 1 Hz uniaxial stretch, 10% 
equibiaxial stretch, or 10% alternating uniaxial stretch in which the direction of uniaxial stretch was 
alternated every cycle. Representative strain waveforms for x and y directions of device are 
illustrated in a) static b) uniaxial c) equibiaxial and d) alternating directions (x then y) of uniaxial 
stretch. Representative images of each stretch condition are shown for (d) static (e) unaxially (f) 
equibiaxial or (g) alternating stretch cells. Green is actin cytoskelteon, blue is nuclei. Scale bar = 50 
um. 
(h) Orientation response of U2OS cells with respect to stretch waveform are represented with a 0-90 
histogram. Uniaxial stretch was in the 0-180 direction;  Uniaxial stretch most strongly encouraged 
U2OS cells to reorient.  
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Raw Data Scatterplots  
Individual cells were not tracked with stretch over time and numerical values reported in table 1 of 
the manuscript represent population averages. Actual raw data values from control and stretched 
cells are shown in scatterplots below. 
 
Supplemental Figure S6- scatterplots of traction force values for static control cells and stretched 
cells showing distributions of raw data. For cells under high pre-stress conditions (cultured on the 
7.5 kPa substrate and stretched biaxially, uniaxially, or stretched uniaxially in the presence of TGF-β1 
)average traction force decreased with stretch. The opposite was true for cells cultured in low pre-
stress conditions. Cells that were treated with Blebbistatin or on the 0.6 kPa substrate increased 
average traction force with stretch 
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Supplemental Figure S7- scatterplots of maximum substrate stress values for static control cells and 
stretched cells showing distributions of raw data. For cells under high pre-stress conditions (cultured 
on the 7.5 kPa substrate and stretched biaxially, uniaxially, or stretched uniaxially in the presence of 
TGF-β1) average maximum substrate stress decreased with stretch. The opposite was true for cells 
cultured in low pre-stress conditions. Cells that were treated with Blebbistatin or on the 0.6 kPa 
substrate increased average maximum substrate stress with stretch. 
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Supplemental Figure S8- scatterplots of contractile moment for static control cells and stretched 
cells showing distributions of raw data. For cells under high pre-stress conditions (cultured on the 
7.5 kPa substrate and stretched biaxially, uniaxially, or stretched uniaxially in the presence of TGF-
β1) contractile moment followed traction force and decreased significantly in all groups. The 
opposite was true for cells cultured in low pre-stress conditions. Cells that were treated with 
Blebbistatin or on the 0.6 kPa substrate increased contractile moment with stretch. A negative 
contractile moment indicates a cell that is pulling inwards, while a positive contractile moment 
indicates a cell is pushing outward. Blebbistatin caused about half of the control cells and all of the 
stretched cells to have a positive contractile moment. It is possible with myosin motors inhibited, 
outward actin polymerization predominates creating the outward pushing motion. Numerical values 
of mean contractile force and significance are shown in table 1 of the manuscript. 
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Supplemental Figure 9- scatterplots of cell area values for static control cells and stretched cells 
showing distributions of raw data. For cells under high pre-stress conditions (cultured on the 7.5 kPa 
substrate and stretched biaxially, uniaxially, or stretched uniaxially in the presence of TGF-β1) 
average cell area with stretch. The opposite was true for cells cultured in low pre-stress conditions. 
Cells that were treated with Blebbistatin or on the 0.6 kPa substrate increased average cell area with 
stretch. Numerical values and significance are shown in table 1 of the manuscript. 
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Supplemental Figure S10- scatterplots of form factor values for static control cells and stretched 
cells showing distributions of raw data. Numerical values and significance are shown in table 1 of the 
manuscript. 
 
Supplemental Figure 11- scatterplots of extension ratio values for static control cells and stretched 
cells showing distributions of raw data. No changes in extension were seen with stretch except for 
the 0.6 kPa group, when increased cellular extension was significant. Numerical values and 
significance are shown in table 1 of the manuscript. 
 
Supplemental Figure 12- Representative images of cell outline (in blue), displacement vectors (blue 
arrows), and contractile moment (red oval). a) For static cells treated with blebbistatin, half of the 
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cells had an inward contractile moment, while others had an outward contractile moment. 
Examination of displacement vectors shows localized regions with outward displacements and 
inward displacements. Whether the static cells had a positive or negative contractile moment 
appeared random and did not show a trend with time of data acquisition. b) Stretched cells all had 
outward pushing displacements and positive contractile moment. 
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Chapter 4: Supporting Information for a Controlled In Vitro Model of 
Calcific Aortic Valvular Disease 
 
 
Supplementary Figure 4.1: Micro-contact printing method allows for tight control of aggregate 
size. a) Aggregates created with micro-contact printing have < 4% variability in size. This control over 
sizes allows for repeatable calcification time-courses b) Number of cells contained within the 
aggregate increases with aggregate size. 
 
 
Supplementary Figure 4.2: Cell area of cells within aggregates does not change with aggregate 
geometry. Cell area was determined by measuring aggregate area and dividing the area by the 
number of nuclei within the aggregate. 
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Chapter 5: Supporting Information for The Distribution of Tension 
within Valvular Interstitial Cell Aggregates and Its Role in Disease 
Initiation 
Representative confocal z-stack showing aggregates are monolayer. 
 
Supplementary Figure- Z-stack of 200 µm aggregate on 38 kPa PA gel. Aggregates are believed to 
be monolayers as nuclei do not appear on top of one another. Additionally, aggregates are 
relatively think, between 8-16 µm tall on average. Images shown above are 1 µm step size apart; 
aggregate height in this representative stack is 8 µm. 
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Appendix C: List of Copy Righted Material and Reprint Permissions 
 
Appendix C.1: Chapter 2 Reprint Permissions 
 
Figure 2.2  was previously published and is approved for noncommercial and educational use 
provided that the original source and the applicable copyright notice are cited. 
 
Aortic-Valve Stenosis — From Patients at Risk to Severe Valve Obstruction 
New England Journal of Medicine  
 
Figure 2.5 was previously published in an open access journal and no permission is required 
from the authors or the publishers so long as the original authors and source are cited.  
 
Hemodynamics and mechanobiology of aortic valve inflammation and calcification. 
International Journal of Inflammation 
 
Figure 2.5 was previously published and copy right permissions were obtained from publisher. 
 
Investigating the role of substrate stiffness in the persistence of valvular interstitial cell activation 
Journal of Biomedical Materials Research 
License Number: 3776620008441 
 
Figure 2.6- was previously published in an open-access article distributed under the terms of 
the Creative Commons Attribution License, which permits unrestricted use, distribution, and 
reproduction in any medium, provided the original author and source are credited. 
 
Combining Dynamic Stretch and Tunable Stiffness to Probe Cell Mechanobiology In Vitro  
Cell 
 
Figure 2.8 was previously published and copyright permissions were obtained from publisher 
 
 
Figure 2.10 was previously published in an open-access article distributed under the terms of 
the Creative Commons Attribution License, which permits unrestricted use, distribution, and 
reproduction in any medium, provided the original author and source are credited. 
 
Role of apoptosis in Disease 
Aging 
 
Figure 2.10 was previously published and copyright permissions were obtained from publisher 
 
Figure 2.12 was previously published and copy right permissions were obtained from publisher. 
 
Alpha-smooth muscle actin expression enhances cell traction force 
Cytoskeleton 
License Number: 3776590570933 
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Figure 2.13 was previously published and copy right permissions were obtained from publisher. 
 
Decoupling Substrate Stiffness, Spread Area, and Micro-post Density: A Close Spatial 
Relationship between Traction Forces and Focal Adhesions 
Biophysical Journal 
License Number: 3776591081907  
 
Figure 2.14 was previously published and permission is not required for reproduction in a 
thesis/dissertation.  
 
Cell prestress. I. Stiffness and prestress are closely associated in adherent contractile cells 
American Journal of Physiology-Cell Physiology 
 
Figure 2.15  was previously published and is approved for noncommercial and educational use 
provided that the original source and the applicable copyright notice are cited. 
 
Emergent Patterns of Growth Controlled by Multicellular Form and Mechanics. 
Proceedings of the National Academy of Sciences of the United States of America 
 
 
 
The following subsections originally appeared in Cirka et al. “Mechanoregulation of Valvular 
Interstial Cell Life and Death” and are reproduced within this document with written permission 
from Begell Publishing House: 
 
2.3 Valvular Interstitial Cell Mechanobiology 
2.3.1 Cell-ECM and cell-cell connections 
2.3.2 Mechanical characterization of VIC phenotype 
2.3.3 Effect of substrate modulus on VIC phenotype and apoptosis 
2.3.4 Cyclic stretch regulation of VIC phenotype and apoptosis 
2.3.5 Integration of multiple mechanical signals 
2.3.6 Interactions between mechanical and soluble stimuli 
2.4 In Vitro Models of Calcific Aortic Valve Disease 
2.4.1 Mechanoregulation of calcification 
2.4.2 Mechanoregulation of apoptosis 
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